US20050038419A9 - Coaxial catheter instruments for ablation with radiant energy - Google Patents

Coaxial catheter instruments for ablation with radiant energy Download PDF

Info

Publication number
US20050038419A9
US20050038419A9 US10/357,156 US35715603A US2005038419A9 US 20050038419 A9 US20050038419 A9 US 20050038419A9 US 35715603 A US35715603 A US 35715603A US 2005038419 A9 US2005038419 A9 US 2005038419A9
Authority
US
United States
Prior art keywords
instrument
radiant energy
light
energy
energy emitter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/357,156
Other versions
US20040006333A1 (en
US8025661B2 (en
Inventor
Jeffrey Arnold
Edward Sinofsky
Lincoln Baxter
Norman Farr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiofocus Inc
Original Assignee
Cardiofocus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/827,631 external-priority patent/US5908415A/en
Priority claimed from US08/991,130 external-priority patent/US5947959A/en
Priority claimed from US09/357,355 external-priority patent/US6423055B1/en
Priority claimed from US09/390,964 external-priority patent/US6270492B1/en
Priority claimed from US09/602,420 external-priority patent/US6572609B1/en
Priority claimed from US09/924,393 external-priority patent/US6676656B2/en
Priority to US10/357,156 priority Critical patent/US8025661B2/en
Application filed by Cardiofocus Inc filed Critical Cardiofocus Inc
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARR, NORMAN E., SINOFSKY, EDWARD L., ARNOLD, JEFFREY M., BAXTER, LINCOLN S.
Publication of US20040006333A1 publication Critical patent/US20040006333A1/en
Priority to JP2006503305A priority patent/JP4732330B2/en
Priority to AU2004208838A priority patent/AU2004208838A1/en
Priority to EP04707827A priority patent/EP1592358A2/en
Priority to PCT/US2004/003141 priority patent/WO2004069072A2/en
Priority to CA002515029A priority patent/CA2515029A1/en
Priority to US10/865,558 priority patent/US8540704B2/en
Publication of US20050038419A9 publication Critical patent/US20050038419A9/en
Priority to US11/062,903 priority patent/US20050234437A1/en
Priority to US11/062,906 priority patent/US20050222558A1/en
Priority to US11/062,774 priority patent/US20050234436A1/en
Priority to US11/062,905 priority patent/US7935108B2/en
Assigned to VENTURE LENDING & LEASING IV, INC. reassignment VENTURE LENDING & LEASING IV, INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARDIOFOCUS, INC.
Priority to US11/481,204 priority patent/US8241272B2/en
Priority to US11/504,354 priority patent/US8277444B2/en
Priority to US12/423,178 priority patent/US9033961B2/en
Priority to US12/423,137 priority patent/US8900219B2/en
Priority to US12/424,757 priority patent/US8366705B2/en
Priority to US12/501,206 priority patent/US20090275934A1/en
Priority to US13/099,070 priority patent/US8231613B2/en
Priority to US13/099,105 priority patent/US8267932B2/en
Publication of US8025661B2 publication Critical patent/US8025661B2/en
Application granted granted Critical
Priority to US13/353,086 priority patent/US8444639B2/en
Priority to US13/545,295 priority patent/US20130012923A1/en
Priority to US13/952,013 priority patent/US20140031802A1/en
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. RELEASE OF SECURITY INTEREST Assignors: VENTURE LENDING & LEASING IV, INC.
Assigned to OXFORD FINANCE LLC, SILICON VALLEY BANK reassignment OXFORD FINANCE LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARDIOFOCUS, INC.
Priority to US14/530,002 priority patent/US9421066B2/en
Adjusted expiration legal-status Critical
Assigned to SILICON VALLEY BANK, OXFORD FINANCE LLC reassignment SILICON VALLEY BANK SECURITY AGREEMENT Assignors: CARDIOFOCUS, INC.
Priority to US15/380,637 priority patent/US9861437B2/en
Assigned to SILICON VALLEY BANK, SOLAR CAPITAL LTD. reassignment SILICON VALLEY BANK SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARDIOFOCUS, INC.
Assigned to GPB DEBT HOLDINGS II LLC reassignment GPB DEBT HOLDINGS II LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARDIOFOCUS, INC.
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: OXFORD FINANCE LLC, SILICON VALLEY BANK
Assigned to KENNEDY LEWIS INVESTMENT MANAGEMENT LLC reassignment KENNEDY LEWIS INVESTMENT MANAGEMENT LLC INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: CARDIOFOCUS, INC.
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: SILICON VALLEY BANK, SOLAR CAPITAL LTD.
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: OXFORD FINANCE LLC, SILICON VALLEY BANK
Assigned to CARDIOFOCUS, INC. reassignment CARDIOFOCUS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: GPB DEBT HOLDINGS II, LLC
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A61B18/245Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/10Ultra-violet radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • A61B2017/00061Light spectrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00964Features of probes
    • A61B2018/0097Cleaning probe surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2261Optical elements at the distal end of probe tips with scattering, diffusion or dispersion of light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2266Optical elements at the distal end of probe tips with a lens, e.g. ball tipped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2272Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
    • A61B2090/065Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia

Definitions

  • the present invention relates to ablation instruments for ablation of tissue for the treatment of diseases, and, in particular, to percutaneous instruments employing radiant energy. Methods of ablating tissue using radiant energy are also disclosed.
  • the instruments can be used, for example, in the treatment of cardiac conditions such as cardiac arrhythmias.
  • Cardiac arrhythmias are irregularities in the normal beating pattern of the heart and can originate in either the atria or the ventricles.
  • atrial fibrillation is a form of arrhythmia characterized by rapid randomized contractions of atrial myocardium, causing an irregular, often rapid ventricular rate.
  • the regular pumping function of the atria is replaced by a disorganized, ineffective quivering as a result of chaotic conduction of electrical signals through the upper chambers of the heart.
  • Atrial fibrillation is often associated with other forms of cardiovascular disease, including congestive heart failure, rheumatic heart disease, coronary artery disease, left ventricular hypertrophy, cardiomyopathy or hypertension.
  • the pulmonary vein has been identified as one of the origins of errant electrical signals responsible for triggering atrial fibrillation.
  • circumferential ablation of tissue within the pulmonary veins or at the ostia of such veins has been practiced to treat atrial fibrillation.
  • ablation of the region surrounding the pulmonary veins as a group has also been proposed.
  • ablation devices have recently been proposed for creating lesions to treat cardiac arrhythmias, including devices which employ electrical current (e.g., radiofrequency “RF”) heating or cryogenic cooling. Such ablation devices have been proposed to create elongated lesions that extend through a sufficient thickness of the myocardium to block electrical conduction. Many of the recently proposed ablation instruments are percutaneous devices that are designed to create such lesions from within the heart. Such devices are positioned in the heart by catheterization of the patient, e.g., by passing the ablation instrument into the heart via a blood vessel, such as the femoral vein.
  • a blood vessel such as the femoral vein.
  • Charring of the surface of the heart tissue can lead to the creation of blood clots on the surface and post-operative complications, including stroke. Even if structural damage is avoided, the extent of the lesion (i.e., the width of the ablated zone) on the surface that has been contacted will typically be greater than necessary.
  • Ablation devices that do not require direct contact have also been proposed, including acoustic and radiant energy.
  • Acoustic energy e.g., ultrasound
  • Laser energy has also been proposed but only in the context of devices that focus light into a scalpel-like point or similar high intensity spot pattern. When the light energy is delivered in the form of a focused spot, the process is inherently time consuming because of the need to expose numerous spots to form a continuous linear or curved lesion.
  • a guide wire or similar guide device is advanced through the left atrium of the heart and into a pulmonary vein.
  • a catheter instrument with an expandable element is then advanced over the guide and into the pulmonary vein where the expandable element (e.g., a balloon) is inflated.
  • the balloon structure also includes a circumferential ablation element, e.g., an RF electrode carried on the outer surface of the balloon, which performs the ablation procedure.
  • the balloon must be large enough and sufficiently rigid to hold the electrode in contact with the inner surface of the pulmonary vein for the length of the procedure.
  • the balloon shape inherently limits the locations where a lesion can be formed, i.e., the lesion must be formed at least partially within the pulmonary vein.
  • a guide wire is again used to percutaneously access a pulmonary vein and a catheter is again slid over the guide to a position within the pulmonary vein.
  • the catheter device includes two spaced-apart balloons, which are inflated in the vein (or in the vein and at its mouth). The space between the two balloons can then be filled with a conductive fluid to delivery RF energy (or, alternatively, ultrasound) to the vein and thereby induce a conduction block in the blood vessel by tissue ablation.
  • RF energy or, alternatively, ultrasound
  • Ablation within the pulmonary vein can result in complications. Overtreatment deep within a vein can result in stenosis (closure of the vein itself), necrosis or other structural damage, any of which can necessitate immediate open chest surgery.
  • each prior art percutaneous instrument is inherently limited by its design to forming an ablative lesion at one and only one location.
  • the lesion can only be formed at a location defined by the geometry of the device. It is not possible to form the lesion at another location because the heating element must contact the target tissue.
  • the above-described tandem balloon device can only form a lesion at a location defined by the space between the balloons that is filled with the ablative fluid.
  • a percutaneous ablation device that allowed the clinician to select the location of the ablation site would be highly desirable.
  • the prior art devices typically can not determine whether continuous circumferential contact has been achieved before heating commences. These devices most often rely on post-ablation electrical mapping to determine whether a circumferential lesion has been formed. If electric conduction is still present, the encircling lesion is incomplete and the procedure must be repeated or abandoned.
  • percutaneous ablation instruments in the form of coaxial catheter bodies having at least one central lumen therein and having one or more balloon structures at the distal end region of the instrument.
  • the balloon structure and catheter bodies are at least partially transmissive to ablative energy.
  • the instruments can further include an energy emitting element, which is independently positionable within the lumen of the instrument and adapted to project ablative energy through a transmissive region of the balloon to a target tissue site. The energy is delivered without the need for contact between the energy emitter and the target tissue because the methods and devices of the present invention do not rely upon conductive or resistive heating. Because the position of the radiant energy emitter can be varied, the clinician can select the location of the desired lesion.
  • determining whether the instrument has been properly seated within the heart e.g., whether the device is in contact with a pulmonary vein and/or the atrial surface, in order to form a lesion by heating, cooling or projecting energy.
  • This contact-sensing feature can be implemented by an illumination source situated within the instrument and an optical detector that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved and whether such contact is continuous over a desired ablation path.
  • the instruments are especially useful in percutaneous access cardiac surgery for rapid and efficient creation of curvilinear lesions to serve as conduction blocks.
  • the instruments are designed to create lesions in the atrial tissue in order to electrically decouple tissue segments on opposite sides of the lesion while presenting low profiles during percutaneous access and retraction.
  • the instruments of the present invention permit the formation of continuous lesions in the atrial wall tissue of the heart, such that the continuous lesion can surround a organ structure, such as a pulmonary vein, without involving the structure itself.
  • a cardiac ablation instrument having a catheter body adapted for disposition within a heart.
  • This catheter body has at least one lumen therein and an expandable, energy-transmitting element which can be deployed at the desired location with or without an anchorage element to contact a cardiac structure and establish a transmission pathway.
  • the expandable element can be a projection balloon that is expandable to fill the space between the energy emitter and the target tissue with an energy-transmissive fluid and, thereby, provide a transmission pathway for projected radiant energy.
  • the instrument further includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site.
  • the instrument can further include additional elements, such fluid delivery ports, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • a cardiac ablation instrument having a catheter body adapted for disposition within a heart and at least one anchorage element which can be deployed at the desired location to contact a cardiac structure and secure the device in place.
  • the instrument again includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site.
  • a projection balloon can again be employed, alone or together with fluid releasing mechanisms, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • Mechanisms are disclosed for determining whether the ablation instruments of the present invention have been properly seated within the heart to form a lesion. For example, if a projection balloon is employed to provide a clear transmission pathway from a radiant energy emitter to the target tissue, the mechanisms of the present invention can sense whether contact has been achieved between the balloon and the target tissue (and/or whether the pathway for projection of radiant energy has been otherwise cleared of obstructions). In one embodiment, this contact-sensing feature can be implemented by an illumination fiber situated within the instrument and an optical detector fiber (or fiber assembly) that monitors the level of reflected light.
  • Measurements of the reflected light can thus be used to determine whether contact has been achieved between the projecxtion balloon and the target tissue, whether blood has been cleared from any gaps and whether a clear and continuous transmission pathway has been established over a desired ablation path.
  • percutaneous instruments are disclosed that can achieve rapid and effective photoablation through the use of tissue-penetrating radiant energy.
  • radiant energy e.g., projected electromagnetic radiation or ultrasound
  • controlled penetrating radiant energy can be used to simultaneously deposit energy throughout the full thickness of a target tissue, such as a heart wall, even when the heart is filled with blood. Radiant energy can also produce better defined and more uniform lesions.
  • radiant energy in conjunction with catheter structures that are substantially transparent to such radiation at the therapeutic wavelengths, is particularly advantageous in affording greater freedom in selecting the location of the lesion, e.g., the site is no longer limited to the pulmonary vein itself. Because the energy can be projected onto the tissue, a ring-like lesion can be formed in atrial tissue at a distance from the vein, thereby reducing the potential for stenosis and/or other damage to the vein itself.
  • the instruments emit radiation at a wavelength in a range from about 800 nm to about 1000 nm, and preferably emit at a wavelength in a range of about 915 nm to about 980 nm. Radiation at a wavelength of 915 nm or 980 nm is commonly preferred, in some applications, because of the optimal absorption of infrared radiation by cardiac tissue at these wavelengths.
  • focused ultrasound energy can be used to ablate cardiac tissue.
  • an ultrasound transducer can be employed to transmit frequencies within the range of about 5 to about 20 MHz, and preferably in some applications within the range of about 7 MHz to about 10 MHz.
  • the ultrasonic emitter can include focusing elements to shape the emitted energy into an annular beam.
  • radiant energy can also be useful including, but not limited to, other wavelengths of light, other frequencies of ultrasound, x-rays, gamma-rays, microwave radiation and hypersound.
  • the energy delivering element can include a light transmitting optical fiber adapted to receive ablative radiation from a radiation source and a light emitting tip at a distal end of the fiber for emitting radiation.
  • the light delivering element can be slidably disposed within an inner lumen of the catheter body and the instrument can further include a translatory mechanism for disposing the tip of the light delivering element at one or more of a plurality of locations with the catheter.
  • the diameter of the projected ring of energy can be readily varied, thereby permitting the clinician control over the location (and size) of the lesion to be formed.
  • a fluid can be disposable between the radiant energy delivery element and the target region.
  • a “projection balloon” is filled with a radiation-transmissive fluid so that radiant energy from the energy emitter can be efficiently pass through the instrument to the target region.
  • the fluid can also be used to cool the energy emitter.
  • it can be desirable to used deuterium oxide (so-called “heavy water”) as a balloon-filling fluid medium because of its loss absorption characteristics vis-a-vis infrared radiation.
  • the inflation fluid can be water or saline.
  • an “ablative fluid” in this context is any fluid that can serve as a conductor of the radiant energy.
  • This fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation.
  • the fluid is released via one or more exit ports in the housing and flows between the projection balloon and the surrounding tissue, thereby filling any gaps where the balloon does not contact the tissue.
  • the fluid can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere because of the highly absorptive nature of blood with respect to radiant light energy.
  • aqueous coupling fluids can be used to ensure high transmission of the energy to the tissue (and likewise displace blood that might interfere with the radiant acoustic energy transfer).
  • the ablative fluids of the present invention can also include various other adjuvants, including, for example, photosensitizing agents, pharmacological agents and/or analgesics.
  • contact sensing mechanisms are also disclosed to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion.
  • the sensor employs a plurality of reflection sensors that indicate whether or not a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • coaxial catheter instruments disclosed herein are of particular use in percutaneous applications whereby a balloon catheter with an ablative light or ultrasound projecting assembly can be disposed within a patient's heart.
  • dual, coaxial balloon structures are disclosed, having both a projection balloon and an anchoring balloon to assist in the properly disposition of the instrument.
  • the catheter instrument can include at least one expandable anchor balloon disposed about, or incorporated into an inner catheter body designed to be slid over a guidewire.
  • This anchor balloon is generally or substantially sealed and serves to position the device within a lumen, such as a pulmonary vein.
  • the anchor balloon structure when filled with fluid, expands and is engaged in contact with tissue, e.g., the inner surface of a pulmonary vein.
  • a second catheter carrying the projection balloon can then be slid over the first (anchor balloon) catheter body and inflated within the heart, e.g., within the left atrium and adjacent to the pulmonary vein where the anchor balloon has already been placed.
  • the expanded projection balloon thus defines a staging from which to project radiant energy in accordance with the invention.
  • An energy emitting element can then be introduced via an inner lumen to project radiant energy, e.g., infrared light or ultrasound, through the coaxial catheter bodies and the projection balloon to form a lesion at the target treatment site.
  • the instrument can also include an irrigation mechanism for delivery of an ablative fluid at the treatment site.
  • irrigation is provided by a sheath, partially disposed about the projecting balloon, and provides irrigation at a treatment site (e.g. so that blood can be cleared from an ablation site).
  • Both the anchor and projection balloon structures can be deflated by applying a vacuum which removes the fluid from the balloons.
  • the coaxial instrument can be removed from the body lumen either as an ensemble, or as individual elements (starting with the innermost element).
  • the energy delivery element can be removed (via an inner lumen balloon structure), followed by the projection balloon catheter and then the anchor balloon catheter.
  • the invention can also be used in conjunction with one or more mapping catheters.
  • the guide wire element and/or the anchorage balloon catheter
  • the present invention also provides methods for ablating tissue.
  • One method of ablating tissue comprises positioning a radiant energy emitting element at a distance from a target region of tissue, providing a blood-free transmission pathway between the emitter and the target region, and then projecting radiant energy to expose the target region and induce a lesion.
  • a guide wire is first inserted into the femoral vein and advanced through the inferior vena cava, and into the right atrium, or, if required, it is guided into the left atrium via an atrial septal puncture. In either event, the guide wire is advanced until it enters a pulmonary vein.
  • the first catheter body is then slid over the guide wire until its anchorage element, e.g., the anchor balloon, is likewise advanced into the pulmonary vein.
  • the anchor balloon is then inflated via an inflation fluid to secure the first catheter body.
  • a second catheter body is advanced, coaxially, over the first catheter body, carrying a projection balloon to the treatment site. Once the projection balloon is proximate to the target tissue ablation site, it can likewise be inflated.
  • a solution can be injected through the instrument to force blood and/or body fluids away from the treatment site.
  • the guide wire is then removed and replaced with the radiant energy emitter, which is positioned to deliver radiant energy through the projection balloon to induce tissue ablation.
  • the methods of the present invention can further include a position sensing step to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion.
  • one or more reflection sensors are activated to determine whether a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • the radiant energy emitter is removed from the central lumen of the first catheter body.
  • the anchor balloon can then be deflated by applying a vacuum that removes the inflation fluid from the balloon.
  • a syringe or other known methods can be used to remove the fluid.
  • the anchor balloon can be deflated first and removed along with the first (inner) catheter body.
  • the first catheter body can then be replaced with a mapping catheter.
  • the mapping catheter can then be activated to determine whether a conduction block has been achieved. If the ablation is successful, the mapping catheter can be removed. If conduction is still present, the procedure can be repeated, for example, by reintroducing the second catheter body, followed by removal of the mapping catheter, and repositioning the anchor balloon and the radiant energy emitter.
  • FIG. 1 is a schematic, cross-sectional view of a coaxial catheter ablation instrument according to the invention
  • FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire is introduced into a heart and passed into a pulmonary vein;
  • FIG. 3 is a schematic illustration of another step in performing ablative surgery with radiant energy according to the invention, in which a first catheter, carrying an anchoring balloon structure, is slid over the guide wire;
  • FIG. 4 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which an anchoring balloon structure is inflated;
  • FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter, carrying a projection balloon element, is slid over the first catheter body;
  • FIG. 6 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon element of the second catheter is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • FIG. 8 is a schematic illustration of a step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a defined location;
  • FIG. 9 is a schematic illustration of an alternative step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a different defined location;
  • FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter is removed and the anchor balloon element of the first catheter is deflated to permit removal of the first catheter body;
  • FIG. 11 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the first catheter is replaced by a mapping electrode;
  • FIG. 12 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block;
  • FIG. 13 is a schematic illustration of alternative approach to ablative surgery with radiant energy according to the invention, in which a catheter carrying an projection balloon structure, is slid over a guide wire without first introducing an anchoring balloon catheter;
  • FIG. 14 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13 , in which the projection balloon element is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13 , in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • FIG. 16 is a schematic illustration of a system according to the invention in which an asymmetric vein mouth is encountered and further showing how the position of the radiant energy emitter can be adjusted to sense contact and select a location;
  • FIG. 16A illustrates how a continuous, vein-encircling lesion can be formed by two partially-encircling lesions;
  • FIG. 17 is a schematic illustration of one embodiment of a radiant light energy emitter according to the invention.
  • FIG. 18 is a schematic illustration of another embodiment of a radiant light energy emitter according to the invention.
  • FIG. 19 is a schematic illustration of an alternative embodiment of a radiant energy emitter according to the invention employing ultrasound energy
  • FIG. 20 is a schematic illustration of an alternative embodiment of a radiant light energy emitter according to the invention employing microwave or ionizing radiation;
  • FIG. 21 is a schematic cross-sectional illustration of one embodiment of a contact sensor according to the invention.
  • FIG. 22 is an end view, schematic illustration of the contact sensor elements shown in FIG. 21 ;
  • FIG. 23 is a schematic view of a contact heating ablation device employing the contacting sensing apparatus of the present invention
  • FIG. 23A is a schematic view of a croygenic ablation device employing the contacting sensing apparatus of the present invention
  • FIG. 23B is a schematic view of a ultrasound heating ablation device employing the contacting sensing apparatus of the present invention
  • FIG. 24 is a schematic illustration of a mechanism for positioning the radiant energy emitter at a selected location relative to the target tissue region.
  • FIG. 1 provides a schematic, cross-sectional view of a coaxial catheter ablation instrument 10 according to the invention, including a first, inner catheter 12 having an elongate body 14 and an anchor balloon 16 , inflatable via one or more ports 18 .
  • a fluid for inflating the anchor balloon can be delivered through a passageway (not shown) within the elongate body or via one or more of the lumens of the device, as discussed in more detail below.
  • the device can further include a second, coaxial, outer catheter 20 having an elongate body 24 and a projection balloon 26 inflatable via one or more ports 22 .
  • the instrument is preferably designed such that upon anchorage of the anchor balloon 16 within the heart (e.g., within a pulmonary vein), the projection balloon can be inflated such a shoulder portion 50 of the balloon 26 will be urged into close proximity with a target region 52 of cardiac tissue (e.g. an annular region of the atrial heart wall surrounding the ostium of a pulmonary vein).
  • a target region 52 of cardiac tissue e.g. an annular region of the atrial heart wall surrounding the ostium of a pulmonary vein.
  • the instrument can also include one or more ports 36 (in fluid communication with either the first catheter 12 or second catheter 20 , or both) for delivering ablative fluid to the target region.
  • the ablative fluid is an energy transmissive medium, which helps deliver light, radiation or acoustic energy from a radiant energy source to a target tissue region.
  • the ablative fluid also serves to clear blood from the vicinity of the instrument and compensate for irregularities in the shape of the heart that might otherwise compromise the seating of the instrument. The ablative fluid thus provides a clear transmission pathway external to the balloon.
  • a radiant energy emitter 40 can be disposed remotely from the target tissue (e.g., within a central lumen of the coaxial catheters 12 , 20 ).
  • the radiant energy source includes at least one optical fiber 42 coupled to a distal light projecting, optical element 44 , which cooperate to project ablative light energy through the instrument to the target site.
  • the catheter bodies, projection balloon and inflation/ablation fluids are all preferably substantially transparent to the radiant energy at the selected wavelength to provide a low-loss transmission pathway from the projection element 44 to the target.
  • FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire 6 is introduced into a heart 2 and passed into a pulmonary vein 4 .
  • FIG. 3 illustrates the next step in performing ablative surgery according to the invention, in which a first catheter 12 , carrying an anchoring balloon structure 16 , is slid over the guide wire 6 .
  • This first catheter 12 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 12 , which is sealed to the body of the catheter 14 by distal seal 15 and proximal seal 17 , such that the introduction of an inflation fluid into the balloon 16 can inflate the balloon as shown in FIG. 4 .
  • an inflation fluid into the balloon 16 can inflate the balloon as shown in FIG. 4 .
  • FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter 20 , likewise having a elongated body 24 and carrying a projection balloon element 26 , is slid over the first catheter body 14 .
  • This second catheter 20 also includes at least one internal fluid passageway (not shown) for inflation of the balloon 26 , which is sealed to the body 24 of the catheter 20 by distal seal 21 and proximal seal 22 , such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon as shown in FIG. 6 .
  • FIG. 6 illustrates how which the projection balloon 26 of the second catheter 20 can be deployed and inflated to define a projection pathway for radiant energy ablation of cardiac tissue.
  • Second catheter body 24 has an inner lumen 27 sized to pass over the inner catheter body 14 .
  • the projection balloon of the second catheter is then inflated.
  • the expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention.
  • the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • the projection balloons described herein can be preshaped to form a parabolic like shape. This can be accomplished, for example, by shaping and melting a TEFLON® film in a preshaped mold to effect the desired form.
  • the projection balloons and sheaths of the present invention can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • an ablative fluid 29 can be employed outside of the instrument (e.g., between the balloon 26 and the target region 52 ) to ensure efficient transmission of the radiant energy when the instrument is deployed.
  • the ablative fluid in this context is any fluid that can serve as a conductor of the radiant energy.
  • This ablative fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation. As shown in FIG.
  • the fluid 29 can be released via one or more exit ports 36 in the first catheter body 14 (and/or second catheter body 24 ) to flow between the projection balloon 26 and the surrounding tissue, thereby filling any gaps where the balloon 26 does not contact the tissue.
  • the fluid 29 can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere with the radiant light energy transmission to the target region 52 .
  • FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart.
  • the energy emitter can be introduced into the instrument via the lumen 13 of the inner catheter.
  • the energy emitter 40 is a radiant energy emitter and includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43 , which cooperate to project ablative light energy through the instrument to the target site.
  • optical element is a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference.
  • FIGS. 8 and 9 taken together, illustrate an advantageous feature of the present invention, namely, the ability to select the location a lesion independent of the instrument design.
  • the radiant energy emitter does not require contact with a target tissue region and is, in fact, decoupled from the rest of the instrument, the present invention permits the clinician to select a desired target region by simply moving the emitter (e.g., within the lumen 14 of the first catheter 12 ).
  • the radiant energy emitter can be positioned to form a wide circumferential lesion (when the shape of the pulmonary vein ostium warrants such a lesion) by positioning the radiant energy emitter at the rear of the projection balloon—at a distance from the target tissue.
  • a smaller diameter lesion can be formed by positioning the radiant energy emitter closer to the front of the project balloon, as shown in FIG. 9 .
  • a lesion can be preferably when the geometer of the vein ostium presents a more gradual change in diameter, as shown.
  • the energy emitter 40 and catheter body 24 can each include one or more markers (shown schematically as elements 33 and 35 respectively) to aid in determining the location or tracking movements of the elements. Markers 33 and 35 , for example, can be radioopaque lines that can visualized fluoroscopically. Various other marker mechanisms, such as magnetic, capacitive or optical markers, can also be used.
  • FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter 40 (shown in FIGS. 7-9 ) has been removed and the anchor balloon element 16 of the first catheter 12 is deflated to permit removal of the first catheter body 14 .
  • the first catheter is replaced by a mapping electrode catheter 88 via, for example, the central lumen of the second catheter 20 .
  • a mapping electrode catheter 88 via, for example, the central lumen of the second catheter 20 .
  • more than one lumen can be used to provide separate pathways for these instruments.
  • FIG. 12 is a schematic illustration of a final step in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block.
  • Various techniques for conducting such tests are known by those skilled in the art. In one simple approach, a voltage pulse is applied by a coronary sinus catheter. The mapping, catheter's electrode is touched to the inner wall of the pulmonary vein. If no signal (or a substantially attenuated signal) is detected, a conduction block can thereby be confirmed. It should also be appreciated that the mapping electrode can in some instances be used even before the projection and/or anchor balloons are removed.
  • FIG. 13 is a schematic illustration of an alternative method of performing ablative surgery with radiant energy according to the invention without the need for an anchoring balloon.
  • a guide wire 6 can again be introduced into a heart and passed into a pulmonary vein 4 .
  • a catheter 20 carrying projection balloon structure 26 , is slid over the guide wire 6 .
  • This catheter 20 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 26 , which is sealed to the body of the catheter 20 by distal seal 21 and proximal seal 22 , such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon.
  • FIG. 14 illustrates how the projection balloon 26 can then be inflated to define a projection pathway for radiant energy ablation of cardiac tissue.
  • the expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention.
  • the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • the projection balloons described herein can be preshaped to form various shapes (e.g., to assist in seating the instrument at the mouth of a pulmonary vein or at other anatomically defined regions of the heart). As noted above, this can be accomplished, for example, by shaping and melting a TEFLON® film in a preshaped mold to effect the desired form.
  • the projection balloons can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • the instrument can further include a fluid releasing mechanism in the form of one or more fluid ports (or a sheath that contains pores for releasing fluid) near or at the target ablation site.
  • the released fluid can serve as an ablative fluid by clearing a transmission pathway for radiant energy.
  • FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the device of FIGS. 13-14 , in which the guide wire is removed and replaced by a radiant energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart.
  • the radiant energy emitter 40 includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43 , which cooperate to project ablative light energy through the instrument to the target site.
  • optical element is again a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference.
  • the radiant energy emitter can be an ultrasound or microwave energy source, as described in more detail below (in connection with FIGS. 19-20 ).
  • FIG. 16 further illustrates the unique utility of the multi-positionable, radiant energy ablation devices of the present invention in treating the complex cardiac geometries that are often encountered.
  • the mouths of pulmonary veins typically do not present simple, funnel-shaped, or regular conical surfaces. Instead, one side of the ostium 4 B can present a gentle sloping surface, while another side 4 A presents a sharper bend.
  • contact-heating, ablation devices such geometries will result in incomplete lesions if the heating element (typically a resisting heating band on the surface of an expandable element) can not fully engage the tissue of the vein or ostium. Because the position of the heating band of the prior art devices is fixed, when it does not fully contact the target tissue, the result is an arc, or incompletely formed ring-type, lesion that typically will be insufficient to block conduction.
  • the heating element typically a resisting heating band on the surface of an expandable element
  • FIG. 16 illustrates how the slidably positionable energy emitters of the present invention can be used to avoid this problem.
  • Three potential positions of the emitter 40 are shown in the figure (labeled as “A”, “B” and “C”). As shown, positions A and C may not result in optimal lesions because of gaps between the balloon and the target tissue. Position B, on the other hand, is preferably because circumferential contact has been achieved.
  • Position B is preferably because circumferential contact has been achieved.
  • the independent positioning of the energy source relative to the balloon allows the clinician to “dial” an appropriately ring size to meet the encountered geometry.
  • emitter can be positioned in many more positions and that the location can be varied in either discrete intervals or continuously, if so desired.
  • the geometries of the pulmonary vein may be such that no single annular lesion can form a continuous conduction block.
  • the present invention provides a mechanism for addressing this problem by adjustment of the location of the energy emitter to form two or more partially circumferential lesions.
  • the devices of the present invention can form a first lesion 94 and a second lesion 96 , each in the form of an arc or partial ring. Because each lesion has a thickness (dependent largely by the amount of energy deposited into the tissue) the two lesions can axially combine, as shown, to form a continuous encircling or circumscribing lesion that blocks conduction.
  • FIG. 17 is a schematic illustration of one embodiment of a radiant energy emitter 40 according to the invention.
  • the radiant energy is electromagnetic radiation, e.g., coherent or laser light
  • the energy emitter 40 projects an hollow cone of radiation that forms an annular exposure pattern upon impingement with a target surface.
  • radiant energy emitter 40 can include an optical fiber 42 in communication with an annulus-forming optical waveguide 44 having a concave interior boundary or surface 45 .
  • the waveguide 44 passes an annular beam of light to a graded intensity (GRIN) lens 46 , which serves to collimate the beam, keeping the beam width the same, over the projected distance.
  • GRIN graded intensity
  • the beam that exits from the distal window 43 of energy emitter 40 will expand (in diameter) over distance, but the energy will remain largely confined to a narrow annular band.
  • the angle of projection from the central axis of the optical fiber 42 or waveguide 44 will be between about 20 and 45 degrees.
  • the diameter of the annular beam of light will be dependent upon the distance from the point of projection to point of capture by a surface, e.g., a tissue site, e.g., an interstitial cavity or lumen.
  • a surface e.g., a tissue site, e.g., an interstitial cavity or lumen.
  • the diameter of the annular beam will be between about 10 mm and about 33 mm, preferably greater than 10 mm, greater than 15 mm, greater than 20 mm, and most preferably, greater than or equal to 23 mm.
  • angle of projected annular light is between about 20 and about 45 degrees, preferably between about 17 and about 30 degrees, most preferably between about 16 and about 25 degrees.
  • Preferred energy sources for use with the percutaneous ablation instruments of the present invention include laser light in the range between about 200 nanometers and 2.5 micrometers.
  • wavelengths that correspond to, or are near, water absorption peaks are often preferred.
  • Such wavelengths include those between about 805 nm and about 1060 nm, preferably between about 900 nm and 1000 nm, most preferably, between about 915 nm and 980 nm.
  • wavelengths around 915 nm or around 980 nm are used during endocardial procedures.
  • Suitable lasers include excimer lasers, gas lasers, solid state lasers and laser diodes.
  • the optical waveguides can be made from materials known in the art such as quartz, fused silica or polymers such as acrylics.
  • acrylics include acrylates, polyacrylic acid (PAA) and methacrylates, polymethacrylic acid (PMA).
  • polyacrylic esters include polymethylacrylate (PMA), polyethylacrylate and polypropylacrylate.
  • polymethacrylic esters include polymethylmethacrylate (PMMA), polyethylmethacrylate and polypropylmethacrylate.
  • the waveguide 44 is formed of quartz and fused to the end face of fiber 42 .
  • Internal shaping of the waveguide can be accomplished by removing a portion of material from a unitary body, e.g., a cylinder or rod.
  • Methods known in the art can be utilized to modify waveguide to have tapered inner walls, e.g., by grinding, milling, ablating, etc.
  • a hollow polymeric cylinder e.g., a tube
  • the conical surface 45 can be formed in a solid quartz cylinder or rod by drilling with a tapered bore.
  • Waveguide 44 can be optical coupled to optical fiber 42 by various methods known in the art. These methods include for example, gluing, or fusing with a torch or carbon dioxide laser.
  • waveguide 44 , optical fiber 42 and, optionally, a gradient index lens (GRIN) 46 are in communication and are held in position by heat shrinking a polymeric jacket material 68 , such as polyethylene terephthalate (PET) about the optical apparatus 40 .
  • PET polyethylene terephthalate
  • FIG. 18 is a schematic illustration of another embodiment of a radiant energy emitter 40 A according to the invention in which optical fiber 42 is coupled to a light diffuser 41 having light scattering particles 47 to produce a sidewise cylindrical exposure pattern of ablative radiation.
  • This embodiment can be useful, for example, in creating a lesion within a pulmonary vein.
  • the radiant energy emitter of the design shown in FIG. 14 can be advanced to front of the projection balloon to permit diffuse exposure of a pulmonary vein ostium if a lesion is desired in that location.
  • FIG. 19 illustrates an alternative embodiment of a radiant energy emitter 40 C in which an ultrasound transducer 60 , comprising individual shaped transducer elements or lenses 62 which direct the ultrasound energy into a cone of energy that can likewise form an annular exposure pattern upon impingement with a target surface.
  • the emitter 40 C is supported by a sheath 66 or similar elongate body, enclosing electrical leads, and thereby permitting the clinician to advance the emitter through an inner lumen of the instrument to a desired position for ultrasound emission.
  • FIG. 20 Yet another embodiment of a radiant energy emitter 40 D is illustrated in FIG. 20 where microwave energy is similarly focused into an annular exposure beam.
  • the radiant energy emitter can include a coaxial transmission line 74 (or similar electrical signal leads) and a helical coil antenna 73 .
  • Radiation reflectors 72 A and 72 B cooperated to shield and direct the radiation into a cone.
  • a radioisotope or other source of ionizing radiation can be used in lieu of the microwave antenna 73 , again with appropriate radiation shielding elements 72 A and 72 B to project a beam of ionizing radiation.
  • FIGS. 21 and 22 illustrate one embodiment of a contact sensor according to the invention incorporated into a radiant emitter assembly.
  • the assembly can includes an outer, radiant energy transparent body 70 that encases the assembly and facilitates its slidable positioning within an inner lumen of catheter body 14 .
  • the assembly further includes an energy emitter 40 (e.g., like those described above in connection with FIGS. 17-20 ) which can also act as the sensing fiber.
  • an energy emitter 40 e.g., like those described above in connection with FIGS. 17-20
  • four illumination fibers 76 A- 76 D are shown. If the ablative apparatus of the invention is properly positioned within the heart, light transmitted via such fibers will strike the target region, be reflected back, and detected by the energy emitter (or other sensing element).
  • the use of four illumination fibers allows simultaneous or sequential sensing of contact in four “quadrants.”
  • the invention can be practiced with various numbers of illuminating and/or sensing elements, and with or without use of the energy emitter as an element in the contact sensing module.
  • ultrasound emitters and detectors can also be used in the same manner in lieu of the light reflecting mechanisms to determine contact.
  • the output signals of the sensors can be electronically processed and incorporated into a display.
  • the sensors of FIGS. 21-22 provide the ability to position the percutaneous ablation instruments of the present invention at a treatment site such that proper location of the energy emitter vis-a-vis the target tissue (as well a satisfactory degree of contact between the projection balloon and the tissue) is achieved.
  • This ability is based on reflectance measurements of light scattered or absorbed by blood, body fluids and tissue.
  • white light projected from sensing fibers 76 toward tissue has several components including red and green light.
  • Red light has a wavelength range of about 600 to about 700 nanometers (nm) and green light has a wavelength range of about 500 to about 600 nm.
  • red light has a wavelength range of about 600 to about 700 nanometers (nm)
  • green light has a wavelength range of about 500 to about 600 nm.
  • the optical assembly which includes a reflected light collector.
  • the reflectance of green and blue light increases as biological tissue tends to reflect more green light.
  • the amount of reflected green or blue light determines whether there is blood between the apparatus and the tissue or not.
  • the green-blue reflectance signal should remain nearly at zero until the projection balloon is inflated and positioned proximal to the surface of the heart tissue.
  • green light is reflected back into the optical assembly and the collector.
  • only green light is projected toward the tissue surface.
  • red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately. The use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned.
  • the ratio of the two different wavelengths can be measured.
  • the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the inflated balloon, with the tissue the ratio of red light to green light would be high. Once a transmission pathway is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • the reflected light is transmitted back through a collector, such as an optical fiber to a spectrophotometer.
  • the spectrophotometer (Ocean Optics Spectrometer, Dunedin, Fla., model S-2000) produces a spectrum for each reflected pulse of reflected light.
  • Commercially available software (LabView Software, Austin, Tex.) can isolate values for specific colors and perform ratio analyses.
  • the use of multiple optical fiber illumination fibers positioned about the lumen of the catheter permit the operator to determine the plane in which the catheter and balloon should be adjusted to minimize blood between the optical assembly and the treatment site.
  • radiant energy can then be projected to the target tissue region.
  • the radiant energy is electromagnetic radiation, e.g., laser radiation
  • it can be emitted onto the tissue site via a separate optical fiber or, alternatively, through the same optical fiber used to transmitting the white, green or red light.
  • the laser light can be pulsed intermittently in synchronous fashion with the positioning/reflecting light to ensure that the pathway remains clear throughout the procedure.
  • a contact-heating device 54 having an expandable element 56 and a contact heating element 58 is shown disposed in a pulmonary vein.
  • the contact heating element can be a line or grid of electrically conductive material printed on the surface of the expandable element.
  • the expandable element can be substantially opaque to certain wavelengths (e.g., visible light) except for a transparent band 59 , on which the contact heating element is situated.
  • the heating wires should also be sufficiently transparent (or cover a substantially small area of the band) so as to not interfere with reflection signal collection.
  • the device 54 can further include a sensor disposed within a central lumen of the device having an illuminating fiber and and a plurality of collecting fibers
  • the contact sensor can operate in substantially same fashion as described above.
  • a green-blue reflectance signal should remain nearly at zero until the expandable element 56 is inflated and positioned proximal to the surface of the heart tissue.
  • green light is reflected back into the optical assembly and the collector. In one embodiment, only green light is projected toward the tissue surface. In another embodiment, red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately.
  • the use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned.
  • the ratio of the two different wavelengths can be measured.
  • the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the contact-heating ablation band, with the tissue, the ratio of red light to green light would be high. Once contact is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • FIG. 23A another embodiment of a contact sensing catheter is shown in the form of a cryogenic ablation catheter 110 having a catheter body 112 and internal conduits 114 for circulation of a cryogenic fluid from a cryogenic fluid source 115 .
  • the catheter body includes conductive regions 116 where the cold temperature can be applied to tissue.
  • the sensors 76 of the present invention can be disposed in proximity to the conductive regions, as shown and used to determine whether tissue contact has been made.
  • FIG. 23B yet another application for the contact sensors is shown in connection with an ultrasound, contact-heating balloon catheter 120 , having a balloon 122 (similar to that discussed above in connection with FIG. 23 ) for contacting a pulmonary vein and having a band 123 for applying heat to tissue.
  • the ultrasound ablation instrument 120 further includes transducers 124 driven by actuator 125 to heat the ablative band 123 .
  • the sensors 76 of the present invention can be disposed in proximity to the ablation band 123 , as shown, and used to determine whether tissue contact has been made.
  • a translatory mechanism 80 is shown for controlled movement of a radiant energy emitter within the instruments of the present invention.
  • the exemplary positioner 80 is incorporated into a handle 84 in the proximal region of the instrument, where the elongate body 82 of the radiant energy emitter 40 engages a thumb wheel 86 to control advancement and retraction of the emitter. It should be clear that various alternative mechanisms of manual or automated nature can be substituted for the illustrated thumb wheel 86 to position the emitter at a desired location relative to the target tissue region.
  • the elongate body 82 that supports the radiant energy emitter 40 can further include position indicia 92 on its surface to assist the clinician in placement of the emitter within the projection balloon.
  • the handle can further include a window 90 whereby the user can read the indicia (e.g., gradation markers) to gauge how far the emitter has been advanced into the instrument.
  • radiatant energy as used herein is intended to encompass energy sources that do not rely primarily on conductive or convective heat transfer. Such sources include, but are not limited to, acoustic and electromagnetic radiation sources and, more specifically, include microwave, x-ray, gamma-ray, and radiant light sources.
  • the term “light” as used herein is intended to encompass electromagnetic radiation including, but not limited to, visible light, infrared and ultraviolet radiation.
  • a lesion in the context of a lesion is intended to mean a lesion that substantial blocks electrical conduction between tissue segments on opposite sides of the lesion.
  • the terms “circumferential” and/or “curvilinear,” including derivatives thereof, are herein intended to mean a path or line which forms an outer border or perimeter that either partially or completely surrounds a region of tissue, or separate one region of tissue from another.
  • a “circumferential” path or element may include one or more of several shapes, and may be for example, circular, annular, oblong, ovular, elliptical, or toroidal.
  • Lumen in the context of biological structures, is herein intended to mean any cavity or lumen within the body which is defined at least in part by a tissue wall.
  • tissue wall For example, cardiac chambers, the uterus, the regions of the gastrointestinal tract, the urinary tract, and the arterial or venous vessels are all considered illustrative examples of body spaces within the intended meaning.
  • Catheter as used herein is intended to encompass any hollow instrument capable of penetrating body tissue or interstitial cavities and providing a conduit for selectively injecting a solution or gas, including without limitation, venous and arterial conduits of various sizes and shapes, bronchoscopes, endoscopes, cystoscopes, culpascopes, colonscopes, trocars, laparoscopes and the like.
  • Catheters of the present invention can be constructed with biocompatible materials known to those skilled in the art such as those listed supra, e.g., silastic, polyethylene, Teflon, polyurethanes, etc.
  • lumen in the context of catheters is intended to encompass any passageway within a catheter instrument (and/or track otherwise joined to such instrument that can serve as a passageway) for the passage of other component instruments or fluids or for delivery of therapeutic agents or for sampling or otherwise detecting a condition at a remote region of the instrument.
  • balloon encompasses deformable hollow shapes which can be inflated into various configurations including balloon, circular, tear drop, etc., shapes dependent upon the requirements of the body cavity.
  • Such balloon elements can be elastic or simply capable of unfolding or unwrapping into an expanded state.
  • transparent is well recognized in the art and is intended to include those materials which allow transmission of energy through, for example, the primary balloon member. Preferred transparent materials do not significantly impede (e.g., result in losses of over 20 percent of energy transmitted) the energy being transferred from an energy emitter to the tissue or cell site. Suitable transparent materials include fluoropolymers, for example, fluorinated ethylene propylene (FEP), perfluoroalkoxy resin (PFA), polytetrafluoroethylene (PTFE), and ethylene-tetrafluoroethylene (ETFE).
  • FEP fluorinated ethylene propylene
  • PFA perfluoroalkoxy resin
  • PTFE polytetrafluoroethylene
  • ETFE ethylene-tetrafluoroethylene

Abstract

Ablation methods and instruments are disclosed for creating lesions in tissue, especially cardiac tissue for treatment of arrhythmias and the like. Percutaneous ablation instruments in the form of coaxial catheter bodies are disclosed having at least one central lumen therein and having one or more balloon structures at the distal end region of the instrument. The instruments include an energy emitting element which is independently positionable within the lumen of the instrument and adapted to project radiant energy through a transmissive region of a projection balloon to a target tissue site. The instrument can optionally include at least one expandable anchor balloon disposed about, or incorporated into an inner catheter body designed to be slid over a guidewire. This anchor balloon can serve to position the device within a lumen, such as a pulmonary vein. A projection balloon structure is also disclosed that can be slid over the first (anchor balloon) catheter body and inflated within the heart, to define a staging from which to project radiant energy. An ablative fluid can also be employed outside of the instrument (e.g., between the balloon and the target region) to ensure efficient transmission of the radiant energy when the instrument is deployed. In another aspect of the invention, generally applicable to a wide range of cardiac ablation instruments, mechanisms are disclosed for determining whether the instrument has been properly seated within the heart, e.g., whether the device is in contact with a pulmonary vein and/or the atrial surface, in order to form a lesion by heating, cooling or projecting energy. This contact-sensing feature can be implemented by an illumination source situated within the instrument and an optical detector that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved and whether such contact is continuous over a desired ablation path.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in part of U.S. patent application Ser. No. 09/924,393, filed on Aug. 7, 2001, which is a continuation-in-part of U.S. patent application Ser. No. 09/390,964, filed Sep. 7, 1999, now U.S. Pat. No. 6,270,492 issued Aug. 7, 2001, which is a continuation-in-part of U.S. patent application Ser. No. 08/991,130, filed Dec. 16, 1997, now U.S. Pat. No. 5,947,595 issued Sep. 7, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 08/827,631, filed Apr. 10, 1997, now U.S. Pat. No. 5,908,415 issued Jun. 1, 1999, which is a continuation of U.S. patent application Ser. No. 08/303,605, filed Sep. 9, 1994, abandoned.
  • This application is also a continuation-in-part of U.S. patent application Ser. No. 09/616,275 filed Jul. 14, 2000, which is a continuation-in-part of U.S. patent application Ser. No. 09/602,420 filed Jun. 23, 2000, which is a continuation-in-part of U.S. patent application Ser. No. 09/357,355, filed on Jul. 14, 1999, now U.S. Pat. No. 6,423,055 issued Jul. 22, 2002. The teachings of all of these prior related applications are hereby expressly incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • The present invention relates to ablation instruments for ablation of tissue for the treatment of diseases, and, in particular, to percutaneous instruments employing radiant energy. Methods of ablating tissue using radiant energy are also disclosed. The instruments can be used, for example, in the treatment of cardiac conditions such as cardiac arrhythmias.
  • Cardiac arrhythmias, e.g., fibrillation, are irregularities in the normal beating pattern of the heart and can originate in either the atria or the ventricles. For example, atrial fibrillation is a form of arrhythmia characterized by rapid randomized contractions of atrial myocardium, causing an irregular, often rapid ventricular rate. The regular pumping function of the atria is replaced by a disorganized, ineffective quivering as a result of chaotic conduction of electrical signals through the upper chambers of the heart. Atrial fibrillation is often associated with other forms of cardiovascular disease, including congestive heart failure, rheumatic heart disease, coronary artery disease, left ventricular hypertrophy, cardiomyopathy or hypertension.
  • Various techniques have been proposed for the treatment of arrhythmia. Although these procedures were originally performed with a scalpel, various other techniques have also been developed to form lesions. Collectively, these treatments are referred to as “ablation.” In non-surgical ablations, the tissue is treated, generally with heat or cold, to cause coagulation and/or tissue necrosis (i.e., cell destruction). In each of these techniques, cardiac muscle cells are replaced with scar tissue which cannot conduct normal electrical activity within the heart.
  • For example, the pulmonary vein has been identified as one of the origins of errant electrical signals responsible for triggering atrial fibrillation. In one known approach, circumferential ablation of tissue within the pulmonary veins or at the ostia of such veins has been practiced to treat atrial fibrillation. Similarly, ablation of the region surrounding the pulmonary veins as a group has also been proposed. By ablating the heart tissue (typically in the form linear or curved lesions) at selected locations, electrical conductivity from one segment to another can be blocked and the resulting segments become too small to sustain the fibrillatory process on their own.
  • Several types of ablation devices have recently been proposed for creating lesions to treat cardiac arrhythmias, including devices which employ electrical current (e.g., radiofrequency “RF”) heating or cryogenic cooling. Such ablation devices have been proposed to create elongated lesions that extend through a sufficient thickness of the myocardium to block electrical conduction. Many of the recently proposed ablation instruments are percutaneous devices that are designed to create such lesions from within the heart. Such devices are positioned in the heart by catheterization of the patient, e.g., by passing the ablation instrument into the heart via a blood vessel, such as the femoral vein.
  • Devices that rely upon resistive or conductive heat transfer can be prone to serious post-operative complications. In order to quickly perform an ablation with such “contact” devices, a significant amount of energy must be applied directly to the target tissue site. In order to achieve transmural penetration, the surface that is contacted will experience a greater degree of heating (or freezing). For example, in RF heating of the heart wall, a transmural lesion requires that the tissue temperature be raised to about 50° C. throughout the thickness of the wall. To achieve this, the temperature at the contact surface will typically be raised to greater than 100° C. In this temperature regime, there is a substantial risk of tissue destruction (e.g., due to water vaporization micro-explosions or due to carbonization). Charring of the surface of the heart tissue, in particular, can lead to the creation of blood clots on the surface and post-operative complications, including stroke. Even if structural damage is avoided, the extent of the lesion (i.e., the width of the ablated zone) on the surface that has been contacted will typically be greater than necessary.
  • Ablation devices that do not require direct contact have also been proposed, including acoustic and radiant energy. Acoustic energy (e.g., ultrasound) is poorly transmitted into tissue (unless a coupling fluid is interposed). Laser energy has also been proposed but only in the context of devices that focus light into a scalpel-like point or similar high intensity spot pattern. When the light energy is delivered in the form of a focused spot, the process is inherently time consuming because of the need to expose numerous spots to form a continuous linear or curved lesion.
  • In addition, existing instruments for cardiac ablation also suffer from a variety of design limitations. The shape of the heart muscle adds to the difficulty in accessing cardiac structures, such as the pulmonary veins on the anterior surface of the heart. Typically, percutaneous devices are positioned with the assistance of a guide wire, which is first advanced into heart. In one common approach, described, for example, in U.S. Pat. No. 6,012,457 issued to Lesh on Jan. 11, 2000 and in International Application Pub. No. WO 00/67656 assigned to Atrionix, Inc, a guide wire or similar guide device is advanced through the left atrium of the heart and into a pulmonary vein. A catheter instrument with an expandable element is then advanced over the guide and into the pulmonary vein where the expandable element (e.g., a balloon) is inflated. The balloon structure also includes a circumferential ablation element, e.g., an RF electrode carried on the outer surface of the balloon, which performs the ablation procedure. The balloon must be large enough and sufficiently rigid to hold the electrode in contact with the inner surface of the pulmonary vein for the length of the procedure. Moreover, because the lesion is formed by an ablation element carried on the surface of the balloon element, the balloon shape inherently limits the locations where a lesion can be formed, i.e., the lesion must be formed at least partially within the pulmonary vein.
  • In another approach described in U.S. Pat. No. 6,235,025 issued to Swartz et al. on May 22, 2001, a guide wire is again used to percutaneously access a pulmonary vein and a catheter is again slid over the guide to a position within the pulmonary vein. The catheter device includes two spaced-apart balloons, which are inflated in the vein (or in the vein and at its mouth). The space between the two balloons can then be filled with a conductive fluid to delivery RF energy (or, alternatively, ultrasound) to the vein and thereby induce a conduction block in the blood vessel by tissue ablation. With the Swartz et al. device, like the Lesh device, the region where tissue ablation can occur is limited by the design. Because two balloons must seal a space that is then filled with an ablative fluid, the lesion is necessarily formed within the pulmonary vein.
  • Ablation within the pulmonary vein can result in complications. Overtreatment deep within a vein can result in stenosis (closure of the vein itself), necrosis or other structural damage, any of which can necessitate immediate open chest surgery.
  • A major limitation in the prior art percutaneous designs is the lack of site selectability. Practically speaking, each prior art percutaneous instrument is inherently limited by its design to forming an ablative lesion at one and only one location. For example, when an expandable balloon carrying an RF heating surface on it surface is deployed at the mouth of a vein, the lesion can only be formed at a location defined by the geometry of the device. It is not possible to form the lesion at another location because the heating element must contact the target tissue. Similarly the above-described tandem balloon device can only form a lesion at a location defined by the space between the balloons that is filled with the ablative fluid.
  • Another major limitation in prior art percutaneous designs is their inability to accommodate the actual and quite varied geometry of the heart. The inner surface of the atrium is not regular. In particular, the mouths of the pulmonary veins do not exhibit regularity; they often bear little resemble to conical or funnel-shaped openings. When the expandable, contact heating devices of the prior art encounter irregularly-shaped ostia, the result can be an incompletely formed (non-circumferential) lesion.
  • Accordingly, a percutaneous ablation device that allowed the clinician to select the location of the ablation site would be highly desirable. An instrument that allows a clinician to choose from a number of different lesion locations, especially in creating continuous conduction blocks around pulmonary veins, would satisfy a long felt need in the art.
  • Moreover, the prior art devices typically can not determine whether continuous circumferential contact has been achieved before heating commences. These devices most often rely on post-ablation electrical mapping to determine whether a circumferential lesion has been formed. If electric conduction is still present, the encircling lesion is incomplete and the procedure must be repeated or abandoned.
  • Accordingly, there also exists a need for better surgical ablation instruments that can form lesions with less trauma to the healthy tissue of the heart and greater likelihood of success. A percutaneous system that could determine whether contact has been achieved (or blood has been cleared from the target site) and predict success based on such determinations would represent a significant improvement over the existing designs.
  • SUMMARY OF THE INVENTION
  • Ablation methods and instruments are disclosed for creating lesions in tissue, especially cardiac tissue for treatment of arrhythmias and the like. In one aspect of the invention, percutaneous ablation instruments in the form of coaxial catheter bodies are disclosed having at least one central lumen therein and having one or more balloon structures at the distal end region of the instrument. The balloon structure and catheter bodies are at least partially transmissive to ablative energy. The instruments can further include an energy emitting element, which is independently positionable within the lumen of the instrument and adapted to project ablative energy through a transmissive region of the balloon to a target tissue site. The energy is delivered without the need for contact between the energy emitter and the target tissue because the methods and devices of the present invention do not rely upon conductive or resistive heating. Because the position of the radiant energy emitter can be varied, the clinician can select the location of the desired lesion.
  • In another aspect of the invention, generally applicable to a wide range of cardiac ablation instruments, mechanisms are disclosed for determining whether the instrument has been properly seated within the heart, e.g., whether the device is in contact with a pulmonary vein and/or the atrial surface, in order to form a lesion by heating, cooling or projecting energy. This contact-sensing feature can be implemented by an illumination source situated within the instrument and an optical detector that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved and whether such contact is continuous over a desired ablation path.
  • The instruments are especially useful in percutaneous access cardiac surgery for rapid and efficient creation of curvilinear lesions to serve as conduction blocks. The instruments are designed to create lesions in the atrial tissue in order to electrically decouple tissue segments on opposite sides of the lesion while presenting low profiles during percutaneous access and retraction. The instruments of the present invention permit the formation of continuous lesions in the atrial wall tissue of the heart, such that the continuous lesion can surround a organ structure, such as a pulmonary vein, without involving the structure itself.
  • In one embodiment a cardiac ablation instrument is disclosed having a catheter body adapted for disposition within a heart. This catheter body has at least one lumen therein and an expandable, energy-transmitting element which can be deployed at the desired location with or without an anchorage element to contact a cardiac structure and establish a transmission pathway. For example, the expandable element can be a projection balloon that is expandable to fill the space between the energy emitter and the target tissue with an energy-transmissive fluid and, thereby, provide a transmission pathway for projected radiant energy. The instrument further includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site. The instrument can further include additional elements, such fluid delivery ports, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • In another embodiment, a cardiac ablation instrument is disclosed having a catheter body adapted for disposition within a heart and at least one anchorage element which can be deployed at the desired location to contact a cardiac structure and secure the device in place. The instrument again includes a radiant energy delivery element movable within the lumen of the catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site. A projection balloon can again be employed, alone or together with fluid releasing mechanisms, to provide a blood-free transmission pathway from the energy emitter to the tissue target.
  • Mechanisms are disclosed for determining whether the ablation instruments of the present invention have been properly seated within the heart to form a lesion. For example, if a projection balloon is employed to provide a clear transmission pathway from a radiant energy emitter to the target tissue, the mechanisms of the present invention can sense whether contact has been achieved between the balloon and the target tissue (and/or whether the pathway for projection of radiant energy has been otherwise cleared of obstructions). In one embodiment, this contact-sensing feature can be implemented by an illumination fiber situated within the instrument and an optical detector fiber (or fiber assembly) that monitors the level of reflected light. Measurements of the reflected light (or wavelengths of the reflected light) can thus be used to determine whether contact has been achieved between the projecxtion balloon and the target tissue, whether blood has been cleared from any gaps and whether a clear and continuous transmission pathway has been established over a desired ablation path.
  • In a further aspect of the invention, percutaneous instruments are disclosed that can achieve rapid and effective photoablation through the use of tissue-penetrating radiant energy. It has been discovered that radiant energy, e.g., projected electromagnetic radiation or ultrasound, can create lesions in less time and with less risk of the adverse types of surface tissue destruction commonly associated with prior art approaches. Unlike instruments that rely on thermal conduction or resistive heating, controlled penetrating radiant energy can be used to simultaneously deposit energy throughout the full thickness of a target tissue, such as a heart wall, even when the heart is filled with blood. Radiant energy can also produce better defined and more uniform lesions.
  • The use of radiant energy, in conjunction with catheter structures that are substantially transparent to such radiation at the therapeutic wavelengths, is particularly advantageous in affording greater freedom in selecting the location of the lesion, e.g., the site is no longer limited to the pulmonary vein itself. Because the energy can be projected onto the tissue, a ring-like lesion can be formed in atrial tissue at a distance from the vein, thereby reducing the potential for stenosis and/or other damage to the vein itself.
  • It has also been discovered that infrared radiation is particularly useful in forming photoablative lesions. In certain preferred embodiments, the instruments emit radiation at a wavelength in a range from about 800 nm to about 1000 nm, and preferably emit at a wavelength in a range of about 915 nm to about 980 nm. Radiation at a wavelength of 915 nm or 980 nm is commonly preferred, in some applications, because of the optimal absorption of infrared radiation by cardiac tissue at these wavelengths.
  • In another embodiment, focused ultrasound energy can be used to ablate cardiac tissue. In certain preferred embodiments, an ultrasound transducer can be employed to transmit frequencies within the range of about 5 to about 20 MHz, and preferably in some applications within the range of about 7 MHz to about 10 MHz. In addition, the ultrasonic emitter can include focusing elements to shape the emitted energy into an annular beam.
  • However, in certain applications, other forms of radiant energy can also be useful including, but not limited to, other wavelengths of light, other frequencies of ultrasound, x-rays, gamma-rays, microwave radiation and hypersound.
  • In the case of radiant light, the energy delivering element can include a light transmitting optical fiber adapted to receive ablative radiation from a radiation source and a light emitting tip at a distal end of the fiber for emitting radiation. The light delivering element can be slidably disposed within an inner lumen of the catheter body and the instrument can further include a translatory mechanism for disposing the tip of the light delivering element at one or more of a plurality of locations with the catheter. Moreover, by moving the energy-projecting tip assembly within the catheter, the diameter of the projected ring of energy can be readily varied, thereby permitting the clinician control over the location (and size) of the lesion to be formed.
  • Optionally, a fluid can be disposable between the radiant energy delivery element and the target region. In one preferred embodiment a “projection balloon” is filled with a radiation-transmissive fluid so that radiant energy from the energy emitter can be efficiently pass through the instrument to the target region. The fluid can also be used to cool the energy emitter. In certain applications, it can be desirable to used deuterium oxide (so-called “heavy water”) as a balloon-filling fluid medium because of its loss absorption characteristics vis-a-vis infrared radiation. In other applications, the inflation fluid can be water or saline.
  • It can also be desirable to employ an “ablative fluid” outside of the instrument (e.g., between the balloon and the target region) to ensure efficient transmission of the radiant energy when the instrument is deployed. An “ablative fluid” in this context is any fluid that can serve as a conductor of the radiant energy. This fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation. In one preferred embodiment, the fluid is released via one or more exit ports in the housing and flows between the projection balloon and the surrounding tissue, thereby filling any gaps where the balloon does not contact the tissue. The fluid can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere because of the highly absorptive nature of blood with respect to radiant light energy.
  • Similarly, if the radiant energy is acoustic, aqueous coupling fluids can be used to ensure high transmission of the energy to the tissue (and likewise displace blood that might interfere with the radiant acoustic energy transfer).
  • The ablative fluids of the present invention can also include various other adjuvants, including, for example, photosensitizing agents, pharmacological agents and/or analgesics.
  • As noted above, contact sensing mechanisms are also disclosed to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion. In one embodiment the sensor employs a plurality of reflection sensors that indicate whether or not a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • The coaxial catheter instruments disclosed herein are of particular use in percutaneous applications whereby a balloon catheter with an ablative light or ultrasound projecting assembly can be disposed within a patient's heart. In another aspect of the invention, dual, coaxial balloon structures are disclosed, having both a projection balloon and an anchoring balloon to assist in the properly disposition of the instrument.
  • In the dual, coaxial, catheter embodiment, the catheter instrument can include at least one expandable anchor balloon disposed about, or incorporated into an inner catheter body designed to be slid over a guidewire. This anchor balloon is generally or substantially sealed and serves to position the device within a lumen, such as a pulmonary vein. The anchor balloon structure, when filled with fluid, expands and is engaged in contact with tissue, e.g., the inner surface of a pulmonary vein.
  • A second catheter carrying the projection balloon can then be slid over the first (anchor balloon) catheter body and inflated within the heart, e.g., within the left atrium and adjacent to the pulmonary vein where the anchor balloon has already been placed. The expanded projection balloon thus defines a staging from which to project radiant energy in accordance with the invention. An energy emitting element can then be introduced via an inner lumen to project radiant energy, e.g., infrared light or ultrasound, through the coaxial catheter bodies and the projection balloon to form a lesion at the target treatment site. The instrument can also include an irrigation mechanism for delivery of an ablative fluid at the treatment site. In one embodiment, irrigation is provided by a sheath, partially disposed about the projecting balloon, and provides irrigation at a treatment site (e.g. so that blood can be cleared from an ablation site).
  • Both the anchor and projection balloon structures can be deflated by applying a vacuum which removes the fluid from the balloons. Once fully deflated, the coaxial instrument can be removed from the body lumen either as an ensemble, or as individual elements (starting with the innermost element). Alternatively, the energy delivery element can be removed (via an inner lumen balloon structure), followed by the projection balloon catheter and then the anchor balloon catheter.
  • The invention can also be used in conjunction with one or more mapping catheters. For example the guide wire element (and/or the anchorage balloon catheter) can be removed and replaced with a mapping catheter before and/or after the lesion is formed to determine whether the ablation has been successful in stopping errant electrical signals from propagating in the atrial wall tissue.
  • The present invention also provides methods for ablating tissue. One method of ablating tissue comprises positioning a radiant energy emitting element at a distance from a target region of tissue, providing a blood-free transmission pathway between the emitter and the target region, and then projecting radiant energy to expose the target region and induce a lesion.
  • In one method according to the invention, a guide wire is first inserted into the femoral vein and advanced through the inferior vena cava, and into the right atrium, or, if required, it is guided into the left atrium via an atrial septal puncture. In either event, the guide wire is advanced until it enters a pulmonary vein. The first catheter body is then slid over the guide wire until its anchorage element, e.g., the anchor balloon, is likewise advanced into the pulmonary vein. The anchor balloon is then inflated via an inflation fluid to secure the first catheter body. Next, a second catheter body is advanced, coaxially, over the first catheter body, carrying a projection balloon to the treatment site. Once the projection balloon is proximate to the target tissue ablation site, it can likewise be inflated. In addition, a solution can be injected through the instrument to force blood and/or body fluids away from the treatment site.
  • The guide wire is then removed and replaced with the radiant energy emitter, which is positioned to deliver radiant energy through the projection balloon to induce tissue ablation. The methods of the present invention can further include a position sensing step to assist the clinician in selecting the location of the lesion and in ensuring a selected location will result in the formation of a continuous (e.g., vein encircling) lesion. In one embodiment, one or more reflection sensors are activated to determine whether a clear transmission pathway has been established (e.g., whether the projection balloon is properly seated and any gaps in contact have been filled by an ablative fluid).
  • Following the ablation procedure, the radiant energy emitter is removed from the central lumen of the first catheter body. The anchor balloon can then be deflated by applying a vacuum that removes the inflation fluid from the balloon. A syringe or other known methods can be used to remove the fluid. In one embodiment, the anchor balloon can be deflated first and removed along with the first (inner) catheter body. The first catheter body can then be replaced with a mapping catheter. Once the mapping electrode is advanced into the pulmonary vein, the projection balloon can be likewise deflated and the second catheter body removed, thus leaving only the mapping catheter in place. The mapping catheter can then be activated to determine whether a conduction block has been achieved. If the ablation is successful, the mapping catheter can be removed. If conduction is still present, the procedure can be repeated, for example, by reintroducing the second catheter body, followed by removal of the mapping catheter, and repositioning the anchor balloon and the radiant energy emitter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which like reference numerals designate like parts throughout the figures, and wherein:
  • FIG. 1 is a schematic, cross-sectional view of a coaxial catheter ablation instrument according to the invention;
  • FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire is introduced into a heart and passed into a pulmonary vein;
  • FIG. 3 is a schematic illustration of another step in performing ablative surgery with radiant energy according to the invention, in which a first catheter, carrying an anchoring balloon structure, is slid over the guide wire;
  • FIG. 4 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which an anchoring balloon structure is inflated;
  • FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter, carrying a projection balloon element, is slid over the first catheter body;
  • FIG. 6 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon element of the second catheter is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • FIG. 8 is a schematic illustration of a step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a defined location;
  • FIG. 9 is a schematic illustration of an alternative step in performing ablative surgery according to the invention, in which the radiant energy emitter is positioned to form a lesion at a different defined location;
  • FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter is removed and the anchor balloon element of the first catheter is deflated to permit removal of the first catheter body;
  • FIG. 11 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the first catheter is replaced by a mapping electrode;
  • FIG. 12 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block;
  • FIG. 13 is a schematic illustration of alternative approach to ablative surgery with radiant energy according to the invention, in which a catheter carrying an projection balloon structure, is slid over a guide wire without first introducing an anchoring balloon catheter;
  • FIG. 14 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13, in which the projection balloon element is inflated to define a projection pathway for radiant energy ablation of cardiac tissue;
  • FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the embodiment illustrated in FIG. 13, in which the guide wire is removed and replaced by a radiant energy emitter located remote from the lesion site but in a position that permits projection of radiant energy onto a target region of the heart;
  • FIG. 16 is a schematic illustration of a system according to the invention in which an asymmetric vein mouth is encountered and further showing how the position of the radiant energy emitter can be adjusted to sense contact and select a location; FIG. 16A illustrates how a continuous, vein-encircling lesion can be formed by two partially-encircling lesions;
  • FIG. 17 is a schematic illustration of one embodiment of a radiant light energy emitter according to the invention;
  • FIG. 18 is a schematic illustration of another embodiment of a radiant light energy emitter according to the invention;
  • FIG. 19 is a schematic illustration of an alternative embodiment of a radiant energy emitter according to the invention employing ultrasound energy;
  • FIG. 20 is a schematic illustration of an alternative embodiment of a radiant light energy emitter according to the invention employing microwave or ionizing radiation;
  • FIG. 21 is a schematic cross-sectional illustration of one embodiment of a contact sensor according to the invention;
  • FIG. 22 is an end view, schematic illustration of the contact sensor elements shown in FIG. 21;
  • FIG. 23 is a schematic view of a contact heating ablation device employing the contacting sensing apparatus of the present invention; FIG. 23A is a schematic view of a croygenic ablation device employing the contacting sensing apparatus of the present invention; FIG. 23B is a schematic view of a ultrasound heating ablation device employing the contacting sensing apparatus of the present invention and
  • FIG. 24 is a schematic illustration of a mechanism for positioning the radiant energy emitter at a selected location relative to the target tissue region.
  • DETAILED DESCRIPTION
  • FIG. 1 provides a schematic, cross-sectional view of a coaxial catheter ablation instrument 10 according to the invention, including a first, inner catheter 12 having an elongate body 14 and an anchor balloon 16, inflatable via one or more ports 18. A fluid for inflating the anchor balloon can be delivered through a passageway (not shown) within the elongate body or via one or more of the lumens of the device, as discussed in more detail below. The device can further include a second, coaxial, outer catheter 20 having an elongate body 24 and a projection balloon 26 inflatable via one or more ports 22. The instrument is preferably designed such that upon anchorage of the anchor balloon 16 within the heart (e.g., within a pulmonary vein), the projection balloon can be inflated such a shoulder portion 50 of the balloon 26 will be urged into close proximity with a target region 52 of cardiac tissue (e.g. an annular region of the atrial heart wall surrounding the ostium of a pulmonary vein).
  • The instrument can also include one or more ports 36 (in fluid communication with either the first catheter 12 or second catheter 20, or both) for delivering ablative fluid to the target region. Preferably, the ablative fluid is an energy transmissive medium, which helps deliver light, radiation or acoustic energy from a radiant energy source to a target tissue region. The ablative fluid also serves to clear blood from the vicinity of the instrument and compensate for irregularities in the shape of the heart that might otherwise compromise the seating of the instrument. The ablative fluid thus provides a clear transmission pathway external to the balloon.
  • Within the projection balloon 26 a radiant energy emitter 40 can be disposed remotely from the target tissue (e.g., within a central lumen of the coaxial catheters 12, 20). In one embodiment, the radiant energy source includes at least one optical fiber 42 coupled to a distal light projecting, optical element 44, which cooperate to project ablative light energy through the instrument to the target site. The catheter bodies, projection balloon and inflation/ablation fluids are all preferably substantially transparent to the radiant energy at the selected wavelength to provide a low-loss transmission pathway from the projection element 44 to the target.
  • FIG. 2 is a schematic illustration of an initial step in performing ablative surgery with radiant energy according to the invention, in which a guide wire 6 is introduced into a heart 2 and passed into a pulmonary vein 4. FIG. 3 illustrates the next step in performing ablative surgery according to the invention, in which a first catheter 12, carrying an anchoring balloon structure 16, is slid over the guide wire 6. This first catheter 12 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 12, which is sealed to the body of the catheter 14 by distal seal 15 and proximal seal 17, such that the introduction of an inflation fluid into the balloon 16 can inflate the balloon as shown in FIG. 4. For further details on anchoring balloon structures, see commonly owned, U.S. patent application Ser. No. 09/616,303 filed Jul. 14, 2000 entitled “Catheter Anchoring Balloon Structure with Irrigation,” the disclosures of which are hereby incorporated by reference.
  • FIG. 5 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which a second catheter 20, likewise having a elongated body 24 and carrying a projection balloon element 26, is slid over the first catheter body 14. This second catheter 20 also includes at least one internal fluid passageway (not shown) for inflation of the balloon 26, which is sealed to the body 24 of the catheter 20 by distal seal 21 and proximal seal 22, such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon as shown in FIG. 6.
  • Thus, FIG. 6 illustrates how which the projection balloon 26 of the second catheter 20 can be deployed and inflated to define a projection pathway for radiant energy ablation of cardiac tissue. Second catheter body 24 has an inner lumen 27 sized to pass over the inner catheter body 14. Once it is positioned in the heart, the projection balloon of the second catheter is then inflated. The expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention. In one preferred embodiment, the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • The projection balloons described herein can be preshaped to form a parabolic like shape. This can be accomplished, for example, by shaping and melting a TEFLON® film in a preshaped mold to effect the desired form. The projection balloons and sheaths of the present invention can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • It should be noted that it is not necessary (and in some cases, not desirable) for the projection balloon 26 to contact the target tissue in order to ensure radiant energy transmission. One purpose of the projection balloon is simply to clear a volume of blood away from the path of the energy emitter. With reference again to FIG. 1, an ablative fluid 29 can be employed outside of the instrument (e.g., between the balloon 26 and the target region 52) to ensure efficient transmission of the radiant energy when the instrument is deployed. The ablative fluid in this context is any fluid that can serve as a conductor of the radiant energy. This ablative fluid can be a physiologically compatible fluid, such as saline, or any other non-toxic aqueous fluid that is substantially transparent to the radiation. As shown in FIG. 1, the fluid 29 can be released via one or more exit ports 36 in the first catheter body 14 (and/or second catheter body 24) to flow between the projection balloon 26 and the surrounding tissue, thereby filling any gaps where the balloon 26 does not contact the tissue. The fluid 29 can also serve an irrigation function by displacing any blood within the path of the radiant energy, which could otherwise interfere with the radiant light energy transmission to the target region 52.
  • For alternative designs for delivery of ablative and/or irrigation fluids, see commonly-owned, U.S. patent application Ser. No. 09/660,601, filed Sep. 13, 2000 entitled “Balloon Catheter with Irrigation Sheath,” the disclosures of which are hereby incorporated by reference. For example, in one embodiment described in patent application Ser. No. 09/660,601, the projection balloon can be partially surrounded by a sheath that contains pores for releasing fluid near or at the target ablation site. One of ordinary skill in the art will readily appreciate that such pores can vary in shape and/or size. A person having ordinary skill in the art will readily appreciate that the size, quantity, and placement of the fluid ports of various designs can be varied to provide a desired amount of fluid to the treatment site.
  • FIG. 7 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which the guide wire is removed and replaced by a energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart. The energy emitter can be introduced into the instrument via the lumen 13 of the inner catheter. In the illustrated embodiment, the energy emitter 40 is a radiant energy emitter and includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43, which cooperate to project ablative light energy through the instrument to the target site. In one preferred embodiment, optical element is a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference.
  • FIGS. 8 and 9, taken together, illustrate an advantageous feature of the present invention, namely, the ability to select the location a lesion independent of the instrument design. Because the radiant energy emitter does not require contact with a target tissue region and is, in fact, decoupled from the rest of the instrument, the present invention permits the clinician to select a desired target region by simply moving the emitter (e.g., within the lumen 14 of the first catheter 12). As shown in FIG. 8, the radiant energy emitter can be positioned to form a wide circumferential lesion (when the shape of the pulmonary vein ostium warrants such a lesion) by positioning the radiant energy emitter at the rear of the projection balloon—at a distance from the target tissue. Alternatively, a smaller diameter lesion can be formed by positioning the radiant energy emitter closer to the front of the project balloon, as shown in FIG. 9. Such a lesion can be preferably when the geometer of the vein ostium presents a more gradual change in diameter, as shown. It should be appreciated that it may be desirable to change the intensity of the emitted radiation depending upon the distance it must be projected; thus a more intense radiant energy beam may be desirable in the scheme illustrated in FIG. 8 versus that shown in FIG. 9. The energy emitter 40 and catheter body 24 can each include one or more markers (shown schematically as elements 33 and 35 respectively) to aid in determining the location or tracking movements of the elements. Markers 33 and 35, for example, can be radioopaque lines that can visualized fluoroscopically. Various other marker mechanisms, such as magnetic, capacitive or optical markers, can also be used.
  • FIG. 10 is a schematic illustration of a further step in performing ablative surgery according to the invention, in which radiant energy emitter 40 (shown in FIGS. 7-9) has been removed and the anchor balloon element 16 of the first catheter 12 is deflated to permit removal of the first catheter body 14.
  • In FIG. 11, the first catheter is replaced by a mapping electrode catheter 88 via, for example, the central lumen of the second catheter 20. However, it should be appreciated that more than one lumen can be used to provide separate pathways for these instruments. Once the mapping electrode is positioned within a pulmonary vein, an electrical pulse can be applied to determine whether the lesion formed by the radiant energy emitter (as described above) is sufficient to serve as a conduction block.
  • FIG. 12 is a schematic illustration of a final step in which the projection balloon is deflated and removed while the mapping electrode remains in place to verify the formation of an electrical conduction block. Various techniques for conducting such tests are known by those skilled in the art. In one simple approach, a voltage pulse is applied by a coronary sinus catheter. The mapping, catheter's electrode is touched to the inner wall of the pulmonary vein. If no signal (or a substantially attenuated signal) is detected, a conduction block can thereby be confirmed. It should also be appreciated that the mapping electrode can in some instances be used even before the projection and/or anchor balloons are removed.
  • FIG. 13 is a schematic illustration of an alternative method of performing ablative surgery with radiant energy according to the invention without the need for an anchoring balloon. As shown in FIG. 13, a guide wire 6 can again be introduced into a heart and passed into a pulmonary vein 4. A catheter 20, carrying projection balloon structure 26, is slid over the guide wire 6. This catheter 20 can further include at least one internal fluid passageway (not shown) for inflation of the balloon 26, which is sealed to the body of the catheter 20 by distal seal 21 and proximal seal 22, such that the introduction of an inflation fluid into the balloon 26 can inflate the balloon.
  • FIG. 14 illustrates how the projection balloon 26 can then be inflated to define a projection pathway for radiant energy ablation of cardiac tissue. The expanded projection balloon defines a staging through which radiant energy can be projected in accordance with the invention. In one preferred embodiment, the projection balloon is filled with a radiation-transmissive fluid so that radiant energy from an energy emitter can be efficiently pass through the instrument to a target region of cardiac tissue.
  • The projection balloons described herein can be preshaped to form various shapes (e.g., to assist in seating the instrument at the mouth of a pulmonary vein or at other anatomically defined regions of the heart). As noted above, this can be accomplished, for example, by shaping and melting a TEFLON® film in a preshaped mold to effect the desired form. Again, the projection balloons can be made, for example, of thin wall polyethylene teraphthalate (PET) with a thickness of the membranes of about 5-50 micrometers.
  • One purpose of the projection balloon is clear a volume of blood away from the path of the energy emitter. Towards this end, the instrument can further include a fluid releasing mechanism in the form of one or more fluid ports (or a sheath that contains pores for releasing fluid) near or at the target ablation site. Again, the released fluid can serve as an ablative fluid by clearing a transmission pathway for radiant energy.
  • FIG. 15 is a schematic illustration of a further step in performing ablative surgery with the device of FIGS. 13-14, in which the guide wire is removed and replaced by a radiant energy emitter 40 located remote from the desired lesion site 52 but in a position that permits projection of radiant energy onto a target region of the heart. In the illustrated embodiment, the radiant energy emitter 40 includes at least one optical fiber 42 coupled to a distal light projecting, optical element 43, which cooperate to project ablative light energy through the instrument to the target site. In one preferred embodiment, optical element is again a lens element capable of projecting an annular (ring-shaped) beam of radiation, as described in more detail in commonly owned U.S. Pat. No. 6,423,055 issued Jul. 22, 2002, herein incorporated by reference. Alternatively, the radiant energy emitter can be an ultrasound or microwave energy source, as described in more detail below (in connection with FIGS. 19-20).
  • FIG. 16 further illustrates the unique utility of the multi-positionable, radiant energy ablation devices of the present invention in treating the complex cardiac geometries that are often encountered. As shown in the figure, the mouths of pulmonary veins typically do not present simple, funnel-shaped, or regular conical surfaces. Instead, one side of the ostium 4B can present a gentle sloping surface, while another side 4A presents a sharper bend. With prior art, contact-heating, ablation devices, such geometries will result in incomplete lesions if the heating element (typically a resisting heating band on the surface of an expandable element) can not fully engage the tissue of the vein or ostium. Because the position of the heating band of the prior art devices is fixed, when it does not fully contact the target tissue, the result is an arc, or incompletely formed ring-type, lesion that typically will be insufficient to block conduction.
  • FIG. 16 illustrates how the slidably positionable energy emitters of the present invention can be used to avoid this problem. Three potential positions of the emitter 40 are shown in the figure (labeled as “A”, “B” and “C”). As shown, positions A and C may not result in optimal lesions because of gaps between the balloon and the target tissue. Position B, on the other hand, is preferably because circumferential contact has been achieved. Thus, the independent positioning of the energy source relative to the balloon allows the clinician to “dial” an appropriately ring size to meet the encountered geometry. (Although three discrete locations are shown in FIG. 16, it should be clear that emitter can be positioned in many more positions and that the location can be varied in either discrete intervals or continuously, if so desired.)
  • Moreover, in some instances the geometries of the pulmonary vein (or the orientation of the projection balloon relative to the ostium) may be such that no single annular lesion can form a continuous conduction block. Again, the present invention provides a mechanism for addressing this problem by adjustment of the location of the energy emitter to form two or more partially circumferential lesions. As shown in FIG. 16A, the devices of the present invention can form a first lesion 94 and a second lesion 96, each in the form of an arc or partial ring. Because each lesion has a thickness (dependent largely by the amount of energy deposited into the tissue) the two lesions can axially combine, as shown, to form a continuous encircling or circumscribing lesion that blocks conduction.
  • FIG. 17 is a schematic illustration of one embodiment of a radiant energy emitter 40 according to the invention. In one preferred embodiment, the radiant energy is electromagnetic radiation, e.g., coherent or laser light, and the energy emitter 40 projects an hollow cone of radiation that forms an annular exposure pattern upon impingement with a target surface. For example, as shown in FIG. 1, radiant energy emitter 40 can include an optical fiber 42 in communication with an annulus-forming optical waveguide 44 having a concave interior boundary or surface 45. The waveguide 44 passes an annular beam of light to a graded intensity (GRIN) lens 46, which serves to collimate the beam, keeping the beam width the same, over the projected distance. The beam that exits from the distal window 43 of energy emitter 40 will expand (in diameter) over distance, but the energy will remain largely confined to a narrow annular band. Generally, the angle of projection from the central axis of the optical fiber 42 or waveguide 44 will be between about 20 and 45 degrees.
  • The diameter of the annular beam of light will be dependent upon the distance from the point of projection to point of capture by a surface, e.g., a tissue site, e.g., an interstitial cavity or lumen. Typically, when the purpose of the radiant energy projection is to form a transmural cardiac lesion, e.g., around a pulmonary vein, the diameter of the annular beam will be between about 10 mm and about 33 mm, preferably greater than 10 mm, greater than 15 mm, greater than 20 mm, and most preferably, greater than or equal to 23 mm. Typically, angle of projected annular light is between about 20 and about 45 degrees, preferably between about 17 and about 30 degrees, most preferably between about 16 and about 25 degrees.
  • Preferred energy sources for use with the percutaneous ablation instruments of the present invention include laser light in the range between about 200 nanometers and 2.5 micrometers. In particular, wavelengths that correspond to, or are near, water absorption peaks are often preferred. Such wavelengths include those between about 805 nm and about 1060 nm, preferably between about 900 nm and 1000 nm, most preferably, between about 915 nm and 980 nm. In a preferred embodiment, wavelengths around 915 nm or around 980 nm are used during endocardial procedures. Suitable lasers include excimer lasers, gas lasers, solid state lasers and laser diodes. One preferred AlGaAs diode array, manufactured by Spectra Physics, Tucson, Ariz., produces a wavelength of 980 nm.
  • The optical waveguides, as described in above, can be made from materials known in the art such as quartz, fused silica or polymers such as acrylics. Suitable examples of acrylics include acrylates, polyacrylic acid (PAA) and methacrylates, polymethacrylic acid (PMA). Representative examples of polyacrylic esters include polymethylacrylate (PMA), polyethylacrylate and polypropylacrylate. Representative examples of polymethacrylic esters include polymethylmethacrylate (PMMA), polyethylmethacrylate and polypropylmethacrylate. In one preferred embodiment, the waveguide 44 is formed of quartz and fused to the end face of fiber 42.
  • Internal shaping of the waveguide can be accomplished by removing a portion of material from a unitary body, e.g., a cylinder or rod. Methods known in the art can be utilized to modify waveguide to have tapered inner walls, e.g., by grinding, milling, ablating, etc. In one approach, a hollow polymeric cylinder, e.g., a tube, is heated so that the proximal end collapses and fuses together, forming an integral proximal portion which tapers to the distal end of the waveguide. In another approach, the conical surface 45 can be formed in a solid quartz cylinder or rod by drilling with a tapered bore.
  • Waveguide 44 can be optical coupled to optical fiber 42 by various methods known in the art. These methods include for example, gluing, or fusing with a torch or carbon dioxide laser. In one embodiment (shown in FIG. 19), waveguide 44, optical fiber 42 and, optionally, a gradient index lens (GRIN) 46 are in communication and are held in position by heat shrinking a polymeric jacket material 68, such as polyethylene terephthalate (PET) about the optical apparatus 40.
  • FIG. 18 is a schematic illustration of another embodiment of a radiant energy emitter 40A according to the invention in which optical fiber 42 is coupled to a light diffuser 41 having light scattering particles 47 to produce a sidewise cylindrical exposure pattern of ablative radiation. This embodiment can be useful, for example, in creating a lesion within a pulmonary vein. With reference again to FIG. 1, it should be clear that the radiant energy emitter of the design shown in FIG. 14 can be advanced to front of the projection balloon to permit diffuse exposure of a pulmonary vein ostium if a lesion is desired in that location. For further details on the construction of light diffusing elements, see U.S. Pat. No. 5,908,415 issued to Sinofsky on Jun. 1, 1999, herein incorporated by reference.
  • FIG. 19 illustrates an alternative embodiment of a radiant energy emitter 40C in which an ultrasound transducer 60, comprising individual shaped transducer elements or lenses 62 which direct the ultrasound energy into a cone of energy that can likewise form an annular exposure pattern upon impingement with a target surface. The emitter 40C is supported by a sheath 66 or similar elongate body, enclosing electrical leads, and thereby permitting the clinician to advance the emitter through an inner lumen of the instrument to a desired position for ultrasound emission.
  • Yet another embodiment of a radiant energy emitter 40D is illustrated in FIG. 20 where microwave energy is similarly focused into an annular exposure beam. As shown in FIG. 20, the radiant energy emitter can include a coaxial transmission line 74 (or similar electrical signal leads) and a helical coil antenna 73. Radiation reflectors 72A and 72B cooperated to shield and direct the radiation into a cone. In other embodiments, a radioisotope or other source of ionizing radiation can be used in lieu of the microwave antenna 73, again with appropriate radiation shielding elements 72A and 72B to project a beam of ionizing radiation.
  • FIGS. 21 and 22 illustrate one embodiment of a contact sensor according to the invention incorporated into a radiant emitter assembly. The assembly can includes an outer, radiant energy transparent body 70 that encases the assembly and facilitates its slidable positioning within an inner lumen of catheter body 14. The assembly further includes an energy emitter 40 (e.g., like those described above in connection with FIGS. 17-20) which can also act as the sensing fiber. In the illustrated embodiment, four illumination fibers 76A-76D are shown. If the ablative apparatus of the invention is properly positioned within the heart, light transmitted via such fibers will strike the target region, be reflected back, and detected by the energy emitter (or other sensing element). The use of four illumination fibers allows simultaneous or sequential sensing of contact in four “quadrants.” (It should be clear that the invention can be practiced with various numbers of illuminating and/or sensing elements, and with or without use of the energy emitter as an element in the contact sensing module. Moreover, ultrasound emitters and detectors can also be used in the same manner in lieu of the light reflecting mechanisms to determine contact. In any event, the output signals of the sensors can be electronically processed and incorporated into a display.) The sensors of FIGS. 21-22 provide the ability to position the percutaneous ablation instruments of the present invention at a treatment site such that proper location of the energy emitter vis-a-vis the target tissue (as well a satisfactory degree of contact between the projection balloon and the tissue) is achieved. This ability is based on reflectance measurements of light scattered or absorbed by blood, body fluids and tissue. For example, white light projected from sensing fibers 76 toward tissue has several components including red and green light. Red light has a wavelength range of about 600 to about 700 nanometers (nm) and green light has a wavelength range of about 500 to about 600 nm. When the projected light encounters blood or body fluids, most if not all green light is absorbed and hence very little green or blue light will be reflected back toward the optical assembly which includes a reflected light collector. As the apparatus is positioned such that blood and body fluids are removed from the treatment field cleared by an inflated balloon member, the reflectance of green and blue light increases as biological tissue tends to reflect more green light. As a consequence, the amount of reflected green or blue light determines whether there is blood between the apparatus and the tissue or not.
  • For example, as the instrument is positioned in a heart chamber, the green-blue reflectance signal should remain nearly at zero until the projection balloon is inflated and positioned proximal to the surface of the heart tissue. When the inflated balloon member contacts the heart tissue (or is close enough that the balloon and ablative fluid released by the instrument form a clear transmission pathway), green light is reflected back into the optical assembly and the collector. In one embodiment, only green light is projected toward the tissue surface. In another embodiment, red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately. The use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned. The ratio of the two different wavelengths can be measured. For example, the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the inflated balloon, with the tissue the ratio of red light to green light would be high. Once a transmission pathway is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • The reflected light is transmitted back through a collector, such as an optical fiber to a spectrophotometer. The spectrophotometer (Ocean Optics Spectrometer, Dunedin, Fla., model S-2000) produces a spectrum for each reflected pulse of reflected light. Commercially available software (LabView Software, Austin, Tex.) can isolate values for specific colors and perform ratio analyses.
  • In any event, the use of multiple optical fiber illumination fibers positioned about the lumen of the catheter, permit the operator to determine the plane in which the catheter and balloon should be adjusted to minimize blood between the optical assembly and the treatment site.
  • One suitable optical fiber/collector is described in U.S. Pat. No. 6,071,302, issued to Edward Sinofsky on Jun. 6, 2000, the contents of which are incorporated herein by reference.
  • Once the operator is satisfied with the positioning of the instrument, radiant energy can then be projected to the target tissue region. If the radiant energy is electromagnetic radiation, e.g., laser radiation, it can be emitted onto the tissue site via a separate optical fiber or, alternatively, through the same optical fiber used to transmitting the white, green or red light. The laser light can be pulsed intermittently in synchronous fashion with the positioning/reflecting light to ensure that the pathway remains clear throughout the procedure.
  • It should be clear that the contact sensing aspects of the present invention are not limited to radiant energy ablation devices but can also be useful in placement of contact heating or cooling ablation instruments as well. For example, in FIG. 23, a contact-heating device 54 having an expandable element 56 and a contact heating element 58 is shown disposed in a pulmonary vein. The contact heating element can be a line or grid of electrically conductive material printed on the surface of the expandable element. In one embodiment, the expandable element can be substantially opaque to certain wavelengths (e.g., visible light) except for a transparent band 59, on which the contact heating element is situated. The heating wires should also be sufficiently transparent (or cover a substantially small area of the band) so as to not interfere with reflection signal collection. The device 54 can further include a sensor disposed within a central lumen of the device having an illuminating fiber and and a plurality of collecting fibers
  • The contact sensor can operate in substantially same fashion as described above. For example, when the ablation device 54 of FIG. 23 is positioned in a pulmonary vein, and illuminated with light from within, a green-blue reflectance signal should remain nearly at zero until the expandable element 56 is inflated and positioned proximal to the surface of the heart tissue. When the portion of inflated expandable element 56 that carries the ablation band 58 contacts the heart tissue, green light is reflected back into the optical assembly and the collector. In one embodiment, only green light is projected toward the tissue surface. In another embodiment, red and green light are both projected toward the tissue surface. The red and green light can be transmitted simultaneously or separately. Again, the use of both red and green light provides the advantage that there is no requirement that the operator needs to know how much light must be transmitted into the balloon toward the tissue surface to insure that a reflectance signal is returned. The ratio of the two different wavelengths can be measured. For example, the instrument can measure reflectance of both green light and red light. When the intensity of the light is sufficient, reflected red light is detected throughout the positioning process. Prior to contact of the instrument, and more specifically the contact-heating ablation band, with the tissue, the ratio of red light to green light would be high. Once contact is established, the ratio drops since more light is reflected from the tissue without any intervening blood to absorb the green light.
  • In FIG. 23A, another embodiment of a contact sensing catheter is shown in the form of a cryogenic ablation catheter 110 having a catheter body 112 and internal conduits 114 for circulation of a cryogenic fluid from a cryogenic fluid source 115. The catheter body includes conductive regions 116 where the cold temperature can be applied to tissue. The sensors 76 of the present invention can be disposed in proximity to the conductive regions, as shown and used to determine whether tissue contact has been made.
  • In FIG. 23B yet another application for the contact sensors is shown in connection with an ultrasound, contact-heating balloon catheter 120, having a balloon 122 (similar to that discussed above in connection with FIG. 23) for contacting a pulmonary vein and having a band 123 for applying heat to tissue. The ultrasound ablation instrument 120 further includes transducers 124 driven by actuator 125 to heat the ablative band 123. Again, the sensors 76 of the present invention can be disposed in proximity to the ablation band 123, as shown, and used to determine whether tissue contact has been made.
  • In FIG. 24, a translatory mechanism 80 is shown for controlled movement of a radiant energy emitter within the instruments of the present invention. The exemplary positioner 80 is incorporated into a handle 84 in the proximal region of the instrument, where the elongate body 82 of the radiant energy emitter 40 engages a thumb wheel 86 to control advancement and retraction of the emitter. It should be clear that various alternative mechanisms of manual or automated nature can be substituted for the illustrated thumb wheel 86 to position the emitter at a desired location relative to the target tissue region.
  • In addition, as shown in FIG. 24, the elongate body 82 that supports the radiant energy emitter 40 (e.g., an optical fiber assembly as shown in FIGS. 21-22 or the sheath for the electrical leads as shown in connection with FIGS. 19-20) can further include position indicia 92 on its surface to assist the clinician in placement of the emitter within the projection balloon. The handle can further include a window 90 whereby the user can read the indicia (e.g., gradation markers) to gauge how far the emitter has been advanced into the instrument.
  • Although described in connection with cardiac ablation procedures, it should be clear that the instruments of the present invention can be used for a variety of other procedures where treatment with radiant energy is desirable, including laparoscopic, endoluminal, perivisceral, endoscopic, thoracoscopic, intra-articular and hybrid approaches.
  • The term “radiant energy” as used herein is intended to encompass energy sources that do not rely primarily on conductive or convective heat transfer. Such sources include, but are not limited to, acoustic and electromagnetic radiation sources and, more specifically, include microwave, x-ray, gamma-ray, and radiant light sources. The term “light” as used herein is intended to encompass electromagnetic radiation including, but not limited to, visible light, infrared and ultraviolet radiation.
  • The term “continuous” in the context of a lesion is intended to mean a lesion that substantial blocks electrical conduction between tissue segments on opposite sides of the lesion. The terms “circumferential” and/or “curvilinear,” including derivatives thereof, are herein intended to mean a path or line which forms an outer border or perimeter that either partially or completely surrounds a region of tissue, or separate one region of tissue from another. Further, a “circumferential” path or element may include one or more of several shapes, and may be for example, circular, annular, oblong, ovular, elliptical, or toroidal.
  • The term “lumen,” including derivatives thereof, in the context of biological structures, is herein intended to mean any cavity or lumen within the body which is defined at least in part by a tissue wall. For example, cardiac chambers, the uterus, the regions of the gastrointestinal tract, the urinary tract, and the arterial or venous vessels are all considered illustrative examples of body spaces within the intended meaning.
  • The term “catheter” as used herein is intended to encompass any hollow instrument capable of penetrating body tissue or interstitial cavities and providing a conduit for selectively injecting a solution or gas, including without limitation, venous and arterial conduits of various sizes and shapes, bronchoscopes, endoscopes, cystoscopes, culpascopes, colonscopes, trocars, laparoscopes and the like. Catheters of the present invention can be constructed with biocompatible materials known to those skilled in the art such as those listed supra, e.g., silastic, polyethylene, Teflon, polyurethanes, etc. The term “lumen,” including derivatives thereof, in the context of catheters is intended to encompass any passageway within a catheter instrument (and/or track otherwise joined to such instrument that can serve as a passageway) for the passage of other component instruments or fluids or for delivery of therapeutic agents or for sampling or otherwise detecting a condition at a remote region of the instrument.
  • It should be understood that the term “balloon” encompasses deformable hollow shapes which can be inflated into various configurations including balloon, circular, tear drop, etc., shapes dependent upon the requirements of the body cavity. Such balloon elements can be elastic or simply capable of unfolding or unwrapping into an expanded state.
  • The term “transparent” is well recognized in the art and is intended to include those materials which allow transmission of energy through, for example, the primary balloon member. Preferred transparent materials do not significantly impede (e.g., result in losses of over 20 percent of energy transmitted) the energy being transferred from an energy emitter to the tissue or cell site. Suitable transparent materials include fluoropolymers, for example, fluorinated ethylene propylene (FEP), perfluoroalkoxy resin (PFA), polytetrafluoroethylene (PTFE), and ethylene-tetrafluoroethylene (ETFE).
  • One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.

Claims (78)

1. A cardiac ablation instrument comprising:
a catheter body adapted for disposition within a heart having at least one lumen therein, which body can be deployed at a desired location within the heart; and
an energy emitter movable within a lumen of the catheter body such that it can be disposed at the desired location and deliver ablative energy to a target tissue site.
2. The instrument of claim 1, wherein the energy emitter is slidably disposed within a lumen of the catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the catheter body.
3. The instrument of claim 1, wherein the energy emitter is a radiant energy emitter.
4. The instrument of claim 1, wherein the energy emitter projects a ring of radiant ablative energy of variable diameter based on its axial position within the catheter body.
5. The instrument of claim 3 wherein the catheter body further comprises a projection balloon.
6. The instrument of claim 5 wherein the catheter body further comprises a projection balloon adapted for inflation in proximity to a pulmonary vein ostium to provide a transmission pathway for radiant energy.
7. The instrument of claim 3, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and a light emitting tip at a distal end of the fiber for emitting light.
8. The instrument of claim 7, wherein the light emitting tip further comprises a beam forming optical waveguide for projecting an annular beam of light, such that the radiant energy emitter projects a ring of ablative energy of variable diameter based on its axial position within the catheter body.
9. The instrument of claim 3 wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm.
10. The instrument of claim 3, wherein the instrument further comprises a light source for generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
11. The instrument of claim 3, wherein the energy emitter comprises an ultrasound generator.
12. The instrument of claim 11, wherein the ultrasound generator generates ultrasound energy at at least one wavelength in the range of about 5 to about 20 MHz.
13. The instrument of claim 11, wherein the ultrasound generator generates ultrasound energy at at least one wavelength in the range of about 7 to about 10 MHz.
14. The instrument of claim 3, wherein the energy emitter comprises a microwave generator.
15. The instrument of claim 5, wherein the instrument further comprises a contact sensor for sensing contact between the projection balloon and target tissue.
16. The instrument of claim 15, wherein the contact sensor further comprises a contact sensing element movable within a lumen of the catheter body such that it can be disposed at various locations to detect reflected radiant energy and, based on the reflected energy, select a desired location for forming a lesion.
17. The instrument of claim 15, wherein the reflectance sensor further comprises a light detector for detecting reflected light energy.
18. The instrument of claim 15, wherein the reflectance sensor further comprises an ultrasound detector for detecting reflected ultrasound energy.
19. A cardiac ablation instrument comprising:
a catheter body adapted for disposition within a heart having at least one lumen therein; and
a contact sensing element movable within a lumen of the catheter body such that it can be disposed at various locations to detect reflected radiant energy and, based on the reflected energy, select a desired location for forming a lesion.
20. The instrument of claim 19, wherein the contact sensing element further comprises a light detector for detecting reflected light energy.
21. The instrument of claim 19, wherein the contact sensing element further comprises an ultrasound detector for detecting reflected ultrasound energy.
22. The instrument of claim 19 wherein the instrument further comprises a projection balloon for clearing a transmission pathway for radiant energy from an energy emitter to a target treatment site.
23. The instrument of claim 19 wherein the instrument further comprises at least one optical sensor within the instrument for receiving reflected light.
24. The instrument of claim 23 wherein the instrument further comprises a source of illumination for illuminating a region surrounding the instrument and inducing reflected light that can be collected by the optical sensor.
25. The instrument of claim 23 wherein the instrument further comprises a detector capable of distinguishing at least two wavelengths of reflected light.
26. The instrument of claim 19, wherein the instrument further comprises a radiant energy emitter that is slidably disposed within a lumen of the catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the catheter body.
27. The instrument of claim 26, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and beam forming optics at a distal end of the fiber for projecting an annular beam of light.
28. The instrument of claim 27, wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm
29. The instrument of claim 26, wherein the radiant energy emitter comprises an ultrasound generator.
30. The instrument of claim 26, wherein the radiant energy emitter comprises a microwave generator.
31. The instrument of claim 19 wherein the instrument further comprises an ablation element at the distal end of the catheter body.
32. The instrument of claim 31 wherein the ablation element is a contact heating element.
33. The instrument of claim 31 wherein the instrument further comprises an expandable element and the ablation element is coupled to at least a portion of the expandable element.
34. The instrument of claim 31 wherein the ablation element comprises at least one electrode adapted to couple to an electric current source.
35. The instrument of claim 34 wherein the electrode is coupled to a radio frequency electric current source.
36. The instrument of claim 31 wherein the ablation element is a cryogenic ablation element.
37. The instrument of claim 31 wherein the ablation element is an ultrasound ablation element.
38. The instrument of claim 31 wherein the ablation element is adapted to be positioned at a location where a pulmonary vein extends from an atrium.
39. The instrument of claim 19 wherein the contact sensor comprises at least one optic fiber for collecting reflected light.
40. The instrument of claim 19 wherein the contact sensor comprises a plurality of optic fibers for illuminating light to different directions.
41. A cardiac ablation instrument comprising:
a first catheter body adapted for disposition within a heart having at least one lumen therein and comprising at least one anchorage element which can be deployed at the desired location to contact a cardiac structure and secure the device in place; and
a radiant energy emitter movable within a lumen of the first catheter body such that it can be disposed at the desired location and deliver radiant energy through a transmissive region of the instrument to a target tissue site.
42. The instrument of claim 41 wherein the anchorage element is an anchor balloon adapted for inflation within a pulmonary vein to secure the instrument at a desired location.
43. The instrument of claim 41, wherein the radiant energy emitter is slidably disposed within a lumen of the first catheter body and the instrument further comprises a translatory mechanism for positioning the emitter at a selected location within the first catheter body.
44. The instrument of claim 41, wherein the radiant energy emitter further comprises a light transmitting optical fiber adapted to receive radiant energy from a light source and a light emitting tip at a distal end of the fiber for emitting light.
45. The instrument of claim 44, wherein the light emitting tip further comprises a beam forming optical waveguide for projecting an annular beam of light.
46. The instrument of claim 44, wherein the light emitting tip further comprises a light diffusing element.
47. The instrument of claim 44, wherein the instrument further comprises a light source for generating photoablative radiation at desired wavelengths ranging from between about 800 nm and about 1000 nm
48. The instrument of claim 44, wherein the instrument further comprises a light source for generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
49. The instrument of claim 41, wherein the radiant energy emitter comprises an ultrasound generator.
50. The instrument of claim 41, wherein the radiant energy emitter comprises a microwave generator.
51. The instrument of claim 41 wherein the instrument further comprises a second catheter body with an inner channel, configured for coupling to the first catheter body via the channel such that the second catheter body can be passed over the first catheter body into a position within the heart, and having an inflatable projection balloon which be deployed to clear blood from a surrounding region within the heart.
52. The instrument of claim 41 wherein the instrument further comprises a contact sensor.
53. The instrument of claim 42 wherein the instrument further comprises at least one optical sensor within the instrument for receiving reflected light.
54. The instrument of claim 53 wherein the instrument further comprises a source of illumination for illuminating a region surrounding the instrument and inducing reflected light that can be collected by the optical sensor.
55. The instrument of claim 53 wherein the instrument further comprises a detector capable of distinguishing at least two wavelengths of reflected light.
56. A method of ablating cardiac tissue, comprising:
positioning a guide wire in proximity to a target region of cardiac tissue;
coupling a first catheter having at least one lumen to the positioned guide wire via the lumen such that the first catheter can be passed over the guide wire into a position within the heart;
removing the guide wire and replacing it with a radiant energy emitter slidable movable within a lumen of the first catheter such that it can be disposed at the desired location; and
activating the radiant energy emitter to deliver radiant energy through a transmissive region of the first catheter to the target tissue region to ablate tissue and form a conduction block.
57. The method of claim 56 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce photocoagulation of cardiac tissue within the target region.
58. The method of claim 57 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce a continuous lesion in the cardiac tissue.
59. The method of claim 57 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element having a beam-forming optical waveguide to expose the target region to an annular beam of light energy to induce a circumferential lesion in cardiac tissue.
60. The method of claim 57, the step of activating the radiant energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 800 nm to about 1000 nm
61. The method of claim 57, the step of activating the radiant energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
62. The method of claim 56, the step of activating the radiant energy emitter further comprises activating an ultrasound emitting element to expose the target region to acoustic energy to induce photocoagulation of cardiac tissue within the target region.
63. The method of claim 56, the step of activating the radiant energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within the target region.
64. The method of claim 56 wherein the method further comprises inflating a projection balloon to clear blood from a transmission pathway between the energy emitter and a target region of cardiac tissue.
65. The method of claim 56 wherein the method further comprises determining whether a clear transmission path has been established between the radiant energy emitter and the target tissue based on reflectance measurements by an optical sensor disposed within the lumen of the first catheter.
66. The method of claim 65 wherein the method further comprises measuring at least two different wavelengths of reflected light collected by the optical sensor to determine whether a projection path exists.
67. A method of treating atrial fibrillation, comprising:
positioning a distal portion of an ablation instrument in proximity to one or more pulmonary veins, the instrument having a hollow housing and an independently positionable energy emitter within the distal portion, the distal portion being transmissive to radiant energy; and
activating the energy emitter to transmit energy through the housing to form an annular lesion in proximity to the one or more pulmonary veins.
68. The method of claim 67, the step of activating the radiant energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of light, ultrasound, microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within a target region.
69. The method of claim 67 wherein the method further comprises
inflating a projection balloon to clear blood from a transmission pathway between the energy emitter and a target region of cardiac tissue.
70. The method of claim 69 wherein the method further comprises determining whether a clear transmission path exists between the energy emitter and the target region based on reflectance measurements by an optical sensor disposed within the ablation instrument.
71. The method of claim 70 wherein the method further comprises measuring at least two different wavelengths of reflected light collected by the optical sensor to determine whether a projection path has been established.
72. The method of claim 67 wherein the step of activating the energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce photocoagulation of cardiac tissue within the target region.
73. The method of claim 67 wherein the step of activating the radiant energy emitter further comprises activating a light emitting element to expose the target region to light energy to induce a continuous lesion in the cardiac tissue.
74. The method of claim 67 wherein the step of activating the energy emitter further comprises activating a light emitting element having a beam-forming optical waveguide to expose the target region to an annular beam of light energy to induce a circumferential lesion in cardiac tissue.
75. The method of claim 67, the step of activating the energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 800 μm to about 1000 nm
76. The method of claim 67, the step of activating the energy emitter further comprises activating a light emitting element generating photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.
77. The method of claim 67, the step of activating the energy emitter further comprises activating an ultrasound emitting element to expose the target region to acoustic energy to induce photocoagulation of cardiac tissue within the target region.
78. The method of claim 67, the step of activating the energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within the target region.
US10/357,156 1994-09-09 2003-02-03 Coaxial catheter instruments for ablation with radiant energy Expired - Fee Related US8025661B2 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
US10/357,156 US8025661B2 (en) 1994-09-09 2003-02-03 Coaxial catheter instruments for ablation with radiant energy
CA002515029A CA2515029A1 (en) 2003-02-03 2004-02-03 Coaxial catheter instruments for ablation with radiant energy
JP2006503305A JP4732330B2 (en) 2003-02-03 2004-02-03 Coaxial catheter device for ablation with radiant energy
PCT/US2004/003141 WO2004069072A2 (en) 2003-02-03 2004-02-03 Coaxial catheter instruments for ablation with radiant energy
EP04707827A EP1592358A2 (en) 2003-02-03 2004-02-03 Coaxial catheter instruments for ablation with radiant energy
AU2004208838A AU2004208838A1 (en) 2003-02-03 2004-02-03 Coaxial catheter instruments for ablation with radiant energy
US10/865,558 US8540704B2 (en) 1999-07-14 2004-06-10 Guided cardiac ablation catheters
US11/062,903 US20050234437A1 (en) 1999-07-14 2005-02-22 Deflectable sheath catheters with out-of-plane bent tip
US11/062,906 US20050222558A1 (en) 1999-07-14 2005-02-22 Methods of cardiac ablation employing a deflectable sheath catheter
US11/062,774 US20050234436A1 (en) 1999-07-14 2005-02-22 Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
US11/062,905 US7935108B2 (en) 1999-07-14 2005-02-22 Deflectable sheath catheters
US11/481,204 US8241272B2 (en) 1994-09-09 2006-07-05 Methods for ablation with radiant energy
US11/504,354 US8277444B2 (en) 1994-09-09 2006-08-15 Treatment of atrial fibrillation by overlapping curvilinear lesions
US12/423,178 US9033961B2 (en) 1999-07-14 2009-04-14 Cardiac ablation catheters for forming overlapping lesions
US12/423,137 US8900219B2 (en) 1999-07-14 2009-04-14 System and method for visualizing tissue during ablation procedures
US12/424,757 US8366705B2 (en) 1994-09-09 2009-04-16 Coaxial catheter instruments for ablation with radiant energy
US12/501,206 US20090275934A1 (en) 1999-07-14 2009-07-10 Ablation instrument having deflectable sheath catheters with out-of plane bent tip
US13/099,105 US8267932B2 (en) 1999-07-14 2011-05-02 Deflectable sheath catheters
US13/099,070 US8231613B2 (en) 1999-07-14 2011-05-02 Deflectable sheath catheters
US13/353,086 US8444639B2 (en) 1994-09-09 2012-01-18 Coaxial catheter instruments for ablation with radiant energy
US13/545,295 US20130012923A1 (en) 1999-07-14 2012-07-10 Deflectable sheath catheters
US13/952,013 US20140031802A1 (en) 1999-07-14 2013-07-26 Guided cardiac ablation catheters
US14/530,002 US9421066B2 (en) 1999-07-14 2014-10-31 System and method for visualizing tissue during ablation procedures
US15/380,637 US9861437B2 (en) 1999-07-14 2016-12-15 Guided cardiac ablation catheters

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US30360594A 1994-09-09 1994-09-09
US08/827,631 US5908415A (en) 1994-09-09 1997-04-10 Phototherapy methods and apparatus
US08/991,130 US5947959A (en) 1994-09-09 1997-12-16 Phototherapeutic apparatus with diffusive tip assembly
US09/357,355 US6423055B1 (en) 1999-07-14 1999-07-14 Phototherapeutic wave guide apparatus
US09/390,964 US6270492B1 (en) 1994-09-09 1999-09-07 Phototherapeutic apparatus with diffusive tip assembly
US09/602,420 US6572609B1 (en) 1999-07-14 2000-06-23 Phototherapeutic waveguide apparatus
US09/616,275 US6626900B1 (en) 1999-07-14 2000-07-14 Intralumenal contact sensor
US09/924,393 US6676656B2 (en) 1994-09-09 2001-08-07 Surgical ablation with radiant energy
US10/357,156 US8025661B2 (en) 1994-09-09 2003-02-03 Coaxial catheter instruments for ablation with radiant energy

Related Parent Applications (4)

Application Number Title Priority Date Filing Date
US09/616,275 Continuation-In-Part US6626900B1 (en) 1994-09-09 2000-07-14 Intralumenal contact sensor
US09/924,393 Continuation-In-Part US6676656B2 (en) 1994-09-09 2001-08-07 Surgical ablation with radiant energy
US09/924,394 Continuation-In-Part US6579285B2 (en) 1994-09-09 2001-08-07 Photoablation with infrared radiation
US11/062,905 Continuation-In-Part US7935108B2 (en) 1999-07-14 2005-02-22 Deflectable sheath catheters

Related Child Applications (13)

Application Number Title Priority Date Filing Date
US08/827,631 Continuation US5908415A (en) 1994-09-09 1997-04-10 Phototherapy methods and apparatus
US09/924,393 Continuation-In-Part US6676656B2 (en) 1994-09-09 2001-08-07 Surgical ablation with radiant energy
US10/674,114 Continuation-In-Part US6942657B2 (en) 1999-07-14 2003-09-29 Intralumenal contact sensor
US10/865,558 Continuation-In-Part US8540704B2 (en) 1999-07-14 2004-06-10 Guided cardiac ablation catheters
US11/062,905 Continuation-In-Part US7935108B2 (en) 1999-07-14 2005-02-22 Deflectable sheath catheters
US11/062,774 Continuation-In-Part US20050234436A1 (en) 1999-07-14 2005-02-22 Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
US11/062,906 Continuation-In-Part US20050222558A1 (en) 1999-07-14 2005-02-22 Methods of cardiac ablation employing a deflectable sheath catheter
US11/062,903 Continuation-In-Part US20050234437A1 (en) 1999-07-14 2005-02-22 Deflectable sheath catheters with out-of-plane bent tip
US11/481,204 Division US8241272B2 (en) 1994-09-09 2006-07-05 Methods for ablation with radiant energy
US11/504,354 Continuation US8277444B2 (en) 1994-09-09 2006-08-15 Treatment of atrial fibrillation by overlapping curvilinear lesions
US12/423,178 Continuation-In-Part US9033961B2 (en) 1999-07-14 2009-04-14 Cardiac ablation catheters for forming overlapping lesions
US12/424,757 Continuation-In-Part US8366705B2 (en) 1994-09-09 2009-04-16 Coaxial catheter instruments for ablation with radiant energy
US12/424,757 Continuation US8366705B2 (en) 1994-09-09 2009-04-16 Coaxial catheter instruments for ablation with radiant energy

Publications (3)

Publication Number Publication Date
US20040006333A1 US20040006333A1 (en) 2004-01-08
US20050038419A9 true US20050038419A9 (en) 2005-02-17
US8025661B2 US8025661B2 (en) 2011-09-27

Family

ID=32849557

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/357,156 Expired - Fee Related US8025661B2 (en) 1994-09-09 2003-02-03 Coaxial catheter instruments for ablation with radiant energy
US11/481,204 Expired - Lifetime US8241272B2 (en) 1994-09-09 2006-07-05 Methods for ablation with radiant energy
US11/504,354 Expired - Fee Related US8277444B2 (en) 1994-09-09 2006-08-15 Treatment of atrial fibrillation by overlapping curvilinear lesions
US12/424,757 Expired - Fee Related US8366705B2 (en) 1994-09-09 2009-04-16 Coaxial catheter instruments for ablation with radiant energy
US13/353,086 Expired - Fee Related US8444639B2 (en) 1994-09-09 2012-01-18 Coaxial catheter instruments for ablation with radiant energy

Family Applications After (4)

Application Number Title Priority Date Filing Date
US11/481,204 Expired - Lifetime US8241272B2 (en) 1994-09-09 2006-07-05 Methods for ablation with radiant energy
US11/504,354 Expired - Fee Related US8277444B2 (en) 1994-09-09 2006-08-15 Treatment of atrial fibrillation by overlapping curvilinear lesions
US12/424,757 Expired - Fee Related US8366705B2 (en) 1994-09-09 2009-04-16 Coaxial catheter instruments for ablation with radiant energy
US13/353,086 Expired - Fee Related US8444639B2 (en) 1994-09-09 2012-01-18 Coaxial catheter instruments for ablation with radiant energy

Country Status (6)

Country Link
US (5) US8025661B2 (en)
EP (1) EP1592358A2 (en)
JP (1) JP4732330B2 (en)
AU (1) AU2004208838A1 (en)
CA (1) CA2515029A1 (en)
WO (1) WO2004069072A2 (en)

Cited By (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065504A1 (en) * 1999-07-14 2005-03-24 Gerald Melsky Guided cardiac ablation catheters
US20050222557A1 (en) * 1999-07-14 2005-10-06 Cardiofocus, Inc. Deflectable sheath catheters
US20060212027A1 (en) * 2005-03-17 2006-09-21 Nassir Marrouche Treating internal body tissue
US20060253113A1 (en) * 1994-09-09 2006-11-09 Cardiofocus, Inc. Methods for ablation with radiant energy
US20070049911A1 (en) * 2005-08-26 2007-03-01 Brown Joe D Endovascular method and apparatus with feedback
US20070055223A1 (en) * 2003-02-04 2007-03-08 Cardiodex, Ltd. Methods and apparatus for hemostasis following arterial catheterization
US20070167828A1 (en) * 2005-02-02 2007-07-19 Vahid Saadat Tissue imaging system variations
US20070293724A1 (en) * 2005-02-02 2007-12-20 Voyage Medical, Inc. Visualization apparatus for transseptal access
US20080015445A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Tissue visualization device and method variations
US20080015569A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Methods and apparatus for treatment of atrial fibrillation
US20080027517A1 (en) * 2003-03-14 2008-01-31 Light Sciences Oncology, Inc. Light generating device for intravascular use
US20080033519A1 (en) * 2003-03-14 2008-02-07 Light Sciences Oncology, Inc. Light generating device for intravascular use
US20080033241A1 (en) * 2006-08-01 2008-02-07 Ruey-Feng Peh Left atrial appendage closure
US20080058591A1 (en) * 2005-10-25 2008-03-06 Voyage Medical, Inc. Tissue visualization device and method variations
US20080064969A1 (en) * 2006-09-11 2008-03-13 Nathan Kastelein Automated Mapping of Anatomical Features of Heart Chambers
US20080154293A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Retractable Separating Systems and Methods
US20080154296A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Tissue Separating Systems and Methods
US20080167643A1 (en) * 2004-11-22 2008-07-10 Cardiodex Ltd. Techniques for Heating-Treating Varicose Veins
US20080183036A1 (en) * 2006-12-18 2008-07-31 Voyage Medical, Inc. Systems and methods for unobstructed visualization and ablation
US20080195088A1 (en) * 1999-07-14 2008-08-14 Cardiofocus, Inc. Method and device for cardiac tissue ablation
US20080269846A1 (en) * 2003-03-14 2008-10-30 Light Sciences Oncology, Inc. Device for treatment of blood vessels using light
US20080275300A1 (en) * 2007-04-27 2008-11-06 Voyage Medical, Inc. Complex shape steerable tissue visualization and manipulation catheter
US20090030276A1 (en) * 2007-07-27 2009-01-29 Voyage Medical, Inc. Tissue visualization catheter with imaging systems integration
US20090030412A1 (en) * 2007-05-11 2009-01-29 Willis N Parker Visual electrode ablation systems
US20090054803A1 (en) * 2005-02-02 2009-02-26 Vahid Saadat Electrophysiology mapping and visualization system
US20090062790A1 (en) * 2007-08-31 2009-03-05 Voyage Medical, Inc. Direct visualization bipolar ablation systems
US20090061681A1 (en) * 2007-09-05 2009-03-05 Mcmunigal Tom Electrical receptacle assembly
US20090076498A1 (en) * 2007-08-31 2009-03-19 Voyage Medical, Inc. Visualization and ablation system variations
US20090125056A1 (en) * 2007-08-15 2009-05-14 Cardiodex Ltd. Systems and methods for puncture closure
US20090125022A1 (en) * 2007-11-12 2009-05-14 Voyage Medical, Inc. Tissue visualization and ablation systems
US20090143640A1 (en) * 2007-11-26 2009-06-04 Voyage Medical, Inc. Combination imaging and treatment assemblies
US20090152990A1 (en) * 2007-12-07 2009-06-18 Veryst Engineering Llc Apparatus for in vivo energy harvesting
US20090177191A1 (en) * 2007-12-11 2009-07-09 Brown Joe D Laser surgery methods and apparatus
US20090203995A1 (en) * 2008-02-08 2009-08-13 Ethicon, Inc. Double balloon isolation catheters and methods therefor
US20090203962A1 (en) * 2008-02-07 2009-08-13 Voyage Medical, Inc. Stent delivery under direct visualization
US20090221871A1 (en) * 2006-09-01 2009-09-03 Voyage Medical, Inc. Precision control systems for tissue visualization and manipulation assemblies
US20090275842A1 (en) * 2006-12-21 2009-11-05 Vahid Saadat Stabilization of visualization catheters
US20090299363A1 (en) * 2006-12-21 2009-12-03 Vahid Saadat Off-axis visualization systems
US20090299354A1 (en) * 1999-07-14 2009-12-03 Cardiofocus, Inc. Cardiac ablation catheters for forming overlapping lesions
US20090326572A1 (en) * 2008-06-27 2009-12-31 Ruey-Feng Peh Apparatus and methods for rapid tissue crossing
US20090326320A1 (en) * 1999-07-14 2009-12-31 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US20100004633A1 (en) * 2008-07-07 2010-01-07 Voyage Medical, Inc. Catheter control systems
US20100004646A1 (en) * 2008-07-02 2010-01-07 Joe Denton Brown Laser delivery apparatus for endovascular applications
US20100010311A1 (en) * 2005-10-25 2010-01-14 Voyage Medical, Inc. Methods and apparatus for efficient purging
WO2010018569A1 (en) * 2008-08-11 2010-02-18 Cardionova Ltd. Method and apparatus for intra-atrial ablation
US20100130836A1 (en) * 2008-11-14 2010-05-27 Voyage Medical, Inc. Image processing systems
US20100256629A1 (en) * 2009-04-06 2010-10-07 Voyage Medical, Inc. Methods and devices for treatment of the ostium
US20100261995A1 (en) * 2009-04-08 2010-10-14 Nellcor Puritan Bennett Llc Medical device and technique for using the same
US20100261996A1 (en) * 2009-04-08 2010-10-14 Nellcor Puritan Bennett Llc Medical device and technique for using same
US20100280362A1 (en) * 2009-05-04 2010-11-04 Nellcor Puritan Bennett Llc Time of flight based tracheal tube placement system and method
US20100292558A1 (en) * 2006-06-14 2010-11-18 Voyage Medical, Inc. In-vivo visualization systems
US20100321192A1 (en) * 2009-06-19 2010-12-23 Vivant Medical, Inc. Microwave Ablation Antenna Radiation Detector
US7860555B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue visualization and manipulation system
US20110054488A1 (en) * 2006-10-18 2011-03-03 Gruber William H Systems and methods for preventing intravasation during intrauterine procedures
US20110077634A1 (en) * 2009-09-28 2011-03-31 Vivant Medical, Inc. Microwave Surface Ablation Using Conical Probe
US7918787B2 (en) 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US20110082452A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with automatic safety shut-off feature
US20110082449A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with pulsed aiming light
US20110082450A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with inflatable member having multiple inflation settings
US20110082451A1 (en) * 2009-10-06 2011-04-07 Cardiofocus, Inc. Cardiac ablation image analysis system and process
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US20110125140A1 (en) * 2008-04-25 2011-05-26 Domier MedTech Laser GmbH Light-Based Method for the Endovascular Treatment of Pathologically Altered Blood Vessels
US20110213349A1 (en) * 2008-11-07 2011-09-01 Joe Denton Brown Apparatus and method for detecting overheating during laser surgery
US20110213241A1 (en) * 2009-06-19 2011-09-01 Vivant Medical, Inc. Laparoscopic Port with Microwave Rectifier
US20110238048A1 (en) * 2010-03-23 2011-09-29 Joe Denton Brown Laser surgery controller with variable time delay and feedback detector sensitivity control
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US8137333B2 (en) 2005-10-25 2012-03-20 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US8152800B2 (en) 2007-07-30 2012-04-10 Vivant Medical, Inc. Electrosurgical systems and printed circuit boards for use therewith
US8298223B2 (en) 2003-05-01 2012-10-30 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US8333012B2 (en) 2008-10-10 2012-12-18 Voyage Medical, Inc. Method of forming electrode placement and connection systems
US8638428B2 (en) 2010-06-01 2014-01-28 Joe Denton Brown Method and apparatus for using optical feedback to detect fiber breakdown during surgical laser procedures
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US8694071B2 (en) 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
US8747398B2 (en) 2007-09-13 2014-06-10 Covidien Lp Frequency tuning in a microwave electrosurgical system
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
AU2011202359B2 (en) * 2010-06-16 2016-03-17 Biosense Webster (Israel) Ltd. Optical contact sensing in medical probes
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
US9492190B2 (en) 2011-02-09 2016-11-15 Covidien Lp Tissue dissectors
US9522033B2 (en) 2012-10-02 2016-12-20 Covidien Lp Devices and methods for optical detection of tissue contact
US9526856B2 (en) 2011-12-15 2016-12-27 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for preventing tracheal aspiration
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US9668802B2 (en) 2012-10-02 2017-06-06 Covidien Lp Devices and methods for optical detection of tissue contact
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US9681916B2 (en) 2012-01-06 2017-06-20 Covidien Lp System and method for treating tissue using an expandable antenna
US9693823B2 (en) 2012-01-06 2017-07-04 Covidien Lp System and method for treating tissue using an expandable antenna
US9770194B2 (en) 2013-11-05 2017-09-26 Ciel Medical, Inc. Devices and methods for airway measurement
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
US9861424B2 (en) 2007-07-11 2018-01-09 Covidien Lp Measurement and control systems and methods for electrosurgical procedures
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9943360B2 (en) 2011-01-30 2018-04-17 University Health Network Coil electrode for thermal therapy
US9949794B2 (en) 2008-03-27 2018-04-24 Covidien Lp Microwave ablation devices including expandable antennas and methods of use
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US10111705B2 (en) 2008-10-10 2018-10-30 Intuitive Surgical Operations, Inc. Integral electrode placement and connection systems
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10154888B2 (en) 2014-12-03 2018-12-18 Cardiofocus, Inc. System and method for visual confirmation of pulmonary vein isolation during abalation procedures
US10307610B2 (en) 2006-01-18 2019-06-04 Light Sciences Oncology Inc. Method and apparatus for light-activated drug therapy
USD851245S1 (en) 2017-04-14 2019-06-11 Cardiofocus, Inc. Compliant balloon
US10314650B2 (en) 2010-06-16 2019-06-11 Biosense Webster (Israel) Ltd. Spectral sensing of ablation
US10335131B2 (en) 2006-10-23 2019-07-02 Intuitive Surgical Operations, Inc. Methods for preventing tissue migration
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US11246476B2 (en) 2014-04-28 2022-02-15 Cardiofocus, Inc. Method for visualizing tissue with an ICG dye composition during ablation procedures
US11344365B2 (en) 2016-01-05 2022-05-31 Cardiofocus, Inc. Ablation system with automated sweeping ablation energy element
US11389236B2 (en) 2018-01-15 2022-07-19 Cardiofocus, Inc. Ablation system with automated ablation energy element
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US11490957B2 (en) 2010-06-16 2022-11-08 Biosense Webster (Israel) Ltd. Spectral sensing of ablation
US11925334B2 (en) 2020-11-30 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object

Families Citing this family (282)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050234437A1 (en) * 1999-07-14 2005-10-20 Cardiofocus, Inc. Deflectable sheath catheters with out-of-plane bent tip
US20050234436A1 (en) * 1999-07-14 2005-10-20 Cardiofocus, Inc. Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US6802825B2 (en) * 2001-07-03 2004-10-12 Coopersurgical, Inc. Access catheter apparatus for use in minimally invasive surgery and diagnostic procedures in the uterus and fallopian tubes
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
ES2289307T3 (en) * 2002-05-06 2008-02-01 Covidien Ag BLOOD DETECTOR TO CONTROL AN ELECTROCHIRURGICAL UNIT.
US7115127B2 (en) * 2003-02-04 2006-10-03 Cardiodex, Ltd. Methods and apparatus for hemostasis following arterial catheterization
CN1764419A (en) * 2003-02-20 2006-04-26 普罗里森姆股份有限公司 Cardiac ablation devices
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
DE202004021943U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US7238179B2 (en) * 2003-10-30 2007-07-03 Medical Cv, Inc. Apparatus and method for guided ablation treatment
US7238180B2 (en) * 2003-10-30 2007-07-03 Medicalcv Inc. Guided ablation with end-fire fiber
EP1680039A1 (en) * 2003-10-30 2006-07-19 Medical Cv, Inc. Apparatus and method for laser treatment
US7232437B2 (en) * 2003-10-30 2007-06-19 Medical Cv, Inc. Assessment of lesion transmurality
EP1706052B1 (en) 2003-12-31 2011-05-04 Biosense Webster, Inc. Circumferential ablation device assembly with dual expandable members
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US7883506B2 (en) * 2004-11-08 2011-02-08 Boston Scientific Scimed, Inc. Devices and methods for the treatment of endometriosis
JP2008519669A (en) * 2004-11-12 2008-06-12 アスマティックス,インコーポレイテッド Apparatus and method for improved energy delivery
US8197472B2 (en) 2005-03-25 2012-06-12 Maquet Cardiovascular, Llc Tissue welding and cutting apparatus and method
US7918848B2 (en) * 2005-03-25 2011-04-05 Maquet Cardiovascular, Llc Tissue welding and cutting apparatus and method
EP3045110B1 (en) 2005-03-28 2019-07-31 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues
US20070038203A1 (en) * 2005-07-11 2007-02-15 Mcintyre Jon T Materials and methods for ablation of the endometrium
EP1906923B1 (en) 2005-07-22 2018-01-24 The Foundry, LLC Systems and methods for delivery of a therapeutic agent
US20070073278A1 (en) * 2005-09-16 2007-03-29 Johnson Kevin C Cardiac Ablation Dosing
US20070073280A1 (en) * 2005-09-16 2007-03-29 Medicalcv, Inc. End-fire guided ablation
US20070073281A1 (en) * 2005-09-16 2007-03-29 Medicalcv, Inc. Guided ablation with motion control
US20070073277A1 (en) 2005-09-16 2007-03-29 Medicalcv, Inc. Controlled guided ablation treatment
US20100286531A1 (en) * 2005-09-30 2010-11-11 Cornova, Inc. Systems and methods for analysis and treatment of a body lumen
JP4409499B2 (en) * 2005-10-25 2010-02-03 国立大学法人浜松医科大学 Thrombolysis device
US8226637B2 (en) * 2005-11-01 2012-07-24 Japan Electel, Inc. Balloon catheter system
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
WO2007140331A2 (en) 2006-05-25 2007-12-06 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US9211393B2 (en) * 2006-06-05 2015-12-15 Medtronic Cryocath Lp Distal cooling distribution system for a medical device
US7871395B2 (en) * 2006-06-05 2011-01-18 Medtronic Cryocath Lp Conduit management system
US9867530B2 (en) 2006-08-14 2018-01-16 Volcano Corporation Telescopic side port catheter device with imaging system and method for accessing side branch occlusions
WO2009089372A2 (en) * 2008-01-08 2009-07-16 Cornova, Inc. Systems and methods for analysis and treatment of a body lumen
WO2008049087A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
US20080132910A1 (en) * 2006-11-07 2008-06-05 Carlo Pappone Control for a Remote Navigation System
WO2008104973A1 (en) * 2007-02-26 2008-09-04 Vision - Sciences Inc. Endoscopic reflector
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
US8577447B2 (en) 2007-05-01 2013-11-05 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
US9855410B2 (en) 2007-05-01 2018-01-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
US9596993B2 (en) 2007-07-12 2017-03-21 Volcano Corporation Automatic calibration systems and methods of use
US9622706B2 (en) 2007-07-12 2017-04-18 Volcano Corporation Catheter for in vivo imaging
WO2009009802A1 (en) 2007-07-12 2009-01-15 Volcano Corporation Oct-ivus catheter for concurrent luminal imaging
US8480662B2 (en) * 2007-08-22 2013-07-09 Cardiac Pacemakers, Inc. Systems and devices for photoablation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
EP2268361B8 (en) 2008-04-09 2019-05-22 Julian Itzcovitz Percutaneous probe
US20100036294A1 (en) 2008-05-07 2010-02-11 Robert Mantell Radially-Firing Electrohydraulic Lithotripsy Probe
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
US9402680B2 (en) 2008-05-27 2016-08-02 Maquet Cardiovasular, Llc Surgical instrument and method
US10702293B2 (en) 2008-06-13 2020-07-07 Shockwave Medical, Inc. Two-stage method for treating calcified lesions within the wall of a blood vessel
CA2727429C (en) * 2008-06-13 2016-01-26 Daniel Hawkins Shockwave balloon catheter system
US9072534B2 (en) 2008-06-13 2015-07-07 Shockwave Medical, Inc. Non-cavitation shockwave balloon catheter system
DE102008045038A1 (en) * 2008-08-29 2010-03-04 Osypka, Peter, Dr.- Ing. Device for ablating the mouth of the pulmonary veins
US20100094270A1 (en) * 2008-10-06 2010-04-15 Sharma Virender K Method and Apparatus for Tissue Ablation
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9180280B2 (en) 2008-11-04 2015-11-10 Shockwave Medical, Inc. Drug delivery shockwave balloon catheter system
US9044618B2 (en) 2008-11-05 2015-06-02 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
EP2355737B1 (en) 2008-11-17 2021-08-11 Boston Scientific Scimed, Inc. Selective accumulation of energy without knowledge of tissue topography
EP2381998B1 (en) 2008-12-31 2018-04-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
US8551096B2 (en) * 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
AU2010256775B2 (en) * 2009-06-01 2015-09-03 Channel Medsystems, Inc. Methods and apparatus for treatment of a body cavity or lumen
US9955858B2 (en) 2009-08-21 2018-05-01 Maquet Cardiovascular Llc Surgical instrument and method for use
CN107049479B (en) * 2009-10-27 2020-10-16 努瓦拉公司 Delivery device with coolable energy emitting assembly
JP6000851B2 (en) 2009-11-11 2016-10-05 ホライラ, インコーポレイテッド Systems, devices, and methods for tissue treatment and stenosis control
EP2335638B1 (en) * 2009-12-10 2011-11-16 W & H Dentalwerk Bürmoos GmbH Medical, in particular dental, treatment device for dispensing a medium
US20110144637A1 (en) * 2009-12-11 2011-06-16 Medtronic Cryocath Lp Vein Occlusion Devices and Methods for Catheter-Based Ablation
IT1405000B1 (en) * 2010-02-04 2013-12-16 El En Spa DEVICE FOR THE TREATMENT OF THE VAGINAL CHANNEL AND ITS APPARATUS
JP2013523318A (en) 2010-04-09 2013-06-17 べシックス・バスキュラー・インコーポレイテッド Power generation and control equipment for tissue treatment
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
AU2011252976A1 (en) 2010-05-12 2012-11-08 Shifamed Holdings, Llc Low profile electrode assembly
US8956346B2 (en) 2010-05-14 2015-02-17 Rainbow Medical, Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US9242122B2 (en) 2010-05-14 2016-01-26 Liat Tsoref Reflectance-facilitated ultrasound treatment and monitoring
KR101455746B1 (en) * 2010-06-08 2014-10-28 도레이 카부시키가이샤 Catheter for measuring electric potential
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element
US8696581B2 (en) 2010-10-18 2014-04-15 CardioSonic Ltd. Ultrasound transducer and uses thereof
US9566456B2 (en) * 2010-10-18 2017-02-14 CardioSonic Ltd. Ultrasound transceiver and cooling thereof
JP2013543423A (en) 2010-10-18 2013-12-05 カーディオソニック リミテッド Tissue treatment
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US20120123276A1 (en) * 2010-11-16 2012-05-17 Assaf Govari Catheter with optical contact sensing
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US8177742B1 (en) 2010-12-23 2012-05-15 Kimberly-Clark Wordwide, Inc. Inflatable retention system for an enteral feeding device
US11141063B2 (en) 2010-12-23 2021-10-12 Philips Image Guided Therapy Corporation Integrated system architectures and methods of use
US11040140B2 (en) 2010-12-31 2021-06-22 Philips Image Guided Therapy Corporation Deep vein thrombosis therapeutic methods
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
MX341823B (en) 2011-02-01 2016-09-05 Channel Medsystems Inc Methods and apparatus for cyrogenic treatment of a body cavity or lumen.
KR20130131471A (en) 2011-04-08 2013-12-03 코비디엔 엘피 Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
EP2701623B1 (en) 2011-04-25 2016-08-17 Medtronic Ardian Luxembourg S.à.r.l. Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
WO2012170401A2 (en) * 2011-06-06 2012-12-13 Percuvision, Llc Sensing catheter emitting radiant energy
US9579030B2 (en) 2011-07-20 2017-02-28 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
CN103813829B (en) 2011-07-22 2016-05-18 波士顿科学西美德公司 There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece
US9360630B2 (en) 2011-08-31 2016-06-07 Volcano Corporation Optical-electrical rotary joint and methods of use
US9949615B2 (en) * 2011-09-21 2018-04-24 Boston Scientific Scimed, Inc. Systems and methods for preventing laser fiber misfiring within endoscopic access devices
EP2757933B1 (en) 2011-09-22 2019-02-06 The George Washington University Systems for visualizing ablated tissue
WO2013044182A1 (en) 2011-09-22 2013-03-28 The George Washington University Systems and methods for visualizing ablated tissue
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013059202A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US9162046B2 (en) 2011-10-18 2015-10-20 Boston Scientific Scimed, Inc. Deflectable medical devices
EP3366250A1 (en) 2011-11-08 2018-08-29 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US8574247B2 (en) 2011-11-08 2013-11-05 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US10456196B2 (en) * 2011-12-15 2019-10-29 Biosense Webster (Israel) Ltd. Monitoring and tracking bipolar ablation
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
JP6130397B2 (en) 2011-12-23 2017-05-17 べシックス・バスキュラー・インコーポレイテッド Device for remodeling tissue in or adjacent to a body passage
WO2013101452A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9707414B2 (en) * 2012-02-14 2017-07-18 Rainbow Medical Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US20150165244A1 (en) * 2012-02-14 2015-06-18 Rainbow Medical Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US10357304B2 (en) 2012-04-18 2019-07-23 CardioSonic Ltd. Tissue treatment
US9883906B2 (en) 2012-04-22 2018-02-06 Newuro, B.V. Bladder tissue modification for overactive bladder disorders
WO2013160772A2 (en) 2012-04-22 2013-10-31 Omry Ben-Ezra Bladder tissue modification for overactive bladder disorders
US10610294B2 (en) 2012-04-22 2020-04-07 Newuro, B.V. Devices and methods for transurethral bladder partitioning
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
US9642673B2 (en) 2012-06-27 2017-05-09 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
CA2881184C (en) 2012-08-06 2019-06-04 Shockwave Medical, Inc. Shockwave catheter
ES2715678T3 (en) 2012-08-06 2019-06-05 Shockwave Medical Inc Low profile electrodes for an angioplasty shock wave catheter
US9138249B2 (en) 2012-08-17 2015-09-22 Shockwave Medical, Inc. Shock wave catheter system with arc preconditioning
US20140073907A1 (en) 2012-09-12 2014-03-13 Convergent Life Sciences, Inc. System and method for image guided medical procedures
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
US9333000B2 (en) 2012-09-13 2016-05-10 Shockwave Medical, Inc. Shockwave catheter system with energy control
US9522012B2 (en) 2012-09-13 2016-12-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
WO2014043687A2 (en) 2012-09-17 2014-03-20 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10568586B2 (en) 2012-10-05 2020-02-25 Volcano Corporation Systems for indicating parameters in an imaging data set and methods of use
US11272845B2 (en) 2012-10-05 2022-03-15 Philips Image Guided Therapy Corporation System and method for instant and automatic border detection
US10070827B2 (en) 2012-10-05 2018-09-11 Volcano Corporation Automatic image playback
US9858668B2 (en) 2012-10-05 2018-01-02 Volcano Corporation Guidewire artifact removal in images
US9324141B2 (en) 2012-10-05 2016-04-26 Volcano Corporation Removal of A-scan streaking artifact
US9292918B2 (en) 2012-10-05 2016-03-22 Volcano Corporation Methods and systems for transforming luminal images
EP2904671B1 (en) 2012-10-05 2022-05-04 David Welford Systems and methods for amplifying light
US9286673B2 (en) 2012-10-05 2016-03-15 Volcano Corporation Systems for correcting distortions in a medical image and methods of use thereof
US9307926B2 (en) 2012-10-05 2016-04-12 Volcano Corporation Automatic stent detection
US9367965B2 (en) 2012-10-05 2016-06-14 Volcano Corporation Systems and methods for generating images of tissue
EP2906135A2 (en) 2012-10-10 2015-08-19 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
US10342608B2 (en) 2012-10-18 2019-07-09 The Board Of Trustees Of The Leland Stanford Junior University Ablation catheter system and method for deploying same
US9840734B2 (en) 2012-10-22 2017-12-12 Raindance Technologies, Inc. Methods for analyzing DNA
WO2014093374A1 (en) 2012-12-13 2014-06-19 Volcano Corporation Devices, systems, and methods for targeted cannulation
EP2934310A4 (en) 2012-12-20 2016-10-12 Nathaniel J Kemp Optical coherence tomography system that is reconfigurable between different imaging modes
JP6785554B2 (en) 2012-12-20 2020-11-18 ボルケーノ コーポレイション Smooth transition catheter
US10942022B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Manual calibration of imaging system
US11406498B2 (en) 2012-12-20 2022-08-09 Philips Image Guided Therapy Corporation Implant delivery system and implants
CA2895770A1 (en) 2012-12-20 2014-07-24 Jeremy Stigall Locating intravascular images
US10939826B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Aspirating and removing biological material
WO2014099672A1 (en) 2012-12-21 2014-06-26 Andrew Hancock System and method for multipath processing of image signals
US10166003B2 (en) 2012-12-21 2019-01-01 Volcano Corporation Ultrasound imaging with variable line density
CA2895993A1 (en) 2012-12-21 2014-06-26 Jason Spencer System and method for graphical processing of medical data
US20140180077A1 (en) * 2012-12-21 2014-06-26 Volcano Corporation Tissue ablation catheter and methods of ablating tissue
CA2895769A1 (en) 2012-12-21 2014-06-26 Douglas Meyer Rotational ultrasound imaging catheter with extended catheter body telescope
EP2936626A4 (en) 2012-12-21 2016-08-17 David Welford Systems and methods for narrowing a wavelength emission of light
US10058284B2 (en) 2012-12-21 2018-08-28 Volcano Corporation Simultaneous imaging, monitoring, and therapy
US9486143B2 (en) 2012-12-21 2016-11-08 Volcano Corporation Intravascular forward imaging device
CA2896004A1 (en) 2012-12-21 2014-06-26 Nathaniel J. Kemp Power-efficient optical buffering using optical switch
US9612105B2 (en) 2012-12-21 2017-04-04 Volcano Corporation Polarization sensitive optical coherence tomography system
US10413317B2 (en) 2012-12-21 2019-09-17 Volcano Corporation System and method for catheter steering and operation
EP2945556A4 (en) 2013-01-17 2016-08-31 Virender K Sharma Method and apparatus for tissue ablation
US10226597B2 (en) 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
EP2965263B1 (en) 2013-03-07 2022-07-20 Bernhard Sturm Multimodal segmentation in intravascular images
US10076384B2 (en) 2013-03-08 2018-09-18 Symple Surgical, Inc. Balloon catheter apparatus with microwave emitter
ES2703539T3 (en) 2013-03-11 2019-03-11 Northgate Tech Inc Unfocused electrohydraulic lithotripter
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US20140276923A1 (en) 2013-03-12 2014-09-18 Volcano Corporation Vibrating catheter and methods of use
EP3895604A1 (en) 2013-03-12 2021-10-20 Collins, Donna Systems and methods for diagnosing coronary microvascular disease
US9301687B2 (en) 2013-03-13 2016-04-05 Volcano Corporation System and method for OCT depth calibration
US11026591B2 (en) 2013-03-13 2021-06-08 Philips Image Guided Therapy Corporation Intravascular pressure sensor calibration
US10758207B2 (en) 2013-03-13 2020-09-01 Philips Image Guided Therapy Corporation Systems and methods for producing an image from a rotational intravascular ultrasound device
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US20160184022A1 (en) * 2013-03-13 2016-06-30 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US10292677B2 (en) 2013-03-14 2019-05-21 Volcano Corporation Endoluminal filter having enhanced echogenic properties
JP6342984B2 (en) 2013-03-14 2018-06-13 ボルケーノ コーポレイション Filter with echogenic properties
US10219887B2 (en) 2013-03-14 2019-03-05 Volcano Corporation Filters with echogenic characteristics
WO2014149690A2 (en) 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
US10349824B2 (en) 2013-04-08 2019-07-16 Apama Medical, Inc. Tissue mapping and visualization systems
EP2983603B1 (en) 2013-04-08 2020-03-25 Apama Medical, Inc. Cardiac ablation catheters
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
US10219724B2 (en) * 2013-05-02 2019-03-05 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
WO2014188430A2 (en) 2013-05-23 2014-11-27 CardioSonic Ltd. Devices and methods for renal denervation and assessment thereof
US10022182B2 (en) 2013-06-21 2018-07-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
CN105473091B (en) 2013-06-21 2020-01-21 波士顿科学国际有限公司 Renal denervation balloon catheter with co-movable electrode supports
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
WO2015002787A1 (en) 2013-07-01 2015-01-08 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US9925001B2 (en) 2013-07-19 2018-03-27 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
US10342609B2 (en) 2013-07-22 2019-07-09 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
CN105392435B (en) 2013-07-22 2018-11-09 波士顿科学国际有限公司 Renal nerve ablation catheter with twisting sacculus
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015035047A1 (en) 2013-09-04 2015-03-12 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
EP3043733A1 (en) 2013-09-13 2016-07-20 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US9907471B2 (en) 2013-10-08 2018-03-06 The Board Of Trustees Of The Leland Stanford Junior University Visualization of heart wall tissue
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
WO2015057584A1 (en) 2013-10-15 2015-04-23 Boston Scientific Scimed, Inc. Medical device balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
EP3060153A1 (en) 2013-10-25 2016-08-31 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
US20150141847A1 (en) 2013-11-20 2015-05-21 The George Washington University Systems and methods for hyperspectral analysis of cardiac tissue
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
EP3102136B1 (en) 2014-02-04 2018-06-27 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US9730715B2 (en) 2014-05-08 2017-08-15 Shockwave Medical, Inc. Shock wave guide wire
US11246659B2 (en) * 2014-08-25 2022-02-15 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
KR102499045B1 (en) 2014-11-03 2023-02-10 더 조지 워싱턴 유니버시티 Systems and methods for lesion assessment
AU2015343274B2 (en) 2014-11-03 2020-07-23 460Medical, Inc. Systems and methods for assessment of contact quality
US11058492B2 (en) * 2014-12-30 2021-07-13 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US10779904B2 (en) 2015-07-19 2020-09-22 460Medical, Inc. Systems and methods for lesion formation and assessment
US10517668B2 (en) * 2015-09-14 2019-12-31 Boisense Webster (Israel) Ltd. Dual node multiray electrode catheter
US10524858B2 (en) * 2015-09-14 2020-01-07 Biosense Webster (Israel) Ltd. Dual node multiray electrode catheter
US10959778B2 (en) * 2015-11-07 2021-03-30 Douglas A. Pinnow Laser surgery employing heavy water to enhance laser beam transmission
EP4302713A2 (en) 2015-11-16 2024-01-10 Boston Scientific Scimed, Inc. Energy delivery devices
WO2017087195A1 (en) 2015-11-18 2017-05-26 Shockwave Medical, Inc. Shock wave electrodes
US10136945B2 (en) * 2015-12-09 2018-11-27 Biosense Webster (Israel) Ltd. Ablation catheter with light-based contact sensors
US11135032B2 (en) 2016-04-04 2021-10-05 Gyrus Acmi, Inc. Electrosurgical illuminating instrument
US10226265B2 (en) 2016-04-25 2019-03-12 Shockwave Medical, Inc. Shock wave device with polarity switching
US20170312008A1 (en) 2016-05-02 2017-11-02 Affera, Inc. Pulsed radiofrequency ablation
US10702163B2 (en) * 2016-05-03 2020-07-07 Precision EP GmbH Systems and methods for intracavitary temperature measurement and monitoring
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
AU2017339980B2 (en) 2016-10-06 2022-08-18 Shockwave Medical, Inc. Aortic leaflet repair using shock wave applicators
EP3531948A1 (en) * 2016-10-26 2019-09-04 Boston Scientific Scimed Inc. Stenosis prevention and ablation delivery system
US10357264B2 (en) 2016-12-06 2019-07-23 Shockwave Medical, Inc. Shock wave balloon catheter with insertable electrodes
US11071584B2 (en) 2016-12-09 2021-07-27 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
WO2018173053A1 (en) 2017-03-20 2018-09-27 Sonievie Ltd. Pulmonary hypertension treatment method and/or system
GB2561167A (en) * 2017-03-30 2018-10-10 Creo Medical Ltd Electrosurgical energy conveying structure and electrosurgical device incorporating the same
US10441300B2 (en) 2017-04-19 2019-10-15 Shockwave Medical, Inc. Drug delivery shock wave balloon catheter system
US11020135B1 (en) 2017-04-25 2021-06-01 Shockwave Medical, Inc. Shock wave device for treating vascular plaques
US10966737B2 (en) 2017-06-19 2021-04-06 Shockwave Medical, Inc. Device and method for generating forward directed shock waves
TWI639407B (en) * 2017-07-31 2018-11-01 上銀科技股份有限公司 Medical device with control module and endoscope control system using the same
CN109419482B (en) 2017-08-21 2021-05-25 上银科技股份有限公司 Medical instrument with control module and endoscope control system applying same
CN109717943B (en) * 2017-10-31 2021-05-28 四川锦江电子科技有限公司 Cryoablation catheter with mapping function and ablation device
CN109717942A (en) * 2017-10-31 2019-05-07 四川锦江电子科技有限公司 A kind of cryoablation conduit
US10709462B2 (en) 2017-11-17 2020-07-14 Shockwave Medical, Inc. Low profile electrodes for a shock wave catheter
JP7337533B2 (en) * 2018-04-26 2023-09-04 タツタ電線株式会社 medical light guide
WO2019232432A1 (en) 2018-06-01 2019-12-05 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
WO2019245746A1 (en) 2018-06-21 2019-12-26 Shockwave Medical, Inc. System for treating occlusions in body lumens
CN108969095B (en) * 2018-09-18 2023-12-12 彭宇程 Laser ablation system for treating CTO lesions
WO2020132379A1 (en) * 2018-12-20 2020-06-25 The Regents Of The University Of Michigan Anastomosis testing device and method
US10828470B1 (en) 2019-08-14 2020-11-10 Vasoinnovations Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
US10773059B1 (en) * 2019-08-14 2020-09-15 Vasoinnovations, Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
US20210220626A1 (en) 2019-08-14 2021-07-22 Vasoinnovations, Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
US10792469B1 (en) 2019-08-14 2020-10-06 Vasoinnovations Inc. Devices, systems, and methods for delivering catheters or other medical devices to locations within a patients body
EP4034006A1 (en) 2019-09-24 2022-08-03 Shockwave Medical, Inc. System for treating thrombus in body lumens
CN111529046B (en) * 2020-05-07 2022-02-11 上海玮启医疗器械有限公司 Freezing sacculus pipe device of controllable accurate treatment of freezing scope
US20220039744A1 (en) * 2020-08-06 2022-02-10 Medtronic Navigation, Inc. Tumor ablation planning using interstitial optical mapping
US11849995B2 (en) 2021-02-18 2023-12-26 Biosense Webster (Israel) Ltd. Detection of balloon catheter tissue contact using optical measurement
CN113331935A (en) * 2021-06-01 2021-09-03 黄松群 Novel atrial fibrillation cryoablation device beneficial to pulmonary vein plugging
USD1014762S1 (en) 2021-06-16 2024-02-13 Affera, Inc. Catheter tip with electrode panel(s)
CN113926061B (en) * 2021-11-18 2023-04-07 苏州海宇新辰医疗科技有限公司 Balloon catheter

Citations (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US224929A (en) * 1880-02-24 Land-marker
US961738A (en) * 1910-02-12 1910-06-14 John H Stickel Combined check and gate valve.
US3821510A (en) * 1973-02-22 1974-06-28 H Muncheryan Hand held laser instrumentation device
US4336809A (en) * 1980-03-17 1982-06-29 Burleigh Instruments, Inc. Human and animal tissue photoradiation system and method
US4585298A (en) * 1982-08-26 1986-04-29 Kei Mori Photoradiator for radiating light
US4660925A (en) * 1985-04-29 1987-04-28 Laser Therapeutics, Inc. Apparatus for producing a cylindrical pattern of light and method of manufacture
US4701166A (en) * 1983-05-03 1987-10-20 Catheter Technology Corp. Valved two-way catheter
US4718417A (en) * 1985-03-22 1988-01-12 Massachusetts Institute Of Technology Visible fluorescence spectral diagnostic for laser angiosurgery
US4819632A (en) * 1986-05-19 1989-04-11 Davies David H Retrolasing catheter and method
US4852567A (en) * 1988-01-21 1989-08-01 C. R. Bard, Inc. Laser tipped catheter
US4860743A (en) * 1986-10-27 1989-08-29 University Of Florida Laser method and apparatus for the recanalization of vessels and the treatment of other cardiac conditions
US4862886A (en) * 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4913142A (en) * 1985-03-22 1990-04-03 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US5026367A (en) * 1988-03-18 1991-06-25 Cardiovascular Laser Systems, Inc. Laser angioplasty catheter and a method for use thereof
US5053033A (en) * 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5078681A (en) * 1989-10-23 1992-01-07 Olympus Optical Co., Ltd. Balloon catheter apparatus with releasable distal seal and method of operation
US5090959A (en) * 1987-04-30 1992-02-25 Advanced Cardiovascular Systems, Inc. Imaging balloon dilatation catheter
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5125925A (en) * 1988-08-03 1992-06-30 Photoradiation Systems Intracavity laser catheter with sensing fiber
US5133709A (en) * 1990-02-23 1992-07-28 Prince Martin R Optical fiber with atraumatic rounded end for use in laser angioplasty
US5140987A (en) * 1989-03-17 1992-08-25 Wayne State University Method for transvenous ablation of cardiac electrically conductive tissue by laser photocoagulation
US5151096A (en) * 1991-03-28 1992-09-29 Angiolaz, Incorporated Laser catheter diffuser
US5151097A (en) * 1989-09-01 1992-09-29 S.L.T. Japan Co., Ltd. Laser light emitter
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US5188634A (en) * 1990-07-13 1993-02-23 Trimedyne, Inc. Rotatable laser probe with beveled tip
US5190538A (en) * 1991-04-22 1993-03-02 Trimedyne, Inc. Method and apparatus for subjecting a body site to a movable beam of laterally directed laser radiation
US5196005A (en) * 1991-11-26 1993-03-23 Pdt Systems, Inc. Continuous gradient cylindrical diffusion tip for optical fibers and method for making
US5207699A (en) * 1989-10-30 1993-05-04 Coe Frederick L Lancet handling and disposal assembly
US5209748A (en) * 1989-08-24 1993-05-11 S.L.T. Japan Co., Ltd. Laser light irradiation apparatus
US5219346A (en) * 1990-01-09 1993-06-15 Ciba-Geigy Corporation Light diffuser for the photodynamic therapy of tumors in the oesophagus of a patient
US5242438A (en) * 1991-04-22 1993-09-07 Trimedyne, Inc. Method and apparatus for treating a body site with laterally directed laser radiation
USRE34544E (en) * 1982-11-23 1994-02-15 The Beth Israel Hospital Association Method of treatment of artherosclerosis and balloon catheter the same
US5337381A (en) * 1993-01-21 1994-08-09 Fiberguide Industries Fiber optic cylindrical diffuser
US5350375A (en) * 1993-03-15 1994-09-27 Yale University Methods for laser induced fluorescence intensity feedback control during laser angioplasty
US5380316A (en) * 1990-12-18 1995-01-10 Advanced Cardiovascular Systems, Inc. Method for intra-operative myocardial device revascularization
US5395362A (en) * 1992-01-14 1995-03-07 Summit Technology Methods and apparatus for distributing laser radiation
US5401270A (en) * 1990-12-19 1995-03-28 Carl-Zeiss-Stiftung Applicator device for laser radiation
US5409483A (en) * 1993-01-22 1995-04-25 Jeffrey H. Reese Direct visualization surgical probe
US5417653A (en) * 1993-01-21 1995-05-23 Sahota; Harvinder Method for minimizing restenosis
US5423805A (en) * 1992-02-05 1995-06-13 Angeion Corporation Laser catheter with moveable integral fixation wires
US5427119A (en) * 1993-11-03 1995-06-27 Daig Corporation Guiding introducer for right atrium
US5431647A (en) * 1994-07-13 1995-07-11 Pioneer Optics Company Fiberoptic cylindrical diffuser
US5437660A (en) * 1991-12-30 1995-08-01 Trimedyne, Inc. Tissue ablation and a lateral-lasing fiber optic device therefor
US5441497A (en) * 1994-07-14 1995-08-15 Pdt Cardiovascular, Inc. Light diffusing guidewire
US5482037A (en) * 1993-01-18 1996-01-09 X-Trode S.R.L. Electrode catheter for mapping and operating on cardiac cavities
US5496305A (en) * 1985-03-22 1996-03-05 Massachusetts Institue Of Technology Catheter for laser angiosurgery
US5497774A (en) * 1993-11-03 1996-03-12 Daig Corporation Guiding introducer for left atrium
US5507725A (en) * 1992-12-23 1996-04-16 Angeion Corporation Steerable catheter
US5531664A (en) * 1990-12-26 1996-07-02 Olympus Optical Co., Ltd. Bending actuator having a coil sheath with a fixed distal end and a free proximal end
US5536265A (en) * 1994-03-25 1996-07-16 Ciba-Geigy Corporation Light diffuser and process for the manufacturing of a light diffuser
US5613965A (en) * 1994-12-08 1997-03-25 Summit Technology Inc. Corneal reprofiling using an annular beam of ablative radiation
US5643253A (en) * 1995-06-06 1997-07-01 Rare Earth Medical, Inc. Phototherapy apparatus with integral stopper device
US5649923A (en) * 1988-10-24 1997-07-22 The General Hospital Corporation Catheter devices for delivering laser energy
US5680860A (en) * 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5722401A (en) * 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US5725522A (en) * 1990-06-15 1998-03-10 Rare Earth Medical, Inc. Laser suturing of biological materials
US5759619A (en) * 1995-12-29 1998-06-02 Lg Electronics Inc. Method of manufacturing second harmonic generation device
US5769843A (en) * 1996-02-20 1998-06-23 Cormedica Percutaneous endomyocardial revascularization
US5772590A (en) * 1992-06-30 1998-06-30 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5779646A (en) * 1995-02-28 1998-07-14 E.P. Technologies Inc. Deflectable biopsy catheter
US5782899A (en) * 1992-06-05 1998-07-21 Cardiac Pathways Corporation Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5782239A (en) * 1992-06-30 1998-07-21 Cordis Webster, Inc. Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US5800482A (en) * 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US5807395A (en) * 1993-08-27 1998-09-15 Medtronic, Inc. Method and apparatus for RF ablation and hyperthermia
US5823955A (en) * 1995-11-20 1998-10-20 Medtronic Cardiorhythm Atrioventricular valve tissue ablation catheter and method
US5824005A (en) * 1995-08-22 1998-10-20 Board Of Regents, The University Of Texas System Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5885278A (en) * 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US5891133A (en) * 1996-03-29 1999-04-06 Eclipse Surgical Technologies, Inc. Apparatus for laser-assisted intra-coronary transmyocardial revascularization and other applications
US5891134A (en) * 1996-09-24 1999-04-06 Goble; Colin System and method for applying thermal energy to tissue
US5904651A (en) * 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5908415A (en) * 1994-09-09 1999-06-01 Rare Earth Medical, Inc. Phototherapy methods and apparatus
US5931834A (en) * 1996-10-15 1999-08-03 Eclipse Surgical Technologies, Inc. Method for non-synchronous laser-assisted myocardial revascularization
US5938660A (en) * 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6064902A (en) * 1998-04-16 2000-05-16 C.R. Bard, Inc. Pulmonary vein ablation catheter
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6071302A (en) * 1997-12-31 2000-06-06 Cardiofocus, Inc. Phototherapeutic apparatus for wide-angle diffusion
US6071281A (en) * 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6086581A (en) * 1992-09-29 2000-07-11 Ep Technologies, Inc. Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
US6090084A (en) * 1994-07-08 2000-07-18 Daig Corporation Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia
US6117101A (en) * 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6120496A (en) * 1998-05-05 2000-09-19 Scimed Life Systems, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and coupling device for use with same
US6179835B1 (en) * 1996-01-19 2001-01-30 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US6237605B1 (en) * 1996-10-22 2001-05-29 Epicor, Inc. Methods of epicardial ablation
US6245064B1 (en) * 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6251109B1 (en) * 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US20020065512A1 (en) * 2000-07-13 2002-05-30 Todd Fjield Thermal treatment methods and apparatus with focused energy application
US6423055B1 (en) * 1999-07-14 2002-07-23 Cardiofocus, Inc. Phototherapeutic wave guide apparatus
US20020107511A1 (en) * 2000-05-03 2002-08-08 Collins Russell F. Apparatus and methods for mapping and ablation in electrophysiology procedures
US6514249B1 (en) * 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417745A (en) 1963-08-23 1968-12-24 Sheldon Edward Emanuel Fiber endoscope provided with focusing means and electroluminescent means
GB1485908A (en) 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
US4273109A (en) * 1976-07-06 1981-06-16 Cavitron Corporation Fiber optic light delivery apparatus and medical instrument utilizing same
US4224929A (en) 1977-11-08 1980-09-30 Olympus Optical Co., Ltd. Endoscope with expansible cuff member and operation section
US4445892A (en) * 1982-05-06 1984-05-01 Laserscope, Inc. Dual balloon catheter device
JPS6131142A (en) 1984-07-25 1986-02-13 富士写真光機株式会社 Blood vessel anastomosis laser probe
US5318024A (en) * 1985-03-22 1994-06-07 Massachusetts Institute Of Technology Laser endoscope for spectroscopic imaging
US5693043A (en) 1985-03-22 1997-12-02 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US4917084A (en) 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
EP0214712B1 (en) 1985-07-31 1992-09-02 C.R. Bard, Inc. Infrared laser catheter apparatus
US4961738A (en) 1987-01-28 1990-10-09 Mackin Robert A Angioplasty catheter with illumination and visualization within angioplasty balloon
EP0292695B1 (en) 1987-05-25 1993-02-17 Deutsche Aerospace AG Device for circumferential irradiation of objects
DE3750879T2 (en) 1987-05-26 1995-05-11 Surgical Laser Tech Laser probe with a wide beam angle for contacting or insertion.
US4770653A (en) 1987-06-25 1988-09-13 Medilase, Inc. Laser angioplasty
IT1220172B (en) * 1987-07-17 1990-06-06 Il Consiglio Nazionale Delle R FIBER OPTIC DEVICE FOR THE TRANSMISSION AND LATERAL IRRADIATION OF LASER ENERGY, PARTICULARLY FOR ANGIOPLASTIC TREATMENTS
US4781681A (en) 1987-09-15 1988-11-01 Gv Medical, Inc. Inflatable tip for laser catheterization
US4878492A (en) 1987-10-08 1989-11-07 C. R. Bard, Inc. Laser balloon catheter
US5242437A (en) * 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
US5030201A (en) 1989-11-24 1991-07-09 Aubrey Palestrant Expandable atherectomy catheter device
DK0437181T3 (en) 1990-01-09 1995-03-20 Ciba Geigy Ag Apparatus for irradiating a patient's bronchia for a photodynamic therapy
US5261904A (en) 1990-01-30 1993-11-16 C. R. Bard, Inc. Laser catheter having diffraction grating for beam shaping
US5071417A (en) 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5269777A (en) 1990-11-01 1993-12-14 Pdt Systems, Inc. Diffusion tip for optical fibers
JP3041099B2 (en) * 1991-02-01 2000-05-15 オリンパス光学工業株式会社 Electronic endoscope device
US5163935A (en) 1991-02-20 1992-11-17 Reliant Laser Corporation Surgical laser endoscopic focusing guide with an optical fiber link
JPH06509949A (en) 1991-04-05 1994-11-10 インディゴ メディカル インコーポレイテッド Device using a laser-transparent needle
US5169395A (en) 1991-04-26 1992-12-08 Pdt Cardiovascular, Inc. Laser delivery system
US5605162A (en) * 1991-10-15 1997-02-25 Advanced Cardiovascular Systems, Inc. Method for using a variable stiffness guidewire
US5830209A (en) 1992-02-05 1998-11-03 Angeion Corporation Multi-fiber laser catheter
JPH05307139A (en) * 1992-04-28 1993-11-19 Olympus Optical Co Ltd Endoscope objective
US5292320A (en) 1992-07-06 1994-03-08 Ceramoptec, Inc. Radial medical laser delivery device
US5700243A (en) 1992-10-30 1997-12-23 Pdt Systems, Inc. Balloon perfusion catheter
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
DE69412474T2 (en) * 1993-04-28 1998-12-17 Focal Inc DEVICE, PRODUCT AND USE REGARDING INTRALUMINAL PHOTOTHERMO MOLDING
DE69432148T2 (en) 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5445608A (en) 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5464404A (en) 1993-09-20 1995-11-07 Abela Laser Systems, Inc. Cardiac ablation catheters and method
US6146379A (en) 1993-10-15 2000-11-14 Ep Technologies, Inc. Systems and methods for creating curvilinear lesions in body tissue
US5575766A (en) 1993-11-03 1996-11-19 Daig Corporation Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers
US5363458A (en) 1994-02-28 1994-11-08 Fiber Guide Industries Fiber optic light diffuser
US6056744A (en) * 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US5690611A (en) 1994-07-08 1997-11-25 Daig Corporation Process for the treatment of atrial arrhythima using a catheter guided by shaped giding introducers
US6270492B1 (en) 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US5947959A (en) 1994-09-09 1999-09-07 Rare Earth Medical, Inc. Phototherapeutic apparatus with diffusive tip assembly
US6676656B2 (en) * 1994-09-09 2004-01-13 Cardiofocus, Inc. Surgical ablation with radiant energy
US6558375B1 (en) * 2000-07-14 2003-05-06 Cardiofocus, Inc. Cardiac ablation instrument
US6102905A (en) 1994-09-09 2000-08-15 Cardiofocus, Inc. Phototherapy device including housing for an optical element and method of making
US6579285B2 (en) 1994-09-09 2003-06-17 Cardiofocus, Inc. Photoablation with infrared radiation
US8025661B2 (en) 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
WO1996007451A2 (en) * 1994-09-09 1996-03-14 Rare Earth Medical, Inc. Phototherapeutic apparatus
US6572609B1 (en) 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US5702438A (en) 1995-06-08 1997-12-30 Avitall; Boaz Expandable recording and ablation catheter system
WO1997001988A1 (en) 1995-06-30 1997-01-23 Boston Scientific Corporation Ultrasound imaging catheter with a cutting element
US5773835A (en) * 1996-06-07 1998-06-30 Rare Earth Medical, Inc. Fiber optic spectroscopy
US6126682A (en) 1996-08-13 2000-10-03 Oratec Interventions, Inc. Method for treating annular fissures in intervertebral discs
US5833682A (en) 1996-08-26 1998-11-10 Illumenex Corporation Light delivery system with blood flushing capability
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US5845646A (en) 1996-11-05 1998-12-08 Lemelson; Jerome System and method for treating select tissue in a living being
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
IL133901A (en) * 1997-07-08 2005-09-25 Univ Emory Circumferential ablation device assembly and method
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6117071A (en) 1997-07-29 2000-09-12 Asahi Kogaku Kogyo Kabushiki Kaisha Endoscope with movable imaging unit for zooming or focusing
US6554794B1 (en) * 1997-09-24 2003-04-29 Richard L. Mueller Non-deforming deflectable multi-lumen catheter
US5995875A (en) 1997-10-01 1999-11-30 United States Surgical Apparatus for thermal treatment of tissue
US6217510B1 (en) * 1997-10-02 2001-04-17 Olympus Optical Co., Ltd. Endoscopes and endoscope devices which image regular observation images and fluorescent images as well as which provide easier operation of treatment tools
US6156029A (en) * 1997-11-25 2000-12-05 Eclipse Surgical Technologies, Inc. Selective treatment of endocardial/myocardial boundary
JP2003521261A (en) * 1997-12-22 2003-07-15 マイクルス コーポレイション Variable rigidity optical fiber shaft
US6251092B1 (en) 1997-12-30 2001-06-26 Medtronic, Inc. Deflectable guiding catheter
US6423058B1 (en) 1998-02-19 2002-07-23 Curon Medical, Inc. Assemblies to visualize and treat sphincters and adjoining tissue regions
US6562020B1 (en) * 1998-07-15 2003-05-13 Corazon Technologies, Inc. Kits for use in the treatment of vascular calcified lesions
US6106515A (en) 1998-08-13 2000-08-22 Intraluminal Therapeutics, Inc. Expandable laser catheter
AU1442500A (en) 1998-10-05 2000-04-26 Scimed Life Systems, Inc. Large area thermal ablation
US6245062B1 (en) 1998-10-23 2001-06-12 Afx, Inc. Directional reflector shield assembly for a microwave ablation instrument
US6352531B1 (en) * 1999-03-24 2002-03-05 Micrus Corporation Variable stiffness optical fiber shaft
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US8540704B2 (en) * 1999-07-14 2013-09-24 Cardiofocus, Inc. Guided cardiac ablation catheters
US8900219B2 (en) 1999-07-14 2014-12-02 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US20050234436A1 (en) 1999-07-14 2005-10-20 Cardiofocus, Inc. Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
US7935108B2 (en) * 1999-07-14 2011-05-03 Cardiofocus, Inc. Deflectable sheath catheters
US20050222558A1 (en) 1999-07-14 2005-10-06 Cardiofocus, Inc. Methods of cardiac ablation employing a deflectable sheath catheter
US9033961B2 (en) 1999-07-14 2015-05-19 Cardiofocus, Inc. Cardiac ablation catheters for forming overlapping lesions
US20050234437A1 (en) 1999-07-14 2005-10-20 Cardiofocus, Inc. Deflectable sheath catheters with out-of-plane bent tip
EP1072231B1 (en) 1999-07-30 2005-12-28 Terumo Kabushiki Kaisha Laser irradiation apparatus
US6702780B1 (en) * 1999-09-08 2004-03-09 Super Dimension Ltd. Steering configuration for catheter with rigid distal device
FR2798371B1 (en) 1999-09-10 2001-11-23 Acemo DEVICE FOR PROVIDING THE TRANSFER OF MATERIALS FROM A DEPRESSED PART TO AN OVERPRESSED PART OF A PNEUMATIC CONVEYOR
US6579279B1 (en) * 1999-09-24 2003-06-17 Omnisonics Medical Technologies, Inc. Steerable catheter device
US6669655B1 (en) 1999-10-20 2003-12-30 Transurgical, Inc. Sonic element and catheter incorporating same
US6551310B1 (en) 1999-11-16 2003-04-22 Robert A. Ganz System and method of treating abnormal tissue in the human esophagus
US20010030107A1 (en) 2000-01-03 2001-10-18 Peter Simpson Auger lock
US7137395B2 (en) * 2000-02-29 2006-11-21 The Johns Hopkins University Circumferential pulmonary vein ablation using a laser and fiberoptic balloon catheter
ATE408436T1 (en) 2000-03-24 2008-10-15 Prorhythm Inc DEVICE FOR INTRACORPORAL THERMOTHERAPY
US6582536B2 (en) 2000-04-24 2003-06-24 Biotran Corporation Inc. Process for producing steerable sheath catheters
US20020107514A1 (en) 2000-04-27 2002-08-08 Hooven Michael D. Transmural ablation device with parallel jaws
US6546935B2 (en) * 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
US6579278B1 (en) 2000-05-05 2003-06-17 Scimed Life Systems, Inc. Bi-directional steerable catheter with asymmetric fulcrum
DE60109444T2 (en) 2000-06-13 2006-04-13 Atrionix, Inc., Irwindale SURGICAL ABLATION PROBE FOR FORMING A RINGED LESION
JP2002078809A (en) 2000-09-07 2002-03-19 Shutaro Satake Balloon catheter for electrically isolating pulmonary vein
US6605055B1 (en) 2000-09-13 2003-08-12 Cardiofocus, Inc. Balloon catheter with irrigation sheath
US6916306B1 (en) 2000-11-10 2005-07-12 Boston Scientific Scimed, Inc. Steerable loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
US20020183739A1 (en) 2001-03-30 2002-12-05 Long Gary L. Endoscopic ablation system with sealed sheath
US6522933B2 (en) * 2001-03-30 2003-02-18 Biosense, Webster, Inc. Steerable catheter with a control handle having a pulley mechanism
DE10116056B4 (en) 2001-03-30 2005-09-08 Karl Storz Gmbh & Co. Kg Endoscopic visualization device with different image systems
US20030120270A1 (en) 2001-04-23 2003-06-26 Transurgical, Inc. Ablation therapy
US6648875B2 (en) 2001-05-04 2003-11-18 Cardiac Pacemakers, Inc. Means for maintaining tension on a steering tendon in a steerable catheter
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
US6706004B2 (en) * 2001-05-31 2004-03-16 Infraredx, Inc. Balloon catheter
US6814730B2 (en) 2001-10-09 2004-11-09 Hong Li Balloon catheters for non-continuous lesions
US6907298B2 (en) 2002-01-09 2005-06-14 Medtronic, Inc. Method and apparatus for imparting curves in implantable elongated medical instruments
JP2003210028A (en) 2002-01-23 2003-07-29 Iseki & Co Ltd Conveying screw of zoom auger
US7717899B2 (en) 2002-01-28 2010-05-18 Cardiac Pacemakers, Inc. Inner and outer telescoping catheter delivery system
US6932809B2 (en) 2002-05-14 2005-08-23 Cardiofocus, Inc. Safety shut-off device for laser surgical instruments employing blackbody emitters
JP2004065076A (en) 2002-08-05 2004-03-04 Iseki & Co Ltd Conveying screw of zoom auger
US6997924B2 (en) 2002-09-17 2006-02-14 Biosense Inc. Laser pulmonary vein isolation
WO2005120379A2 (en) 2004-06-07 2005-12-22 Edwards Lifesciences Corporation Methods and devices for delivering ablative energy
WO2007140331A2 (en) * 2006-05-25 2007-12-06 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US20080108870A1 (en) * 2006-11-06 2008-05-08 Wiita Bruce E Apparatus and method for stabilizing an image from an endoscopic camera
US20080195008A1 (en) * 2007-01-26 2008-08-14 Davis Reginald J Therapeudic massage sock
US8696653B2 (en) * 2009-10-02 2014-04-15 Cardiofocus, Inc. Cardiac ablation system with pulsed aiming light
WO2011041638A2 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with automatic safety shut-off feature
WO2011041635A2 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with inflatable member having multiple inflation settings
WO2011044248A2 (en) * 2009-10-06 2011-04-14 Cardiofocus, Inc. Cardiac ablation image analysis system and process

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US224929A (en) * 1880-02-24 Land-marker
US961738A (en) * 1910-02-12 1910-06-14 John H Stickel Combined check and gate valve.
US3821510A (en) * 1973-02-22 1974-06-28 H Muncheryan Hand held laser instrumentation device
US4336809A (en) * 1980-03-17 1982-06-29 Burleigh Instruments, Inc. Human and animal tissue photoradiation system and method
US4585298A (en) * 1982-08-26 1986-04-29 Kei Mori Photoradiator for radiating light
USRE34544E (en) * 1982-11-23 1994-02-15 The Beth Israel Hospital Association Method of treatment of artherosclerosis and balloon catheter the same
US4701166A (en) * 1983-05-03 1987-10-20 Catheter Technology Corp. Valved two-way catheter
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US4718417A (en) * 1985-03-22 1988-01-12 Massachusetts Institute Of Technology Visible fluorescence spectral diagnostic for laser angiosurgery
US5496305A (en) * 1985-03-22 1996-03-05 Massachusetts Institue Of Technology Catheter for laser angiosurgery
US4913142A (en) * 1985-03-22 1990-04-03 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US4660925A (en) * 1985-04-29 1987-04-28 Laser Therapeutics, Inc. Apparatus for producing a cylindrical pattern of light and method of manufacture
US4862886A (en) * 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4819632A (en) * 1986-05-19 1989-04-11 Davies David H Retrolasing catheter and method
US4860743A (en) * 1986-10-27 1989-08-29 University Of Florida Laser method and apparatus for the recanalization of vessels and the treatment of other cardiac conditions
US5090959A (en) * 1987-04-30 1992-02-25 Advanced Cardiovascular Systems, Inc. Imaging balloon dilatation catheter
US4852567A (en) * 1988-01-21 1989-08-01 C. R. Bard, Inc. Laser tipped catheter
US5026367A (en) * 1988-03-18 1991-06-25 Cardiovascular Laser Systems, Inc. Laser angioplasty catheter and a method for use thereof
US5125925A (en) * 1988-08-03 1992-06-30 Photoradiation Systems Intracavity laser catheter with sensing fiber
US5649923A (en) * 1988-10-24 1997-07-22 The General Hospital Corporation Catheter devices for delivering laser energy
US5140987A (en) * 1989-03-17 1992-08-25 Wayne State University Method for transvenous ablation of cardiac electrically conductive tissue by laser photocoagulation
US5209748A (en) * 1989-08-24 1993-05-11 S.L.T. Japan Co., Ltd. Laser light irradiation apparatus
US5151097A (en) * 1989-09-01 1992-09-29 S.L.T. Japan Co., Ltd. Laser light emitter
US5109859A (en) * 1989-10-04 1992-05-05 Beth Israel Hospital Association Ultrasound guided laser angioplasty
US5078681A (en) * 1989-10-23 1992-01-07 Olympus Optical Co., Ltd. Balloon catheter apparatus with releasable distal seal and method of operation
US5207699A (en) * 1989-10-30 1993-05-04 Coe Frederick L Lancet handling and disposal assembly
US5219346A (en) * 1990-01-09 1993-06-15 Ciba-Geigy Corporation Light diffuser for the photodynamic therapy of tumors in the oesophagus of a patient
US5133709A (en) * 1990-02-23 1992-07-28 Prince Martin R Optical fiber with atraumatic rounded end for use in laser angioplasty
US5725522A (en) * 1990-06-15 1998-03-10 Rare Earth Medical, Inc. Laser suturing of biological materials
US5188634A (en) * 1990-07-13 1993-02-23 Trimedyne, Inc. Rotatable laser probe with beveled tip
US5053033A (en) * 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5380316A (en) * 1990-12-18 1995-01-10 Advanced Cardiovascular Systems, Inc. Method for intra-operative myocardial device revascularization
US5401270A (en) * 1990-12-19 1995-03-28 Carl-Zeiss-Stiftung Applicator device for laser radiation
US5531664A (en) * 1990-12-26 1996-07-02 Olympus Optical Co., Ltd. Bending actuator having a coil sheath with a fixed distal end and a free proximal end
US5151096A (en) * 1991-03-28 1992-09-29 Angiolaz, Incorporated Laser catheter diffuser
US5242438A (en) * 1991-04-22 1993-09-07 Trimedyne, Inc. Method and apparatus for treating a body site with laterally directed laser radiation
US5190538A (en) * 1991-04-22 1993-03-02 Trimedyne, Inc. Method and apparatus for subjecting a body site to a movable beam of laterally directed laser radiation
US5330465A (en) * 1991-11-26 1994-07-19 Laser Therapeutics, Inc. Continuous gradient cylindrical diffusion tip for optical fibers and method for using
US5196005A (en) * 1991-11-26 1993-03-23 Pdt Systems, Inc. Continuous gradient cylindrical diffusion tip for optical fibers and method for making
US5437660A (en) * 1991-12-30 1995-08-01 Trimedyne, Inc. Tissue ablation and a lateral-lasing fiber optic device therefor
US5395362A (en) * 1992-01-14 1995-03-07 Summit Technology Methods and apparatus for distributing laser radiation
US5423805A (en) * 1992-02-05 1995-06-13 Angeion Corporation Laser catheter with moveable integral fixation wires
US5782899A (en) * 1992-06-05 1998-07-21 Cardiac Pathways Corporation Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5772590A (en) * 1992-06-30 1998-06-30 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5782239A (en) * 1992-06-30 1998-07-21 Cordis Webster, Inc. Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US6086581A (en) * 1992-09-29 2000-07-11 Ep Technologies, Inc. Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
US5507725A (en) * 1992-12-23 1996-04-16 Angeion Corporation Steerable catheter
US5482037A (en) * 1993-01-18 1996-01-09 X-Trode S.R.L. Electrode catheter for mapping and operating on cardiac cavities
US5417653A (en) * 1993-01-21 1995-05-23 Sahota; Harvinder Method for minimizing restenosis
US5337381A (en) * 1993-01-21 1994-08-09 Fiberguide Industries Fiber optic cylindrical diffuser
US5409483A (en) * 1993-01-22 1995-04-25 Jeffrey H. Reese Direct visualization surgical probe
US5350375A (en) * 1993-03-15 1994-09-27 Yale University Methods for laser induced fluorescence intensity feedback control during laser angioplasty
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5807395A (en) * 1993-08-27 1998-09-15 Medtronic, Inc. Method and apparatus for RF ablation and hyperthermia
US5497774A (en) * 1993-11-03 1996-03-12 Daig Corporation Guiding introducer for left atrium
US5427119A (en) * 1993-11-03 1995-06-27 Daig Corporation Guiding introducer for right atrium
US5536265A (en) * 1994-03-25 1996-07-16 Ciba-Geigy Corporation Light diffuser and process for the manufacturing of a light diffuser
US5680860A (en) * 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US6090084A (en) * 1994-07-08 2000-07-18 Daig Corporation Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia
US5431647A (en) * 1994-07-13 1995-07-11 Pioneer Optics Company Fiberoptic cylindrical diffuser
US5441497A (en) * 1994-07-14 1995-08-15 Pdt Cardiovascular, Inc. Light diffusing guidewire
US5908415A (en) * 1994-09-09 1999-06-01 Rare Earth Medical, Inc. Phototherapy methods and apparatus
US6214002B1 (en) * 1994-10-07 2001-04-10 Ep Technologies, Inc. Structures and methods for deploying electrode elements
US5885278A (en) * 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US5722401A (en) * 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US5613965A (en) * 1994-12-08 1997-03-25 Summit Technology Inc. Corneal reprofiling using an annular beam of ablative radiation
US5779646A (en) * 1995-02-28 1998-07-14 E.P. Technologies Inc. Deflectable biopsy catheter
US5643253A (en) * 1995-06-06 1997-07-01 Rare Earth Medical, Inc. Phototherapy apparatus with integral stopper device
US5824005A (en) * 1995-08-22 1998-10-20 Board Of Regents, The University Of Texas System Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US5823955A (en) * 1995-11-20 1998-10-20 Medtronic Cardiorhythm Atrioventricular valve tissue ablation catheter and method
US5759619A (en) * 1995-12-29 1998-06-02 Lg Electronics Inc. Method of manufacturing second harmonic generation device
US6179835B1 (en) * 1996-01-19 2001-01-30 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US5769843A (en) * 1996-02-20 1998-06-23 Cormedica Percutaneous endomyocardial revascularization
US5800482A (en) * 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US5891133A (en) * 1996-03-29 1999-04-06 Eclipse Surgical Technologies, Inc. Apparatus for laser-assisted intra-coronary transmyocardial revascularization and other applications
US5891134A (en) * 1996-09-24 1999-04-06 Goble; Colin System and method for applying thermal energy to tissue
US5931834A (en) * 1996-10-15 1999-08-03 Eclipse Surgical Technologies, Inc. Method for non-synchronous laser-assisted myocardial revascularization
US6237605B1 (en) * 1996-10-22 2001-05-29 Epicor, Inc. Methods of epicardial ablation
US5904651A (en) * 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6254599B1 (en) * 1997-05-09 2001-07-03 Atrionix, Inc. Circumferential ablation device assembly
US6416511B1 (en) * 1997-05-09 2002-07-09 The Regents Of The University Of California Circumferential ablation device assembly
US20090221996A1 (en) * 1997-05-09 2009-09-03 The Regents Of The University Of California Circumferential ablation device assembly
US6251109B1 (en) * 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5938660A (en) * 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6514249B1 (en) * 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6245064B1 (en) * 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6383151B1 (en) * 1997-07-08 2002-05-07 Chris J. Diederich Circumferential ablation device assembly
US6117101A (en) * 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6502576B1 (en) * 1997-07-08 2003-01-07 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6071302A (en) * 1997-12-31 2000-06-06 Cardiofocus, Inc. Phototherapeutic apparatus for wide-angle diffusion
US6064902A (en) * 1998-04-16 2000-05-16 C.R. Bard, Inc. Pulmonary vein ablation catheter
US6120496A (en) * 1998-05-05 2000-09-19 Scimed Life Systems, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and coupling device for use with same
US6071281A (en) * 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6423055B1 (en) * 1999-07-14 2002-07-23 Cardiofocus, Inc. Phototherapeutic wave guide apparatus
US20020107511A1 (en) * 2000-05-03 2002-08-08 Collins Russell F. Apparatus and methods for mapping and ablation in electrophysiology procedures
US20020065512A1 (en) * 2000-07-13 2002-05-30 Todd Fjield Thermal treatment methods and apparatus with focused energy application

Cited By (245)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444639B2 (en) 1994-09-09 2013-05-21 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US8241272B2 (en) 1994-09-09 2012-08-14 Cardiofocus, Inc. Methods for ablation with radiant energy
US8277444B2 (en) 1994-09-09 2012-10-02 Cardiofocus, Inc. Treatment of atrial fibrillation by overlapping curvilinear lesions
US20060253113A1 (en) * 1994-09-09 2006-11-09 Cardiofocus, Inc. Methods for ablation with radiant energy
US8366705B2 (en) 1994-09-09 2013-02-05 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US20090221997A1 (en) * 1994-09-09 2009-09-03 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US8267932B2 (en) 1999-07-14 2012-09-18 Cardiofocus, Inc. Deflectable sheath catheters
US20080195088A1 (en) * 1999-07-14 2008-08-14 Cardiofocus, Inc. Method and device for cardiac tissue ablation
US20050065504A1 (en) * 1999-07-14 2005-03-24 Gerald Melsky Guided cardiac ablation catheters
US8540704B2 (en) 1999-07-14 2013-09-24 Cardiofocus, Inc. Guided cardiac ablation catheters
US9033961B2 (en) 1999-07-14 2015-05-19 Cardiofocus, Inc. Cardiac ablation catheters for forming overlapping lesions
US9421066B2 (en) 1999-07-14 2016-08-23 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US9861437B2 (en) 1999-07-14 2018-01-09 Cardiofocus, Inc. Guided cardiac ablation catheters
US7935108B2 (en) 1999-07-14 2011-05-03 Cardiofocus, Inc. Deflectable sheath catheters
US20090299354A1 (en) * 1999-07-14 2009-12-03 Cardiofocus, Inc. Cardiac ablation catheters for forming overlapping lesions
US8152795B2 (en) 1999-07-14 2012-04-10 Cardiofocus, Inc. Method and device for cardiac tissue ablation
US8231613B2 (en) 1999-07-14 2012-07-31 Cardiofocus, Inc. Deflectable sheath catheters
US20090326320A1 (en) * 1999-07-14 2009-12-31 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US20050222557A1 (en) * 1999-07-14 2005-10-06 Cardiofocus, Inc. Deflectable sheath catheters
US8900219B2 (en) 1999-07-14 2014-12-02 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US20070055223A1 (en) * 2003-02-04 2007-03-08 Cardiodex, Ltd. Methods and apparatus for hemostasis following arterial catheterization
US8372072B2 (en) 2003-02-04 2013-02-12 Cardiodex Ltd. Methods and apparatus for hemostasis following arterial catheterization
US20080269846A1 (en) * 2003-03-14 2008-10-30 Light Sciences Oncology, Inc. Device for treatment of blood vessels using light
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
US7730894B2 (en) 2003-03-14 2010-06-08 Light Sciences Oncology, Inc. Photodynamic therapy apparatus and method for vascular tissue treatment
US20100274330A1 (en) * 2003-03-14 2010-10-28 Light Sciences Oncology, Inc. Device for treatment of blood vessels using light
US20080033519A1 (en) * 2003-03-14 2008-02-07 Light Sciences Oncology, Inc. Light generating device for intravascular use
US20080027517A1 (en) * 2003-03-14 2008-01-31 Light Sciences Oncology, Inc. Light generating device for intravascular use
US8298223B2 (en) 2003-05-01 2012-10-30 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US20080167643A1 (en) * 2004-11-22 2008-07-10 Cardiodex Ltd. Techniques for Heating-Treating Varicose Veins
US8435236B2 (en) 2004-11-22 2013-05-07 Cardiodex, Ltd. Techniques for heat-treating varicose veins
US7860556B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue imaging and extraction systems
US20110060298A1 (en) * 2005-02-02 2011-03-10 Voyage Medical, Inc. Tissue imaging and extraction systems
US7918787B2 (en) 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US8934962B2 (en) 2005-02-02 2015-01-13 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US9332893B2 (en) 2005-02-02 2016-05-10 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US20080015445A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Tissue visualization device and method variations
US9526401B2 (en) 2005-02-02 2016-12-27 Intuitive Surgical Operations, Inc. Flow reduction hood systems
US8419613B2 (en) 2005-02-02 2013-04-16 Voyage Medical, Inc. Tissue visualization device
US8417321B2 (en) 2005-02-02 2013-04-09 Voyage Medical, Inc Flow reduction hood systems
US20070167828A1 (en) * 2005-02-02 2007-07-19 Vahid Saadat Tissue imaging system variations
US20090054803A1 (en) * 2005-02-02 2009-02-26 Vahid Saadat Electrophysiology mapping and visualization system
US11889982B2 (en) 2005-02-02 2024-02-06 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US10064540B2 (en) 2005-02-02 2018-09-04 Intuitive Surgical Operations, Inc. Visualization apparatus for transseptal access
US10278588B2 (en) 2005-02-02 2019-05-07 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US7860555B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue visualization and manipulation system
US20070293724A1 (en) * 2005-02-02 2007-12-20 Voyage Medical, Inc. Visualization apparatus for transseptal access
US10368729B2 (en) 2005-02-02 2019-08-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US10463237B2 (en) 2005-02-02 2019-11-05 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US8814845B2 (en) 2005-02-02 2014-08-26 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US10772492B2 (en) 2005-02-02 2020-09-15 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US11406250B2 (en) 2005-02-02 2022-08-09 Intuitive Surgical Operations, Inc. Methods and apparatus for treatment of atrial fibrillation
US20110060227A1 (en) * 2005-02-02 2011-03-10 Voyage Medical, Inc. Tissue visualization and manipulation system
US8050746B2 (en) 2005-02-02 2011-11-01 Voyage Medical, Inc. Tissue visualization device and method variations
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US11819190B2 (en) 2005-02-02 2023-11-21 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US20080015569A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Methods and apparatus for treatment of atrial fibrillation
US8123741B2 (en) 2005-03-17 2012-02-28 Boston Scientific Scimed, Inc. Treating internal body tissue
US7674256B2 (en) 2005-03-17 2010-03-09 Boston Scientific Scimed, Inc. Treating internal body tissue
US20060212027A1 (en) * 2005-03-17 2006-09-21 Nassir Marrouche Treating internal body tissue
US20090209951A1 (en) * 2005-03-17 2009-08-20 Boston Scientific Scimed, Inc. Treating Internal Body Tissue
US20110015622A1 (en) * 2005-08-26 2011-01-20 Joe Denton Brown Endovascular method and apparatus with feedback
US20070049911A1 (en) * 2005-08-26 2007-03-01 Brown Joe D Endovascular method and apparatus with feedback
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US9510732B2 (en) 2005-10-25 2016-12-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US8137333B2 (en) 2005-10-25 2012-03-20 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US9192287B2 (en) 2005-10-25 2015-11-24 Intuitive Surgical Operations, Inc. Tissue visualization device and method variations
US20100010311A1 (en) * 2005-10-25 2010-01-14 Voyage Medical, Inc. Methods and apparatus for efficient purging
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US20080058591A1 (en) * 2005-10-25 2008-03-06 Voyage Medical, Inc. Tissue visualization device and method variations
US10307610B2 (en) 2006-01-18 2019-06-04 Light Sciences Oncology Inc. Method and apparatus for light-activated drug therapy
US9055906B2 (en) 2006-06-14 2015-06-16 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US10470643B2 (en) 2006-06-14 2019-11-12 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US20100292558A1 (en) * 2006-06-14 2010-11-18 Voyage Medical, Inc. In-vivo visualization systems
US11882996B2 (en) 2006-06-14 2024-01-30 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US20080033241A1 (en) * 2006-08-01 2008-02-07 Ruey-Feng Peh Left atrial appendage closure
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US10070772B2 (en) 2006-09-01 2018-09-11 Intuitive Surgical Operations, Inc. Precision control systems for tissue visualization and manipulation assemblies
US20090221871A1 (en) * 2006-09-01 2009-09-03 Voyage Medical, Inc. Precision control systems for tissue visualization and manipulation assemblies
US11337594B2 (en) 2006-09-01 2022-05-24 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US11779195B2 (en) 2006-09-01 2023-10-10 Intuitive Surgical Operations, Inc. Precision control systems for tissue visualization and manipulation assemblies
US20080064969A1 (en) * 2006-09-11 2008-03-13 Nathan Kastelein Automated Mapping of Anatomical Features of Heart Chambers
US7537570B2 (en) * 2006-09-11 2009-05-26 Stereotaxis, Inc. Automated mapping of anatomical features of heart chambers
US20110054488A1 (en) * 2006-10-18 2011-03-03 Gruber William H Systems and methods for preventing intravasation during intrauterine procedures
US8834487B2 (en) * 2006-10-18 2014-09-16 Hologic, Inc. Systems and methods for preventing intravasation during intrauterine procedures
US11369356B2 (en) 2006-10-23 2022-06-28 Intuitive Surgical Operations, Inc. Methods and apparatus for preventing tissue migration
US10335131B2 (en) 2006-10-23 2019-07-02 Intuitive Surgical Operations, Inc. Methods for preventing tissue migration
US10441136B2 (en) 2006-12-18 2019-10-15 Intuitive Surgical Operations, Inc. Systems and methods for unobstructed visualization and ablation
US20080183036A1 (en) * 2006-12-18 2008-07-31 Voyage Medical, Inc. Systems and methods for unobstructed visualization and ablation
US8131350B2 (en) 2006-12-21 2012-03-06 Voyage Medical, Inc. Stabilization of visualization catheters
US20090275842A1 (en) * 2006-12-21 2009-11-05 Vahid Saadat Stabilization of visualization catheters
US11559188B2 (en) 2006-12-21 2023-01-24 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US20090299363A1 (en) * 2006-12-21 2009-12-03 Vahid Saadat Off-axis visualization systems
US8758229B2 (en) 2006-12-21 2014-06-24 Intuitive Surgical Operations, Inc. Axial visualization systems
US9226648B2 (en) 2006-12-21 2016-01-05 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US10390685B2 (en) 2006-12-21 2019-08-27 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US9289226B2 (en) 2006-12-22 2016-03-22 The Spectranetics Corporation Retractable separating systems and methods
US9801650B2 (en) 2006-12-22 2017-10-31 The Spectranetics Corporation Tissue separating systems and methods
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US10537354B2 (en) 2006-12-22 2020-01-21 The Spectranetics Corporation Retractable separating systems and methods
US9808275B2 (en) 2006-12-22 2017-11-07 The Spectranetics Corporation Retractable separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US20080154296A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Tissue Separating Systems and Methods
US10869687B2 (en) 2006-12-22 2020-12-22 Spectranetics Llc Tissue separating systems and methods
US20080154293A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Retractable Separating Systems and Methods
US20080275300A1 (en) * 2007-04-27 2008-11-06 Voyage Medical, Inc. Complex shape steerable tissue visualization and manipulation catheter
US9155452B2 (en) 2007-04-27 2015-10-13 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US10092172B2 (en) 2007-05-08 2018-10-09 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US20090030412A1 (en) * 2007-05-11 2009-01-29 Willis N Parker Visual electrode ablation systems
US9155587B2 (en) 2007-05-11 2015-10-13 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US8709008B2 (en) 2007-05-11 2014-04-29 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US10624695B2 (en) 2007-05-11 2020-04-21 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US9861424B2 (en) 2007-07-11 2018-01-09 Covidien Lp Measurement and control systems and methods for electrosurgical procedures
US20090030276A1 (en) * 2007-07-27 2009-01-29 Voyage Medical, Inc. Tissue visualization catheter with imaging systems integration
US8152800B2 (en) 2007-07-30 2012-04-10 Vivant Medical, Inc. Electrosurgical systems and printed circuit boards for use therewith
US9190704B2 (en) 2007-07-30 2015-11-17 Covidien Lp Electrosurgical systems and printed circuit boards for use therewith
US20090125056A1 (en) * 2007-08-15 2009-05-14 Cardiodex Ltd. Systems and methods for puncture closure
US8366706B2 (en) 2007-08-15 2013-02-05 Cardiodex, Ltd. Systems and methods for puncture closure
US20090062790A1 (en) * 2007-08-31 2009-03-05 Voyage Medical, Inc. Direct visualization bipolar ablation systems
US20090076498A1 (en) * 2007-08-31 2009-03-19 Voyage Medical, Inc. Visualization and ablation system variations
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US7645142B2 (en) 2007-09-05 2010-01-12 Vivant Medical, Inc. Electrical receptacle assembly
US20090061681A1 (en) * 2007-09-05 2009-03-05 Mcmunigal Tom Electrical receptacle assembly
US8747398B2 (en) 2007-09-13 2014-06-10 Covidien Lp Frequency tuning in a microwave electrosurgical system
US9498285B2 (en) 2007-09-13 2016-11-22 Covidien Lp Impedance matching in a microwave electrosurgical system
US20090125022A1 (en) * 2007-11-12 2009-05-14 Voyage Medical, Inc. Tissue visualization and ablation systems
US20090143640A1 (en) * 2007-11-26 2009-06-04 Voyage Medical, Inc. Combination imaging and treatment assemblies
US20090152990A1 (en) * 2007-12-07 2009-06-18 Veryst Engineering Llc Apparatus for in vivo energy harvesting
US8217523B2 (en) * 2007-12-07 2012-07-10 Veryst Engineering Llc Apparatus for in vivo energy harvesting
US20090177191A1 (en) * 2007-12-11 2009-07-09 Brown Joe D Laser surgery methods and apparatus
US20090203962A1 (en) * 2008-02-07 2009-08-13 Voyage Medical, Inc. Stent delivery under direct visualization
US8858609B2 (en) 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US10278849B2 (en) 2008-02-07 2019-05-07 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US11241325B2 (en) 2008-02-07 2022-02-08 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US8892182B2 (en) * 2008-02-08 2014-11-18 Ethicon, Inc. Double balloon isolation catheters and methods therefor
US20090203995A1 (en) * 2008-02-08 2009-08-13 Ethicon, Inc. Double balloon isolation catheters and methods therefor
US9949794B2 (en) 2008-03-27 2018-04-24 Covidien Lp Microwave ablation devices including expandable antennas and methods of use
US20130289547A1 (en) * 2008-04-25 2013-10-31 Tobias Beck Light-Based Method for the Endovascular Treatment of Pathologically Altered Blood Vessels
US9168098B2 (en) * 2008-04-25 2015-10-27 Dornier Medtech Laser Gmbh Light-based method for the endovascular treatment of pathologically altered blood vessels
US20110125140A1 (en) * 2008-04-25 2011-05-26 Domier MedTech Laser GmbH Light-Based Method for the Endovascular Treatment of Pathologically Altered Blood Vessels
US9149334B2 (en) * 2008-04-25 2015-10-06 Dornier Medtech Laser Gmbh Light-based method for the endovascular treatment of pathologically altered blood vessels
US20090326572A1 (en) * 2008-06-27 2009-12-31 Ruey-Feng Peh Apparatus and methods for rapid tissue crossing
US20100004646A1 (en) * 2008-07-02 2010-01-07 Joe Denton Brown Laser delivery apparatus for endovascular applications
US9345543B2 (en) 2008-07-02 2016-05-24 Joe Denton Brown Laser delivery apparatus for endovascular applications
US9101735B2 (en) 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US20100004633A1 (en) * 2008-07-07 2010-01-07 Voyage Medical, Inc. Catheter control systems
US11350815B2 (en) 2008-07-07 2022-06-07 Intuitive Surgical Operations, Inc. Catheter control systems
WO2010018569A1 (en) * 2008-08-11 2010-02-18 Cardionova Ltd. Method and apparatus for intra-atrial ablation
US8333012B2 (en) 2008-10-10 2012-12-18 Voyage Medical, Inc. Method of forming electrode placement and connection systems
US10111705B2 (en) 2008-10-10 2018-10-30 Intuitive Surgical Operations, Inc. Integral electrode placement and connection systems
US9259270B2 (en) 2008-11-07 2016-02-16 Joe Denton Brown Apparatus and method for detecting overheating during laser surgery
US20110213349A1 (en) * 2008-11-07 2011-09-01 Joe Denton Brown Apparatus and method for detecting overheating during laser surgery
US9468364B2 (en) 2008-11-14 2016-10-18 Intuitive Surgical Operations, Inc. Intravascular catheter with hood and image processing systems
US11622689B2 (en) 2008-11-14 2023-04-11 Intuitive Surgical Operations, Inc. Mapping and real-time imaging a plurality of ablation lesions with registered ablation parameters received from treatment device
US20100130836A1 (en) * 2008-11-14 2010-05-27 Voyage Medical, Inc. Image processing systems
US20100256629A1 (en) * 2009-04-06 2010-10-07 Voyage Medical, Inc. Methods and devices for treatment of the ostium
US8886290B2 (en) 2009-04-08 2014-11-11 Covidien Lp Method and system for determining placement of a tracheal tube in a subject
US20100261996A1 (en) * 2009-04-08 2010-10-14 Nellcor Puritan Bennett Llc Medical device and technique for using same
US8280489B2 (en) * 2009-04-08 2012-10-02 Nellcor Puritan Bennett Llc Method and system for determining placement of a tracheal tube in a subject
US8457715B2 (en) * 2009-04-08 2013-06-04 Covidien Lp System and method for determining placement of a tracheal tube
US20100261995A1 (en) * 2009-04-08 2010-10-14 Nellcor Puritan Bennett Llc Medical device and technique for using the same
US20100280362A1 (en) * 2009-05-04 2010-11-04 Nellcor Puritan Bennett Llc Time of flight based tracheal tube placement system and method
US8457716B2 (en) * 2009-05-04 2013-06-04 Covidien Lp Time of flight based tracheal tube placement system and method
US9625395B2 (en) 2009-06-19 2017-04-18 Covidien Lp Microwave ablation antenna radiation detector
US8552915B2 (en) * 2009-06-19 2013-10-08 Covidien Lp Microwave ablation antenna radiation detector
US20100321192A1 (en) * 2009-06-19 2010-12-23 Vivant Medical, Inc. Microwave Ablation Antenna Radiation Detector
US20110213241A1 (en) * 2009-06-19 2011-09-01 Vivant Medical, Inc. Laparoscopic Port with Microwave Rectifier
US8847830B2 (en) 2009-06-19 2014-09-30 Covidien Lp Microwave ablation antenna radiation detector
US8323275B2 (en) * 2009-06-19 2012-12-04 Vivant Medical, Inc. Laparoscopic port with microwave rectifier
US8343145B2 (en) 2009-09-28 2013-01-01 Vivant Medical, Inc. Microwave surface ablation using conical probe
US20110077634A1 (en) * 2009-09-28 2011-03-31 Vivant Medical, Inc. Microwave Surface Ablation Using Conical Probe
US20110082450A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with inflatable member having multiple inflation settings
US20110082452A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with automatic safety shut-off feature
US20110082449A1 (en) * 2009-10-02 2011-04-07 Cardiofocus, Inc. Cardiac ablation system with pulsed aiming light
US8696653B2 (en) 2009-10-02 2014-04-15 Cardiofocus, Inc. Cardiac ablation system with pulsed aiming light
US8702688B2 (en) 2009-10-06 2014-04-22 Cardiofocus, Inc. Cardiac ablation image analysis system and process
US20110082451A1 (en) * 2009-10-06 2011-04-07 Cardiofocus, Inc. Cardiac ablation image analysis system and process
US8694071B2 (en) 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
US20110238048A1 (en) * 2010-03-23 2011-09-29 Joe Denton Brown Laser surgery controller with variable time delay and feedback detector sensitivity control
US9314303B2 (en) 2010-03-23 2016-04-19 Joe Denton Brown Laser surgery controller with variable time delay and feedback detector sensitivity control
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
US8638428B2 (en) 2010-06-01 2014-01-28 Joe Denton Brown Method and apparatus for using optical feedback to detect fiber breakdown during surgical laser procedures
AU2011202359B2 (en) * 2010-06-16 2016-03-17 Biosense Webster (Israel) Ltd. Optical contact sensing in medical probes
US10314650B2 (en) 2010-06-16 2019-06-11 Biosense Webster (Israel) Ltd. Spectral sensing of ablation
US11490957B2 (en) 2010-06-16 2022-11-08 Biosense Webster (Israel) Ltd. Spectral sensing of ablation
US9943360B2 (en) 2011-01-30 2018-04-17 University Health Network Coil electrode for thermal therapy
US9492190B2 (en) 2011-02-09 2016-11-15 Covidien Lp Tissue dissectors
US9526856B2 (en) 2011-12-15 2016-12-27 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for preventing tracheal aspiration
US10271902B2 (en) 2012-01-06 2019-04-30 Covidien Lp System and method for treating tissue using an expandable antenna
US9693823B2 (en) 2012-01-06 2017-07-04 Covidien Lp System and method for treating tissue using an expandable antenna
US9681916B2 (en) 2012-01-06 2017-06-20 Covidien Lp System and method for treating tissue using an expandable antenna
US11596435B2 (en) 2012-09-14 2023-03-07 Specrtranetics Llc Tissue slitting methods and systems
US9763692B2 (en) 2012-09-14 2017-09-19 The Spectranetics Corporation Tissue slitting methods and systems
US10531891B2 (en) 2012-09-14 2020-01-14 The Spectranetics Corporation Tissue slitting methods and systems
US9724122B2 (en) 2012-09-14 2017-08-08 The Spectranetics Corporation Expandable lead jacket
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
US10213257B2 (en) 2012-10-02 2019-02-26 Covidien Lp Devices and methods for optical detection of tissue contact
US9668802B2 (en) 2012-10-02 2017-06-06 Covidien Lp Devices and methods for optical detection of tissue contact
US9522033B2 (en) 2012-10-02 2016-12-20 Covidien Lp Devices and methods for optical detection of tissue contact
US10080603B2 (en) 2012-10-02 2018-09-25 Covidien Lp Devices and methods for optical detection of tissue contact
US10485613B2 (en) 2013-03-13 2019-11-26 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US10265520B2 (en) 2013-03-13 2019-04-23 The Spetranetics Corporation Alarm for lead insulation abnormality
US9937005B2 (en) 2013-03-13 2018-04-10 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9925371B2 (en) 2013-03-13 2018-03-27 The Spectranetics Corporation Alarm for lead insulation abnormality
US10799293B2 (en) 2013-03-13 2020-10-13 The Spectranetics Corporation Laser ablation catheter
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US11160579B2 (en) 2013-03-15 2021-11-02 Spectranetics Llc Multiple configuration surgical cutting device
US10524817B2 (en) 2013-03-15 2020-01-07 The Spectranetics Corporation Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US10052129B2 (en) 2013-03-15 2018-08-21 The Spectranetics Corporation Medical device for removing an implanted object
US9918737B2 (en) 2013-03-15 2018-03-20 The Spectranetics Corporation Medical device for removing an implanted object
US10314615B2 (en) 2013-03-15 2019-06-11 The Spectranetics Corporation Medical device for removing an implanted object
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10849603B2 (en) 2013-03-15 2020-12-01 Spectranetics Llc Surgical instrument for removing an implanted object
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10219819B2 (en) 2013-03-15 2019-03-05 The Spectranetics Corporation Retractable blade for lead removal device
US9956399B2 (en) 2013-03-15 2018-05-01 The Spectranetics Corporation Medical device for removing an implanted object
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9770194B2 (en) 2013-11-05 2017-09-26 Ciel Medical, Inc. Devices and methods for airway measurement
US11246476B2 (en) 2014-04-28 2022-02-15 Cardiofocus, Inc. Method for visualizing tissue with an ICG dye composition during ablation procedures
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10154888B2 (en) 2014-12-03 2018-12-18 Cardiofocus, Inc. System and method for visual confirmation of pulmonary vein isolation during abalation procedures
USD806245S1 (en) 2015-02-20 2017-12-26 The Spectranetics Corporation Medical device handle
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
USD854682S1 (en) 2015-02-20 2019-07-23 The Spectranetics Corporation Medical device handle
USD819204S1 (en) 2015-02-20 2018-05-29 The Spectranetics Corporation Medical device handle
US11344365B2 (en) 2016-01-05 2022-05-31 Cardiofocus, Inc. Ablation system with automated sweeping ablation energy element
US11832878B2 (en) 2016-01-05 2023-12-05 Cardiofocus, Inc. Ablation system with automated ablation energy element
USD851245S1 (en) 2017-04-14 2019-06-11 Cardiofocus, Inc. Compliant balloon
US11389236B2 (en) 2018-01-15 2022-07-19 Cardiofocus, Inc. Ablation system with automated ablation energy element
US11925380B2 (en) 2020-11-17 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
US11925334B2 (en) 2020-11-30 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object

Also Published As

Publication number Publication date
JP4732330B2 (en) 2011-07-27
AU2004208838A2 (en) 2004-08-19
US20040006333A1 (en) 2004-01-08
US20090221997A1 (en) 2009-09-03
US20060253113A1 (en) 2006-11-09
AU2004208838A1 (en) 2004-08-19
US8444639B2 (en) 2013-05-21
US8277444B2 (en) 2012-10-02
US8025661B2 (en) 2011-09-27
EP1592358A2 (en) 2005-11-09
CA2515029A1 (en) 2004-08-19
WO2004069072A3 (en) 2004-10-07
US20120116353A1 (en) 2012-05-10
US8366705B2 (en) 2013-02-05
US8241272B2 (en) 2012-08-14
US20070078451A1 (en) 2007-04-05
WO2004069072A2 (en) 2004-08-19
JP2006516465A (en) 2006-07-06

Similar Documents

Publication Publication Date Title
US8025661B2 (en) Coaxial catheter instruments for ablation with radiant energy
US9861437B2 (en) Guided cardiac ablation catheters
US9033961B2 (en) Cardiac ablation catheters for forming overlapping lesions
US8696653B2 (en) Cardiac ablation system with pulsed aiming light
US8231613B2 (en) Deflectable sheath catheters
EP1866019B1 (en) Deflectable sheath catheters
US20110082450A1 (en) Cardiac ablation system with inflatable member having multiple inflation settings
US20130289358A1 (en) Cardiac ablation system with automatic safety shut-off feature
US20050234437A1 (en) Deflectable sheath catheters with out-of-plane bent tip
US20050222558A1 (en) Methods of cardiac ablation employing a deflectable sheath catheter
US20050234436A1 (en) Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
WO2004110258A2 (en) Guided cardiac ablation catheters

Legal Events

Date Code Title Description
AS Assignment

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ARNOLD, JEFFREY M.;SINOFSKY, EDWARD L.;BAXTER, LINCOLN S.;AND OTHERS;REEL/FRAME:014302/0237;SIGNING DATES FROM 20030609 TO 20030626

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ARNOLD, JEFFREY M.;SINOFSKY, EDWARD L.;BAXTER, LINCOLN S.;AND OTHERS;SIGNING DATES FROM 20030609 TO 20030626;REEL/FRAME:014302/0237

AS Assignment

Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:016547/0536

Effective date: 20050415

ZAAA Notice of allowance and fees due

Free format text: ORIGINAL CODE: NOA

ZAAB Notice of allowance mailed

Free format text: ORIGINAL CODE: MN/=.

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:VENTURE LENDING & LEASING IV, INC.;REEL/FRAME:033275/0601

Effective date: 20061109

AS Assignment

Owner name: SILICON VALLEY BANK, MASSACHUSETTS

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:033434/0399

Effective date: 20140730

Owner name: OXFORD FINANCE LLC, VIRGINIA

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:033434/0399

Effective date: 20140730

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: OXFORD FINANCE LLC, VIRGINIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:035497/0393

Effective date: 20150424

Owner name: SILICON VALLEY BANK, MASSACHUSETTS

Free format text: SECURITY AGREEMENT;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:035497/0393

Effective date: 20150424

AS Assignment

Owner name: SOLAR CAPITAL LTD., NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:041805/0976

Effective date: 20170331

Owner name: SILICON VALLEY BANK, MASSACHUSETTS

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:041805/0976

Effective date: 20170331

AS Assignment

Owner name: GPB DEBT HOLDINGS II LLC, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:045478/0532

Effective date: 20180404

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8

AS Assignment

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:SILICON VALLEY BANK;OXFORD FINANCE LLC;REEL/FRAME:049133/0474

Effective date: 20190509

AS Assignment

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:SILICON VALLEY BANK;SOLAR CAPITAL LTD.;REEL/FRAME:049138/0362

Effective date: 20190509

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:SILICON VALLEY BANK;OXFORD FINANCE LLC;REEL/FRAME:049138/0233

Effective date: 20190509

Owner name: KENNEDY LEWIS INVESTMENT MANAGEMENT LLC, NEW YORK

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:CARDIOFOCUS, INC.;REEL/FRAME:049149/0356

Effective date: 20190510

AS Assignment

Owner name: CARDIOFOCUS, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GPB DEBT HOLDINGS II, LLC;REEL/FRAME:049200/0597

Effective date: 20190510

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20230927